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Abstract 
The effect of parasite antigen on experimentally induced ‘asthma’ in lambs 
by 
Omega Yaw Amoafo 
 
There is a worldwide consensus that the incidence of asthma and allergy is exhibiting a 
rising trend in western societies. There is also epidemiological evidence that New 
Zealand children raised on farms are less likely to experience asthma than those in 
urban environments.  
The aims of this study were to firstly set up a sheep model for the study of asthma and 
secondly, examine the effect of intrauterine and neonatal inoculation of an asthma-
causing allergen [house dust mite (HDM) - Dermatophagoides pteronyssinus] or 
helminth antigen [Trichostrongylus colubriformis L3 (TCL3)] on the development of 
experimentally induced ‘asthma’ in sheep. Feti or neonates of twin-bearing ewes (n=22) 
were treated with TCL3, HDM or PBS (control) given by lavage following 
hysterectomy (prenatal).  
At ten months of age, these lambs with additional control lambs (n=6) were sensitized 
by the subcutaneous inoculation of HDM and later challenged intra-bronchially with 
HDM, using a fibre-optic bronchoscope. At birth, lambs treated in utero with HDM 
antigen had the highest levels of HDM-specific IgE compared with lambs treated 
prenatally with TCL3 or PBS. HDM-specific IgE levels for the different treatment 
groups decreased significantly over the 4 week postnatal period but not their HDM-
specific IgG1.Twin lambs (control and treated) showed similar levels of specific–HDM 
antibody after suckling from the same ewe. At 10 months of age following sensitization 
and challenge, there were no significant differences among white blood cells of the 
peripheral blood but cytology of bronchoaveolar lavage fluid following challenge 
showed that treatment with HDM antigen had a significant (P=0.003) effect on 
increasing lymphocyte percentage in the left lung of the experimental sheep but not in 
the right (PBS treated) lung.  
  iii 
The atopic TCL3 and PNTCL3 sheep had significantly less eosinophils (P=0.05) in the 
left (treated) lung compared with the right (control) lung BAL, 24 h and 48 h after 
challenge. The atopic sheep from the other groups did not show any significant 
differences between their left and right lungs. Gross pathology of the sheep lung 
showed hepatisation of both treated and control lungs of the sheep with a trend for the 
animals treated prenatally (with either TCL3 or HDM, or their controls) to have less 
extensive lung changes. Histological examination indicated that prenatal (TCL3) or 
neonatal (PNTCL3) exposure to helminth antigen compared with HDM and control 
resulted in less inflammation of the lung tissue after sensitization and challenge with 
HDM antigen.  
This study showed that research sheep can be used as a model for asthma studies and 
that exposure of lambs to a helminth antigen in utero or as neonates suppress 
inflammatory responses to asthma-causing allergen in the lungs, later in life. 
Keywords: Dermatophagoides pteronyssinus; Trichostrongylus colubriformis; antigen; 
antibody; feti; cross-reaction; allergy; allergen; hygiene hypothesis; in utero; post natal; 
prenatal; neonatal; intrauterine; HDM-challenge; HDM-specific; sensitization; 
challenge; intra-bronchial; bronchoaveolar lavage; bronchoscopy; hepatisation; atopy, 
responder; leucocyte. 
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Chapter 1 
Introduction 
Asthma is a chronic respiratory disease of humans characterized by variable and 
reversible obstruction, eosinophilic airway and bronchial hypersensitivity causing 
narrowing of airways. Asthma attacks can vary from mild to life threatening and 
involve shortness of breath, coughing, wheezing, chest pain or tightness, or a 
combination of these symptoms. Many factors can trigger an asthma attack, including 
allergens, infections, exercise, abrupt changes in the weather, or exposure to airway 
irritants, such as plant pollens, household dust, tobacco smoke and other environmental 
pollutants (Kay et al., 2004; Lemanske & Busse, 2006). 
In recent times, not only has the prevalence of asthma been noted to increase 
worldwide, but so has its severity (Pearce et al., 1998). Currently, reports are emerging, 
showing decrease or stabilisation in asthma prevalence (Hertzen & Haahtela, 2005; 
Pearce et al., 2007a; Solé et al., 2007). In 1991, an initiative proposed at a meeting of 
asthma researchers held in Bochum, Germany to conduct an international study to 
monitor time trends and determinants of the prevalence of asthma and allergies in 
children, resulted in the creation of an international collaborative body for the study and 
monitoring of asthma. The body, known as ISAAC (International Study of Asthma and 
Allergic Diseases in Children) has coordinated the largest worldwide collaborative 
research project ever undertaken on asthma (Beasley, 1998). Phase I of this study 
maximized the value of epidemiological research into asthma and allergic disease, by 
establishing a standardized methodology and facilitating international collaboration. 
(Asher et al., 1995). This phase of the study involved 155 collaborating centres in 56 
countries (Pearce et al., 2007b). 
 
One of the key findings of the ISAAC phase I research (1994-1995) is the increased 
prevalence of asthma in developed countries, which is matched by a lower prevalence in 
developing countries (Beasley, 1998; Pearce et al., 2000a). Not only are allergic 
diseases on the rise, but also other autoimmune diseases such as type I diabetes 
(Feltbower et al., 2003; Harjutsalo et al., 2008), multiple sclerosis (Grytten et al., 2006), 
rheumatoid arthritis and Crohn’s disease (Kappelman et al., 2007; Munkholm et al., 
1992). According to Okada et al. (2010) migration studies showed that people migrating 
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from areas of low incidence of low autoimmune diseases (these areas have high 
incidence of infectious diseases) to areas of high prevalence of autoimmune diseases 
(areas of low incidence of infectious diseases) showed in their first generation, an 
increase in prevalence of autoimmune diseases amongst these people. The countries that 
are witnessing these rising trends in allergic and other autoimmune diseases have over 
the same period seen tremendous improvements in sanitation and economic status 
(Zaccone et al., 2006). According to da Cunha et al. (2007) this has been attributed to 
the hygiene hypothesis where the lower exposure to infection resulted from improved 
living standards, though his study in Brazil of asthma prevalence among a populace of 
more affluent and poor communities refuted this hypothesis (da Cunha et al., 2007).  
Phase III of global asthma prevalence by ISAAC (a repeat of phase I study after 5-10 
years involved 106 centres in 56 countries) concluded that there was an increase in 
prevalence in countries in Africa, Latin America and Asia (where previous studies 
showed low prevalence) but prevalence in Western Europe and English-speaking 
countries where previous studies showed high prevalence had reduced or stabilised 
(Pearce et al., 2007b).  
Epidemiological studies demonstrate that world regions with high rates of helminth 
infection consistently have reduced incidence of autoimmune and other 
allergic/inflammatory conditions (Cookson, 1987; McKay, 2006). This inverse 
relationship between prevalence of allergy and infectious (bacterial and helminth) 
disease in the world led to the hygiene hypothesis which states that “the exposure of 
microbial agents to an individual earlier on in life affects the way the individual 
responds to allergens later in life” (Strachan, 1989). An important aspect of this 
hypothesis is the exposure to helminths, endotoxins and pets on farms and their 
influence on the prevalence of allergic diseases later in the individual’s life (Platts-Mills 
et al., 2005). In New Zealand epidemiological studies indicate that children born to 
mothers who carried their pregnancy in a farming environment have a low asthma 
prevalence compared with their urban counterparts (Douwes et al., 2008). Studies in the 
United States, Europe and Canada have also made similar links between farm-reared 
children and protection against asthma (Adler et al., 2005).  
It has been stated that no other animal can substitute for humans in the study of asthma 
as none exhibit identical features of the human disease (Bates et al., 2009). Much of the 
invasive experimentation has been carried out in mice (Yu et al., 2006). The anatomy 
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and physiology of sheep is much closer to that of humans than laboratory animals 
(Collie, 2001; Wenzel & Holgate, 2006). In contrast to the monopodial branching of 
mice and rats, the sheep tracheobronchial tube is dichotomous and branching pattern is 
similar to humans. Further, the sheep lung has lobes which are well separated by tissue 
septa with limited connectivity between compartments which allows for treatments or 
infections to be localized, while using other parts as control tissues (Collie et al., 2006; 
Meeusen et al., 2009). The incidence of twinning in the pregnant sheep and the relative 
ease of the surgical procedure for intra-uterine inoculation allow for the use of one 
sibling as the text subject, reserving the other twin fetus as a control (Silverstein et al., 
1963). The comparable ease of longitudinal and repetitive reproducible sampling of 
sheep lung (Abraham, 2008; Collie et al., 1999) and the depth of immunological and 
parasitological knowledge of sheep at Lincoln University encouraged us to use this 
animal as the model to study human asthma. 
Our objective was to determine whether early exposure to HDM or TCL3 affected the 
immune or inflammatory response to HDM, later in life. We modified the sheep model 
as per Bischof et al. (2003), and administered the asthma-causing antigen (allergen), 
Dermatophagoides pteronyssinus (HDM) or sheep internal parasite, Trichostrongylus 
colubriformis infective larvae (TCL3) antigens to fetal and neonatal sheep. The effect of 
exposure of the intra-uterine or neonates to parasite antigen inoculation on the 
subsequent development, or not, of asthma-like symptoms was investigated when the 
lambs were 10 months old following sensitisation and challenge with the HDM antigen. 
The immune response of the experimental sheep was analysed by serological and 
cytological analyses of blood, bronchoaveolar lavage fluid from the respiratory system 
and lung tissue after necropsy.  
This thesis will review current literature on asthma with regards to its global distribution 
and prevalence. The review will also address the pathology of asthma and the 
mechanisms leading to asthma symptoms following contact with asthma causing 
allergens resulting from sensitization and challenge. The aetiology of asthma with 
regards to the genetic and environmental risk factors of asthma will also be deliberated 
upon. Further, various experimental animals’ models that are currently used in asthma 
studies will be discussed and compared. The thesis will then elaborate on the materials 
and methods used in our study with specific reference to the two phases that the study is 
divided into. Twinning in sheep will help us to use one twin feti as a test subject 
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(inoculation with an antigen) and the other twin-sibling will be used as a control subject 
to the antigen-inoculated sibling (PBS inoculation). Phase I of the study will describe in 
detail the procedures to inoculate the feti and neonates with antigen which was 
introduced via a catheter into the stomach; which in the feti will circulate to the lungs in 
the amniotic fluid (instead of the more cumbersome procedure of inoculating the 
antigen or neutral PBS directly into the lungs). The humoral immune response of these 
neonatal lambs will be assessed by ELISA to verify the lambs’ response to the antigen 
inoculated earlier (either at the prenatal or post natal stage). 
During the second phase (II) of the study, a new group of sheep (M group) who had 
never been part of the first group of sheep will be added to help tease out any influence 
of earlier handling practices and antigen inoculation. This group had a completely 
different environment during their life. The second phase of the study will give detailed 
account of the process of titration of the allergen to choose the most effective dose and 
route of inoculation during the sensitization period. In this study we will use 
bronchoscope to introduce the allergen directly into one of the lungs of the sheep while 
introducing a neutral substance (PBS) into the opposite lung for comparison during the 
challenge stage. Humoral and cellular immune responses to sensitization and challenge 
will be assessed by ELISA and whole blood leucocyte count of peripheral blood (HDM-
specific IgE and IgG1 in peripheral blood serum and leucocytes respectively). 
Leukocytes from bronchoaveolar lavage from the lungs will also be studied by cell 
counting after H&E staining. Forty eight hours after challenge the sheep will be 
euthanized and a necropsy performed on the respiratory tract. Samples from the lungs 
will be taken and analysed by histological analysis. 
Later results from these studies will be discussed in light of recent literature on asthma 
studies and conclusion drawn in line with our study aims and hypothesis. A list of 
bibliography will be provided at the end. Data that will not have direct reference to our 
discussion will be included in the appendix of the thesis. 
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1.1 Aims of study 
 To test whether prenatal and/or post natal introduction of lambs with helminth or 
house dust mite antigen will reduce their cellular and humoral responses to 
house dust mite antigen later in life. 
 To assess associations between immune responses and pathology of the 
respiratory tract after sensitization and challenge with house dust mite antigen. 
 
1.2 Hypothesis of study 
 That early-in-life exposure of lambs to helminth antigen (T colubriformis) will 
reduce immune responses or degree of pathology later in life when sensitized 
and challenged with an asthma-causing allergen (house dust mite). 
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Chapter 2 
Literature Review 
2.1 Definition of asthma (historical and modern view) 
Asthma is not a disease of the modern world. Hippocrates coined the term ‘asthma’ 
(Paul, 2003) and there has been mention of asthma either as a symptom or a disease 
throughout the Middle Ages. There is evidence in the papyrus writings in ancient Egypt 
detailing concoctions used to cure the distresses of asthma (Cohen, 1992; Marketos & 
Ballas, 1982). While the clinical symptoms of the disease have been clear through the 
ages, researchers from various scientific disciplines (immunology, pharmacology, 
pathophysiology and others) define the disease differently and there is no standard 
definition of asthma (Contopoulos-Ioannidis et al., 2007). 
 
Asthma may be classified or defined as severe or nocturnal asthma, bronchial hyper-
responsiveness, bronchial inflammation, a high serum IgE level to specific allergens, a 
positive skin prick test, allergic rhinitis, and severe atopic dermatitis (Contopoulos-
Ioannidis et al., 2007; Postma et al., 1995). Whether these conditions/symptoms do 
describe asthma per se or only define risk factors to the condition also depends on the 
point of view of the investigator and the goal and purpose of the study (Pearce et al., 
2000a). A modern and objective definition of asthma is a reversibility of airway 
obstruction during bronchial hyper-responsive tests (BHR) (Pearce et al., 2000b) but 
this has low sensitivity and excludes many. Peat et al. (1996) found a close relationship 
between high IgE levels, airway hyper-responsiveness and reduced lung function in 
children in different regions of New South Wales, Australia. In their study they found a 
high correlation between ‘atopy’ (raised IgE levels to specific allergens) (Jarvis & 
Burney, 1998; Shirakawa et al., 2000) and positive skin prick test (Pearce, 1999) at an 
early age and asthma later in life. In a quantitative study by Eder et al. (2004), atopy 
was defined as a specific IgE level of 3.5 kU/L or greater to at least one of the allergens 
they tested. Asthma described as an atopic condition may be acceptable in children with 
asthma but may not be acceptable when considering occupational asthma (Mapp et al., 
2002; Pearce, 1999; Robinson, 2010) and asthma with a non-allergic aetiology 
(Cookson et al., 2006; Cushley et al., 2012; Peat et al., 1996). 
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2.2 Asthma prevalence 
2.2.1 Spatial distribution of asthma 
The highest asthma prevalence internationally is found in the United Kingdom (> 15%), 
New Zealand (15.1%), Australia (14.7%), the Republic of Ireland (14.6%), Canada 
(14.1%), and the United States (10.9%) (Masoli et al., 2004), (Figure 2.1). In 
developing regions (Africa, Central and South America, Asia, and the Pacific), asthma 
continues to rise sharply with increasing urbanization and westernization. Estimates 
suggest that >40 million individuals in South and Central America and >50 million 
individuals in Africa currently have the disease. A high prevalence has been reported in 
Peru (13.0%), Costa Rica (11.9%), and Brazil (11.4%). In Africa, asthma prevalence is 
highest in South Africa (8.1%), perhaps the most westernized of the African countries 
(Masoli et al., 2004). 
Studies done in the Asia-Pacific region have indicated a wide range of asthma 
prevalence, with figures ranging from 1.1% in countries like Papua New Guinea and 
Indonesia (Beasley et al., 2000; Masoli et al., 2004) to 19.5% in countries such as 
Australia, New Zealand, Singapore, Hong Kong and Japan (Wong et al., 2004). In New 
Zealand the asthma hospitalisation rate of children ranging from 0-14 years of age was 
520 per 100,000 persons (Holt & Beasley, 2002). A study conducted in New Zealand 
comparing the incidence of asthma in Tokelauan children (aged between 0-14 years) 
found that in the case of 706 Tokelauan children living in Tokelau, the prevalence of 
asthma was 11.0% while in 1,160 Tokelauan children living in New Zealand, the 
asthma incidence was 25% (Waite et al., 2006). Other studies have shown that the 
prevalence in allergic diseases in rural areas (farming environments) is generally less 
than urban areas (Douwes et al., 2008; Riedler et al., 2001; Waser et al., 2004).  
Recent figures in the USA over a 12-month period indicate that of the approximately 
9% of asthma patients that required hospitalization, 23% needed emergency department 
treatment, and 29% had to have an unscheduled emergency appointment because of 
their asthma (Braman, 2006). Similarly in Europe, surveys show that up to 27% of a UK 
sample of asthmatics needed acute health-care services for their asthma over the past 
year, including hospital, emergency department, and urgent care-visits (Rabe et al., 
2000). 
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Figure 2.1 Proportion of a country’s population presenting signs of asthma during 
2003/2004 (Masoli et al., 2004). 
 
2.2.2 Temporal prevalence of asthma 
The last 40 years have seen a sharp increase in the morbidity and mortality of asthma 
worldwide, particularly in children. Further, the increase in asthma prevalence is in 
parallel to the rise in atopic sensitization and other allergic conditions (e.g., eczema and 
rhinitis) (Braman, 2006). In New Zealand a report commissioned by the Asthma and 
Respiratory Foundation in 2001 indicated that about 15-20% of both adults and children 
have asthma and that it is the commonest reason for hospitalisation of both children and 
adults in New Zealand. The rate of hospitalisation rose from about 100 in 1969 through 
>950 in 1985 to about 550 in 1999 per 100,000 persons (Figure 2.2). This incidence 
peak was in part due to exacerbation of symptoms following use of beta 2 adrenergic 
agonist, fenoterol (Pearce et al., 1995). Generally, epidemiologic studies indicate that 
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children do not appear to be “growing out” of asthma (Gerritsen et al., 1989; Martin et 
al., 1982). The disease may sometimes “disappear” in 30 to 50% of children, but it does 
tend to show up again in adulthood and even among those who do not have clinical 
symptoms, where lung function may remain compromised. Usually, more than half of 
asthmatic children will still have symptoms at 21 years of age, and 5 to 10% of those 
with “trivial” asthma as children will have a severe form of the disease as adults 
(Gerritsen et al., 1989).  
In the elderly, asthma incidence may actually be underestimated. In this population, 
lung function testing is more limited and patients are also less likely to complain about 
respiratory symptoms, regarding them, perhaps, as simply related to increasing age 
(Brogger et al., 2004; Hartert & Peebles, 2000). Furthermore, asthma symptoms often 
overlap with those of other diseases commonly found among the elderly, including 
cardiovascular disease and chronic obstructive pulmonary disease (Braman, 2003).  
 
Figure 2.2 Asthma hospitalisation rates in New Zealand per 100,000 in person 
aged 0-14 years (Holt & Beasley, 2002). 
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2.3 Pathology of asthma 
The early stages of asthmatic inflammation include changes in vascular permeability, 
inflammatory cell infiltration, and hyperplasia of goblet cells which replace the normal 
ciliated epithelial cells (Laitinen & Laitinen, 1994).Transudation of oedema fluid from 
the submucosa layer of the bronchus occurs in association with shedding of bronchial 
mucosal cells. This results from the release of basic proteins and oxygen-derived free 
radicals and various other proteases by the inflamed cells (Barnes, 1996). 
Histologically, areas of regeneration of the mucosa with the presence of simple 
stratified epithelial cells are noted. This leads to the failure of clearance of bronchial 
secretions (Dunnill, 1960). A major pathological finding is the thickening of the 
basement membrane (Figure 2.3), increased airway smooth muscle mass and variable 
broncho-constriction which is largely responsible for the greatly increased respiratory 
effort and symptoms (wheezing) of asthmatics (Fish & Peters, 1999). 
Figure 2.3 Pathology of asthmatic lung compared with a normal lung. Thicker 
arrow show thickened submucosa muscle layer. Thinner arrow shows 
mucus accumulation in bronchus, (retrieved from UCLA Health Sytem 
website, 2011)
 
(modified).
 
  
 11 
 
Changes in airway smooth muscle vasculature due to angiogenesis result in airway wall 
oedema. Further, increased airway blood flow may increase removal of inflammatory 
mediators and may be a major factor in exercise-induced asthma (Barnes, 1996). 
Changes in airway cartilage integrity due to decreased volume of cartilage and 
deposition of fibronectin is also observed in the asthmatic lung (Sumi & Hamid, 2007). 
The asthmatic smooth muscle has reduced responsiveness to β-adrenoceptor agonists 
which may be attributed to the activities of inflammatory mediators (Barnes, 1996).  
Hogg (1997) describes the lung in cases where death is attributed to asthma as 
heterogeneous, but, has features that are common enough for asthma to be distinguished 
from other conditions. The key features include the presence of intraluminal mucus, 
airway epithelial desquamation and repair, airway inflammatory infiltrates consisting of 
an admixture of mononuclear cells and eosinophils and the presence of a thickened, 
hyalinised subepithelial basement membrane (Figure 2.4). 
Figure 2.4 Cut surface of human lung showing airway inflammatory infiltrates 
consisting of an admixture of eosinophils and other inflammatory cells 
(arrowed) in medium sized bronchi, ×1 (Dunnill, 1960) (modified). 
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2.4 Immune mechanisms in asthma 
On the basis of an individual’s genetic make-up, environmental factors interact to 
produce a series of reactions that lead to asthma (Djukanovic, 2000). The interaction of 
environmental allergens [harmless environmental substances which cause disease in 
sensitized individuals (Paul, 2003)] with antigen presenting cells of the innate immune 
system leads to priming of T cells which stimulate IgE production and increase the 
influx of eosinophils and mast cells to the region (Yazdanbakhsh et al., 2002). That is, 
an inflammation response driven by a Th2 dominated immune response. Eosinophils 
release granule-associated basic proteins (which damage nerve and epithelial cells), 
lipid mediators (which cause bronchoconstriction, vaso-dilation and mucus 
hypersecretion) and reactive oxygen species which generally injure mucosal cells (Kay 
et al., 2004). Repeated injury to the airway cells causes excessive repair processes with 
the release of extracellular matrix proteins in the reticular basement membrane and 
bronchial mucosa as well as an increase in smooth muscle mass, goblet cell hyperplasia 
and new blood vessel formation (Kay et al., 2004). This series of reactions that take 
place when a sensitized individual is exposed to asthma-causing allergens may be 
divided into three phases: early, late and chronic (tissue remodelling) phases (Bousquet 
et al., 2000). 
A non-eosinophilic, pathway leading to asthma (which explains occupational and other 
non-allergic asthma) has been proposed. In this case, the innate immune system is 
triggered by environmental substances such as virus, endotoxins and other airway 
irritants and leads to the expression of innate pattern-recognition receptors TLR2, 
TLR4, surfactant protein A (SP-A) and CD14, and a corresponding cytokine response 
(Simpson et al., 2007) on the epithelial cells and macrophages in the respiratory tract. 
Through IL-8 mediated neutrophil inflammation with FcRI, FcRII, TLR4, CD14 
receptors and transcription factors (NFAT, GATA, NF-kB) as intermediates, this leads 
to neutrophilic asthma (Douwes et al., 2002). Non-eosinophilic, innate immune 
response to inhaled steroid and gases has been extensively reviewed and according to 
Pavord (2007), although observations are cross-sectional, this phenomenon is worth 
further investigation. 
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2.4.1 Early phase asthma 
A sensitized individual’s initial response to allergen is dominated by products 
associated with mast cell degranulation (Figure 2.5), particularly histamine, 
prostaglandin D2, (PGD2), leukotriene C4 (LTC4), and tryptase (Hamid et al., 2003; 
Holgate, 1993). Within 15-20 min of a sensitized individual’s contact with allergen, the 
early phase of bronchoconstriction reaches its maximum with a decrease in forced 
xpiratory volume followed by recovery over an hour (Hamid et al., 2003).  
 
Figure 2.5 A scheme of putative immune and inflammatory events associated with 
the pathophysiology of asthma, with an emphasis on early- versus late-
phase asthmatic responses. Sites of inflammatory action of leukotrienes 
(LTs) are shown by large arrows. An ECP, eosinophil cationic protein; 
EPO, eosinophil peroxidase; PG, prostaglandin; PAF, platelet 
activating factor; APC, antigen presenting cell; TCR, T-cell receptor 
(Hamid et al., 2003). 
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2.4.2 Late phase asthma 
The late phase starts at around 1-2 hours after the early phase (Holgate, 1993). 
Inflammatory cells, including T lymphocytes, neutrophils, eosinophils, basophils and 
monocytes are recruited from the general blood circulation to the bronchus and other 
parts of the airways (Hamid et al., 2003).  
Bronchial biopsy samples taken 4-6 hours after local allergen challenge show an 
increase in neutrophils and eosinophils within the submucosa and epithelium of the 
bronchus (Holgate, 1993). These inflammatory cells release chemokines and other 
mediators such as IL-3, IL-9 and cysteinyl leukotrienes which induce multiple 
mechanisms including mucus hypersecretion, increased micro-vascular permeability, 
ciliary activity impairment, inflammatory cell recruitment, oedema and neuronal 
dysfunction (Drazen & Austen, 1987). The late phase is maximal at about 6-8 hours, 
and recovery occurs over the following 24 hours (Holgate, 1993).  
 
2.4.3 Tissue remodelling (chronic asthma) 
Asthma is a chronic disease and its natural progression is associated with cycles of 
airway tissue damage and healing. The healing process involves the replacement of 
damaged tissue by parenchymal cells of the original tissue (regeneration) as well as 
fibrous tissue formation, resulting in the creation of scars (Kay et al., 2004; Vignola et 
al., 2000). Though asthma is a reversible disease, some patients still show signs of 
organ remodelling (Djukanovic, 2000; Vignola et al., 2000).  
The walls of the asthmatic bronchus thicken due to the thickening of the lamina 
reticularis of the surface epithelium of the basement membrane (Paganin et al., 1992; 
Vignola et al., 2000). The thickening of the bronchial walls is caused by the deposition 
of immunoglobulins and /or collagen I and III and fibronectin. These are produced by 
activated myofibroblasts and lead to fibrosis of the chronic asthmatic airways (Altraja et 
al., 1996). According to Poiseuille’s law of laminar flow, thickening in the muscular 
layer of the airways will lead to a considerable increase in airway resistance, which will 
in turn cause a rise in the sensitivity of the airways (Bosse et al., 2009).  
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2.5 Aetiology of asthma 
2.5.1 Genetic resistance/susceptibility 
A study of various data bases including MEDLINE, Human Genome Epidemiology 
Network (HuGE Net), that published literature for all genetic association studies on 
asthma and atopy from 2000 to 2006 and asthma workshop databases, failed to yield 
any conclusive evidence that asthma prevalence or outcome has direct link to any 
specific gene (Contopoulos-Ioannidis et al., 2007; Sandford & Pare, 2000). 
Contopoulos-Ioannidis et al. (2007) attributed this finding to the different definitions 
given to asthma, small case numbers in most studies as well as inconsistencies in 
asthma studies.  
Resistance or susceptibility to asthma, like most complex diseases, reflects multigenetic 
inheritance (Contopoulos-Ioannidis et al., 2007). A population based study done by 
Zamel et al. (1996) on 97% of the inhabitants of the remote island of
 
Tristan da Cunha 
(islanders are direct
 
descendants of 15 original settlers, and historical records suggest 
that at
 
least two founders may have been asthmatic), confirmed the report that there is a 
high prevalence of asthma on the island and that, the high prevalence is due to gene 
enrichment as a result of inbreeding. A British study by Koeppen-Schomerus et al. 
(2001) involving 4910 twin pairs: 1658 monozygotic (MZ), 1651 dizygotic same sex 
(DZss), and 1601 dizygotic opposite sex (DZos) indicated that genetic influence is 
substantial and accounts for 68%-95% of the asthma prevalence with at most 50% of 
asthma being attributed to eosinophilic airway inflammation (Douwes et al., 2002). 
Susceptibility to asthma is a result of the combination of many genes (polygenic) with 
markers on a variety of chromosomes (Koeppen-Schomerus et al., 2001). Although the 
mode of inheritance is not known, it has been shown by the work of many researchers 
from various countries (Western Australia, United Kingdom, United States and the 
Netherlands) that there is linkage to at least chromosomes 5q, 6q, 11q, 12q and 13q 
(Los et al., 2001). Moffatt et al. (2007) systematically mapped the effects of single 
nucleotide polymorphisms (SNPs) on the presence of childhood-onset asthma by 
genome-wide association. They characterized more than 317,000 SNPs in DNA from 
994 patients with childhood onset asthma and 1,243 non-asthmatics, using family and 
case-referenced panels. Their study indicated multiple markers on chromosome 17q21 
to be strongly and reproducibly associated with childhood-onset asthma in family and 
case-referenced panels. The Dutch study by Los et al. (2001) of children (n=303) and 
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grandchildren (n=84) of probands with asthma selected from a homogenous population 
indicated that an elevated level of serum total IgE is co-inherited with a trait for 
bronchial hyper-responsiveness and that a gene governing bronchial hyper-
responsiveness is located near a major locus that regulates serum IgE levels on 
chromosome 5q (Postma et al., 1995). Also, on chromosome 5q there are many 
candidate genes relevant for asthma and allergy such as the interleukin-4 and β2 
adrenergic receptor genes and CD14 gene (the major receptor that mediates the cellular 
response to endotoxin) (Moffatt & Cookson, 1997; Sandford & Pare, 2000). More 
recent studies shows genetic links with asthma with identification of loci on 
chromosome 1q31 having a link to asthma susceptibility in over 2500 test subjects of 
both European and African ancestry (Feero et al., 2010; Sleiman et al., 2010). While in 
a study of over 20,000 test subjects genetic linkage to asthma was found on 
chromosomes 2, 6 and 9 with the locus on 17q21 again being linked to childhood onset 
of asthma (Moffatt et al., 2010). 
 
2.5.2 Environmental risk factors  
The recent increase in asthma prevalence globally is occurring too rapidly for it to be 
attributed primarily to genetic factors, thus environmental factors must play a 
significant role in the aetiology of the disease (Douwes & Pearce, 2002). Environmental 
factors such as changes in diet, increased fetal growth, smaller family sizes, reduced 
infant infection and increased use of antibiotics have all been implicated in the modern 
increasing trend of asthma prevalence (Douwes & Pearce, 2002).  
Environmental risk factors associated with asthma have a close association to risk 
factors for atopic sensitization (positive skin prick test) (Dreborg & Frew, 2008; von 
Mutius, 2002). In infants, the time in life as well as the period of sensitization that 
contact is made with allergens is crucial for asthma development, or not, later in life 
(von Mutius, 2002). In this German cohort study it was noted that while transient 
sensitization of children with an allergen during the first year in life did not increase the 
incidence of asthma 7 years later, those who were persistently exposed, had a highly 
significantly higher prevalence of asthma at age 7 (von Mutius, 2002). In contrast, a 
New Zealand study pointed to the importance of persistent exposure within a farm 
environment for protection against asthma later in life (Douwes et al., 2008) and 
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repeated exposure to allergens increased the protection (Riedler et al., 2001; Sporik et 
al., 1992). In summary, this is evidence that the presence of allergens in the 
environment contributes to asthma prevalence, but paradoxically, decreased exposure to 
environmental antigens at particular ages may increase asthma prevalence (the so called 
hygiene hypothesis – see later sections) (Bach, 2005). 
Domestic micro-climate and asthma incidence 
A number of investigators have related the environmental conditions in homes, such as 
dampness and presence of visible fungal growths and moulds, to increasing trends in the 
rise of asthma and other respiratory diseases (Brasche & Bischof, 2005; Platts-Mills, 
1994). A study by Williamson et al. (1997) showed that there was a dose-response 
relationship between the presence of asthma and dampness in homes. Other work 
supports the widely held view of a relationship between dampness and low temperatures 
in-doors to an increase in asthma (Guo et al., 1999; Platts-Mills et al., 1997; Weiland et 
al., 2004).  
The ethnically similar, but sociologically diverse society that existed immediately after 
the unification of the two German states (East and West) gave an interesting opportunity 
to study asthma since the rate of asthma in the two states was very different. According 
to von Mutius et al. (1994), the prevalence of current asthma and hay fever was 
significantly higher in West Germany when compared with that in East Germany (5.9% 
versus 3.9%; OR = 1.5, P < 0.0001 and 8.6% versus 2.7%; OR = 3.4, P < 0.0001, 
respectively). The household conditions existing between these two states have been 
studied in relation to asthma prevalence and there was a strong indication that the type 
of indoor heating such as wood or coal, and feather bedding were negatively associated 
with asthmatic symptoms, whereas exposure to fumes from truck traffic in a residential 
street or active smoking were positively associated with asthmatic symptoms (Baeza-
Bacab, 2011; Duhme et al., 1998b). 
Link between house dust mite (HDM) and asthma 
Among other allergens, house dust mites (Dermatophagoides pteronyssinus) have been 
directly linked to causing asthma (Bisgaard & Bønnelykke, 2010; Custovic et al., 1996; 
Holt & Strickland, 2010; Peat et al., 1996; Sporik et al., 1992; Tournoy et al., 2000). In 
particular, the neutral proteases Der p I (a cysteine protease) Der p II (lysozyme), and 
Der p III (serine protease) from the gastrointestinal tract of the HDM have been 
implicated as major causes of asthma in temperate climates (Holgate, 1993). Der p I is a 
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major allergen of the HDM which has been shown in vitro to induce mast cell and 
basophil degranulation and stimulate IL-4 synthesis and secretion. The enzymatic 
activity of Der p I causes naive CD4 cells to be more biased towards the stimulation of 
Th-2 cells which creates an allergic microenvironment (Schulz et al., 1998). The 
protease Der p I (Paul, 2003) increases the permeability of the bronchial mucosa and 
facilitates its own passage, with other allergens, along the epithelium and allows access 
to, and sensitizes, cells of the immune system (Delves et al., 2006).  
In an Australian study, the number of children with asthma doubled with every doubling 
of the amount of HDM allergen in their environment (Peat et al., 1996; Sporik et al., 
1990 ). The average level of HDM in Australian homes varied greatly, with levels of up 
to 83 µg HDM/mg of sieved dust recorded in coastal areas while levels elsewhere 
averaged 11 µg HDM/mg (Peat et al., 1996).  
A cohort study conducted by Lau et al. (2000) including 1,314 children from five major 
German cities did not find any relationship between the presence of HDM antigen in the 
house and asthma development in children. In another German study, children who 
were exposed to house dust mites at least once during years 1-3, had a highly significant 
risk (P=0.001) of being asthmatic compared with children who had not (Wahn et al., 
1997). The concentration and not just the presence of HDM allergen was cited as the 
possible cause of conflict between the two studies (Wahn et al., 1997). 
Contrary to the situations above, children born in Los Alamos, New Mexico (a high-
altitude desert environment with very few or no house dust mites) were significantly 
(P=0.025) more prone to developing asthma than those who moved to this community 
(presumably having had more exposure to house dust mites than those children born and 
bred in the nil or low house dust mite environment of Los Alamos). Thus, though the 
house dust mite sensitization is reduced in this community, asthma prevalence is not 
(Sporik et al., 1995), which may indicate the importance of age when exposure to HDM 
occurred or alternatively the importance of other contributory factors in the 
environment. 
Influence of infectious agents (pathogens) 
Studies carried out in Europe showed that exposure to lipopolysaccharide (LPS) from 
gram-negative bacteria early in life gave protection against asthma (Douwes et al., 
2003; Gereda et al., 2000; Riedler et al., 2001). The direct introduction of LPS into the 
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lungs of sheep (Bischof et al., 2003) and calves (Brogden et al., 1995) by the use of a 
fibre-optic bronchoscope did not cause asthma-like symptoms of narrow airways 
(bronchi and bronchioles). Rather a moderate enlargement of the bronchi and 
bronchioles as well as mass infiltration of alveolar lumen by macrophages and 
neutrophils was noted. Typically, lipopolysaccharide (LPS) is inhaled in a form of 
organic dust (bioaerosol) which consists mainly of pathogenic or non-pathogenic, live 
or dead, whole or parts of microbe(s) (Douwes et al., 2003). The effects of LPS on 
asthma prevalence may be dose, route or timing dependant (Bischof et al., 2003; Duhme 
et al., 1998a; Wickens et al., 2003). The bacterial influence on asthma may be explained 
immunologically on the basis that, microbial exposure may affect T lymphocytes which 
play important roles in monitoring immune responses. T-helper-2 (Th-2) cells stimulate 
B-cells to produce IgE during contact with allergens (Holgate, 1993). On the other 
hand, T-helper-1 (Th-1) cells may inhibit the process of IgE production during allergen 
invasion of the immune system (Gale, 2002). During early stages of life, exposure to 
microbial and parasitic antigens (common in developing countries) stimulates a Th-1 
type immune response, which down-regulates Th-2 responses (Liu, 2004; Martinez, 
1999). In a more hygienic environment (western countries), Th-2 type responses are 
more pronounced and allergy is thus more common (Gale, 2002). However, it has 
recently been observed that Th-1-autoimmune
 
diseases in developed countries are also 
on the rise and that Th-2-skewed parasitic worm
 
(helminth) infections are not associated 
with allergy (Wills-Karp et al., 2001; Yazdanbakhsh et al., 2002).  
Internal parasites and asthma  
Despite the difficulty in eliminating confounding factors, some studies have linked the 
drastic reduction in prevalence of multicellular parasite infestation in most developed 
countries to a rise in asthma incidence (Huovinen et al., 2003; Yazdanbakhsh et al., 
2002). That is, the higher incidence of asthma in developed countries (where parasite 
infection is minimal), compares with the lower incidence of asthma in developing 
countries where helminth incidence is higher (Masters & Barrett-Connor, 1985; van den 
Biggelaar et al., 2004). For instance an African study of children infested with 
shistosomiasis found that children with urinary shistosomiasis (caused by a trematode) 
had a lower prevalence of a positive skin reaction to HDM (asthma-causing) allergen 
than those free of this infection (van den Biggelaar et al., 2004). 
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Researchers in Southern America have also indicated that people living in helminth 
endemic areas have milder forms of asthma and generally low asthma prevalence 
(Araujo & de Carvalho, 2006; Medeiros et al., 2003; Pacífico et al., 2009). It is 
hypothesized that the inverse relationship between asthma and helminth infestation 
could be due to competition between helminth-induced polyclonal IgE and 
aeroallergen-specific IgE for high affinity receptors present on mast cells, increased 
number of regulatory T cells, and high levels of regulatory cytokines, such as IL-10, 
produced during helminth infections. They showed that cells from asthmatic 
individuals infected with Schistosoma mansoni produce lower levels of IL-5 than 
asthmatics free of infections which contrasts the more readily produced IL-10 by 
allergen stimulated cells from asthmatics who are infected (Araujo & de Carvalho, 
2006; Pacífico et al., 2009). An Asian study indicated that Shistosoma japonicum egg 
antigen and can induce production of CD4+and CD25+ T cells which have regulatory 
activity to reduce airway inflammation and inhibit asthma development (Yang et al., 
2007). 
 
A case-control study in Ethiopia found that the risk of wheeze was significantly 
decreased with increasing intensity of hookworm (an internal helminth) infestation 
(Scrivener et al., 2001). Hagel et al. (1993) studied the relationship between helminth 
infection and allergic disease prevalence amongst slum children in Caracas, Venezuela 
and found that the polyclonal production of IgE stimulated by helminth infection was 
inversely associated with the allergic response to environmental and parasite allergens. 
In a different study of the same populace, it was found that inhibition of allergic 
response in individuals due to the presence of elevated levels of polyclonal IgE caused 
by helminth infestation was reversible with anthelmintic treatment (Lynch et al., 1993). 
Similarly anthelmintic treatment of Gabonese school children with intestinal helminth 
resulted in increased atopic reactivity, which indicated that helminths directly suppress 
allergic reactions (van den Biggelaar et al., 2004). This has been attributed to the strong 
Th-2 responses which characterise helminth infections (van den Biggelaar et al., 2004). 
The polyclonal stimulation of the synthesis of IgE, present during parasite infestation 
control is dependent on interleukin-4 (IL-4) production which down regulates allergic 
response reactivity (Lynch et al., 1993). More recently,
 
elevations of anti-inflammatory 
cytokines, such as interleukin-10 (IL-10),
 
that occur during long-term helminth 
infections have been shown
 
to be inversely correlated with allergy. The induction of a 
robust
 
anti-inflammatory regulatory network by persistent immune challenge
 
offers a 
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unifying explanation for the observed inverse association
 
of helminths with allergic 
disorders (Yazdanbakhsh et al., 2002).  
 
2.6 Experimental models of asthma 
Human versus other species 
According to Tschering et al. (2008) no single species reflects the complete range of 
human anatomy, physiology relative to age and its related changes. Most of the 
knowledge we have today of asthma has been made possible through collections of 
epidemiological information gained by different types of epidemiological studies 
(cohort, case control and cross sectional), as well as clinical and experimental studies 
conducted in animal models (Parker et al., 2003; Strachan et al., 1994; Temelkovski et 
al., 1998; Wenzel & Holgate, 2006).  
Picher et al. (2011) indicated that over the past 20 years, the growing awareness that 
purinergic signalling events literally shape the immune and inflammatory responses to 
infection and allergic reactions has warranted the development of animal models to 
assess their importance in vivo, in acute lung injury and chronic airway diseases. For 
instance, mice infected with influenza A virus helped to identify the human alveolar 
cells which accounts for the majority of calcium ion transfer in the human lungs. The 
immunologic pathways leading to bronchoconstriction and mucociliary dysfunction are 
essentially the same in allergic animals as in human patients with allergic bronchial 
asthma (Wanner & Abraham, 1982).  
The use of murine subjects in the study of asthma, though attractive from a logistical 
perspective has a range of shortcomings. In mice, a broad spectrum of molecular and 
immunological tools is available, particularly to study the balance between Th1 and Th2 
responses, and inbred strains may be useful for the genetic dissection of susceptibility to 
human asthma (Bice et al., 2000). The mechanisms of chemical sensitization during 
occupational asthma are currently not well understood and animal models can be used 
to study such parameters as airway hyper-responsiveness, elevated IgE or other 
anaphylactic antibody classes, pulmonary eosinophilia and diaphragmatic contractions 
(Karol, 1994). In humans a limited number of approaches to asthma study are ethically 
acceptable and humans almost always have the disease before they are studied making 
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dynamic studies of asthma development difficult (Wenzel & Holgate, 2006). So while it 
is understood that the typical features of human bronchial asthma have not been 
observed in any animal model and these limitations are recognized, use of animals is 
still useful (Wanner & Abraham, 1982).  
Sheep model 
According to Meeusen et al. (2009) and Scheerlinck et al. (2008) sheep offer advantages 
over other commonly used animal models such as rodents, dogs, horses and non-human 
primates for asthma studies including the similarities in anatomy (lungs divided into 
lobes, dichotomous branching of the lungs, presence of airway smooth muscles and 
size) and physiology (circulation and ventilation) (Table 2.1).  
It has been demonstrated experimentally that allergic responses including characteristic 
early- and late- phase asthmatic response and hyper-responsiveness in the sheep lung 
closely reproduce the progression of human asthma (Abraham et al., 1983; Fujimoto et 
al., 1996; Rice et al., 2001). Measures of respiratory physiology (lung volumes, 
respiratory mechanics, and gas exchange measurements), the sampling for trans-
bronchial lung biopsy, and bronchoaveolar lavage taken in sheep are similar to those in 
humans or anaesthetized primates (Begin et al., 1981). The activity of respiratory cilia 
epithelial and mucous production is important during asthma. The use of sheep enables 
the measurement of whole lung mucociliary clearance repetitively (Abraham, 2008). 
Lower airway secretions are a characteristic feature of human bronchial asthma and this 
has been successfully studied in allergic sheep by investigating in vivo, the 
glycoconjugate profiles of secretions of the apical glycocalyx of the epithelium in the 
allergic sheep (Mariassy et al., 1994). The distribution, structure and function of mast 
cell tryptases (family of serine proteinases which are implicated in the proliferation of 
smooth muscle cells and fibroblasts), upregulation of interleukin-8 synthesis by 
endothelial cells, and recruitment of neutrophils and eosinophils in the sheep lung is 
similar to that of humans and this further validates the use of sheep lung as a model for 
studying human respiratory disease of asthma (Pemberton et al., 2000). 
Sheep are more closely related to humans than rodents, resulting in stronger homologies 
in protein structures, growth factors and mediators. The recent sequencing of the 
bovine/ovine genome and development of microarrays, means that sheep models for 
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human respiratory diseases may become available for detailed molecular analysis and 
drug discovery (Meeusen et al., 2009). 
 
Table 2.1 Similarities between the anatomy and physiology of sheep, mice and 
humans (Scheerlinck et al., 2008). 
Similarity with human 
Sheep Mice 
Similar alveoli Similar alveoli 
Similar bronchial glands present Only in the upper airways 
Similar cartilage distribution Only in the upper airways 
Similar sensory nerves Only in the upper airways 
Similar airway capillaries No small airway capillaries 
Similar mast cell distribution Only upper airway 
Similar mucus secreting cells Similar mucus secreting cells 
Similar airway collagen Similar airway collagen 
Similar effect of histamine Histamine has no effect 
Similar cough reflex/wheeze No cough reflex/wheeze 
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Chapter 3 
Materials and Methods 
3.1 Phase one – inoculation of lambs 
3.1.1  Selection of experimental animals 
Twenty two, twin-bearing, pregnant Coopworth ewes (confirmed by ultrasound 
detection) of similar live weight and sired by the same ram were obtained from the 
Lincoln University (LU) research farm for this study. Ewes were grazed together on a 
mixed ryegrass/white clover pasture. 
 
Figure 3.1 Schematic representation of phase 1 of the study.  
The ewes were assigned into 4 experimental groups, 3 of which were subjected to 
surgery (Figure 3.1). Antigen was given to one of the twin feti of the ewes: either 
Trichostrongylus colubriformis L3 (TCL3) antigen (n=4; TCL3 group) or house dust mite 
[Dermatophagoides pteronyssinus (HDM)] antigen (n=7; HDM group). The ‘contra-
lateral’ (sibling of ‘treated’ feti) twins were administered PBS. In another group (n=3) 
Experimental design
Group of twin bearing
Coopworth ewes ( n=22)
n=6 n=7 n=3
TCL PBS HDM PBS PBS PBSTCLPBS
Postnatal
(inoculated on day of birth)
n=6
Inoculated in utero
Neonatal groups TCL3 c/TCL3 HDM c/HDM Ctrl Ctrl PNTCL3 c/PNTCL3
TCL
3
= Trichostrongylus colubriformis L3 antigen
HDM = House dust mite antigen
PBS  = Isotonic solution of phosphate buffered saline
= Booster administration of antigen; 21 days after first antigen/PBS administration
Fetal inoculation 
Booster inoculation
(at birth)
n=16
M
= group raised completely different from all other groups (added during phase II of study)
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both twin feti were treated with PBS solution (Ctrl group). At birth, in August 
(approximately 21 days after the sensitisation treatment) all of the treated feti were 
retreated (boostered). The 4th group of twin-bearing ewes did not undergo surgery; 
following birth, one of the lambs was administered TCL3; intragastrically [post natal 
TCL3 treated (PNTCL3) group] and the other twin sibling was treated similarly with 
PBS (c/PNTCL3). Both were retreated identically at 21 days of age. The lambs and their 
mothers were grazed together on a mixed ryegrass/white clover pasture and were 
subjected to routine husbandry practices - tailing, tagging, castration, and at 5 months of 
age, internal and external parasite control was carried out as per normal New Zealand 
sheep farming practice. At 9 months of age, another 6 lambs from a group of clinically 
normal ewes of the same breed (the M group) were included in the sensitization and 
challenge (phase 2) of the study.  
3.1.2 Preparation of the TCL3  
Trichostrongylus colubriformis L3 larvae were gifted to us by Mr. Robin McAnulty, 
Lincoln University. Living TCL3 stored in 500 ml tissue culture flasks were aliquoted 
into 50 ml Falcon tubes and centrifugated at 2600 g for 5 min followed by washing in 
PBS and re-centrifugation. Homogenization in a Teflon-glass tube on ice was continued 
until microscopically no whole (uncrushed) larvae were viewed. The homogenised 
TCL3 were subjected to 3 cycles of ultrasonication (Watson Victor, model W-225) with 
6 cycles of 30 sec per cycle and intermittent cooling on ice for 30 sec between the 
sonication periods (Shaw et al., 1998). The resulting solution was centrifugated at 
10,000 g for 1 h, the supernatant was filtered through a 0.22 µm filter and its protein 
concentration determined by the Bradford method (BCA kit, Thermo Scientific Pierce, 
New Zealand) and stored at -20°C (Paalangara, 2000).  
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Figure 3.2 SDS-polyacrylamide gel electrophoresis of Trichostrongylus 
colubriformis larvae (stages 5,4 or 3). The TCL3 were used for 
inoculation 
 
3.1.3 Preparation of the HDM antigen 
Whole bodied house dust mites [Dermatophagoides pteronyssinus (HDM)] that had 
been crushed by ball milling, extracted in ammonium bicarbonate, concentrated and 
dialyzed against distilled water (Greer Laboratories, Lenoir, USA), were used as the 
antigen in the inoculums and the immunological assays. The lyophilised HDM 
preparation (2.5 mg/vial) was re-solubilised in 5 ml of endotoxin-free sterile water for 
injection and further diluted in PBS before use. According to the manufacturer, each 
vial of lyophilised HDM extract contained 50 endotoxic units (EU) of 
lipopolysaccharide (LPS). At the time of usage, a serial dilution of the protein solution 
was prepared to the required concentration and confirmation of protein concentration of 
the final working solution was measured using the Qubit® system (Invitrogen, New 
Zealand). The antigen to be administered was prepared the day prior to surgery and 
stored in hypodermic syringes at 4°C. 
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Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) was used to 
separate proteins according to their size. SDS loading buffer was added to the sample 
that was then denatured by heating at 90°C for 5 min and then loaded onto wells and 
electrophoresed for 60 min. (Fernandez et al., 1998) (Figures. 3.2 & 3.6). 
 
 
 
Figure 3.3 . SDS-polyacrylamide gel electrophoresis of HDM antigen 
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3.1.4 Surgery on the experimental twin-bearing ewes 
Surgery was carried out on Coopworth ewes (n=16) carrying twin feti at 110 days of 
gestation (calculated by ultrasound imaging and with known mating dates). Ewes were 
starved of food for at least 18 h prior to surgery. The temperature, pulse rate and a 
general clinical assessment of the ewes was undertaken to make sure they were healthy.  
Anaesthesia was induced with a mixture of ketamine (10 mg/kg of live weight) and 
diazepam (0.5 mg/kg) injected slowly into the jugular vein. A 9.5 mm diameter cuffed 
endotracheal tube was introduced into the trachea of the ewe to maintain its airway 
during surgery. A gas mixture of 1-3% halothane in 100% oxygen was administered to 
the sheep in a supine position through the endotracheal tube from a closed circuit 
anaesthetic apparatus.  
The surgical site was prepared by first removing the wool cover with shearing clippers 
and then scrubbing the area with 7.5% aqueous iodine followed by 70% ethanol. Sterile 
surgical drapes were used to cover all areas of the abdominal and chest region leaving 
only the surgical site exposed. All surgical equipment was sterilized by autoclaving at 
121°C for 15 min or sterile disposable equipment was used.  
A centro-medial incision was made, cranial to the udder, cutting through the skin, linea 
alba and peritoneal layer of the abdominal wall of the ewe, and the uterus was 
exteriorised. An incision of 1-2 cm was made through the wall of the uterus, and the 
mouth of the fetal lamb was held open and a sterile 3.3 × 500 mm dog urinary catheter 
(BUSTER®, Denmark) was inserted through the mouth of the fetus and progressed into 
the stomach.  
One of the lambs of a twin-bearing ewe was treated with antigens (administered via 
catheter into the stomach) from either Trichostrongylus colubriformis (0.2 mg in 1.5 ml 
PBS) or alternatively HDM (0.2 mg in 1.5 ml PBS). Contralateral twins were given PBS 
(1.5 ml). All inoculants were warmed to the physiological body temperature of sheep 
(39.0°C), prior to administration. 
The experimental lambs (given TCL3 or HDM) and the control lamb (given sterile PBS) 
were able to be differentiated at lambing by placing an identifiable non-absorbable 
stitch on the upper lip at the time of surgery. The uterine incision was closed with 
 29 
 
inverted, serosa to serosa, interrupted sutures using 0.0 Vicryl (Ethicon, New Zealand). 
The uterus was replaced and the abdominal incision closed in 3 layers; simple 
interrupted for the peritoneal and abdominal muscular layer (Vicryl 0), simple 
continuous suture with for the subcutaneous fascia (2-0 Vicryl) and vertical mattress 
suture for the skin layer (0 Vicryl) (Figure 3.4, A-F). 
The ewes were given post-operative antibiotic subcutaneously as a precaution against 
infection and were monitored until revival was complete and they were able to eat or 
drink. They were kept in a warm indoor environment for at least 5 days where their 
surgical wound was closely monitored then later returned to pasture.  
 
Figure 3.4 Surgery on the twin-bearing experimental ewes/ inoculation of feti with 
antigen. A – ewe in supine position for laparotomy. B – head of fetus 
held against uterus and a small incision made to expose opened mouth. 
C – mouth of fetus ready for introduction of catheter tube into stomach. 
D – inoculation of antigen/PBS into stomach of fetus. E - suturing of 
uterine wall. F- suturing of abdominal wall.  
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3.1.5 Postnatal lamb care and blood sampling  
Blood samples (5 ml) were taken from the jugular vein of experimental lambs as soon 
as possible after birth using a 21 G needle into a 6 ml plain (no anticoagulant) evacuated 
tube (Vacuette, Greiner, Austria). This was repeated weekly, until the fourth week. 
Serum was harvested from the blood samples by centrifugation of the clotted blood at 
2600 g for 10 min. The supernatant (serum) was collected and stored at -20
o
C. The 
experimental lambs were tagged and treated at birth (see below), tailed and castrated 
with rubber rings (Elastrator, Heiniger Pty. Ltd., Australia) at 3 weeks of age and 
weaned at 10 weeks.  
On the day of birth, lambs that were weak and had trouble suckling from their ewes 
were force fed with their mother’s colostrum on the first day using a stomach tube. 
These lambs were monitored until they showed signs of being able to walk on their feet 
and suckle. At 10, 22 and 36 weeks of age, the lambs were treated with anthelminthic 
Coopers SCANDA
®
[ 80 g/L levamisole hydrochloride (HCl); 45.3 g/L oxfendazole] at 
a dose of 1 mL/10 kg live weight.  
 
3.2 Phase two – sensitization and challenge 
3.2.1 Titration of the HDM antigen 
A titration of HDM antigen was conducted on a group of twenty four, 5-6 month old 
sheep divided into 4 treatment groups of 6 animals per group in order to maximise the 
production of IgE. The 4 groups were given doses of 200 µg, 50 µg, 5 µg, or 0 µg HDM 
in a 1 ml subcutaneous injection mixed with 50 µg Quil A adjuvant (1:1 v/v) (Dalsgaard 
et al., 1990). Two inoculations of the HDM/Quil A were carried out with a week 
interval between sensitization and booster as per Bischof et al. (2003). HDM-specific 
IgE levels of the four different dose groups were assessed at 0, 7, 14, 21 and 28 days 
after the booster injection. Based on the level of IgE determined for the groups, the dose 
of 50 μg/ml of HDM (at a 1:1 ration with Quil A) was selected to be the sensitization 
dose for the experimental group of sheep as 5 out of 6 animals had HDM-specific IgE 
levels above 0.3 O.D (A450nm-A650nm). 
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3.2.2 Sensitization and challenge of the experimental sheep 
At approximately 10 months of age the group of experimental lambs resulting from the 
in utero treatment and post natal treatment (HDM, c/HDM, TCL3, c/TCL3, PNTCL3 and 
c/PNTCL3 groups) and 6 hitherto, untreated lambs (M group) were sensitized 3 times 
with 50 μg HDM with 50 μg Quil A (1:1 v/v) given subcutaneously, 14 days apart 
(Figure 3.5), at three time points (day 0, 14, and 28) and later challenged intra-
bronchially with HDM antigen on day 56. 
Blood samples were collected by venipuncture of the jugular vein using an 18 G needle 
and an evacuated tube containing ethylenediaminetetraacetic acid (EDTA) anticoagulant 
and plain (red topped) for complete blood count (CBC) and antibody titres analysis, 
respectively. Samples were taken before the first sensitization injection of HDM antigen 
(day 0) and at days 21, 56, 57, and 58. Bronchoaveolar lavage (BAL) [carried out on 
days 56 (prior to challenge), 57 and 58] and challenge (1 mg of HDM in 10 ml sterile 
PBS) (Bischof et al., 2003; Collie, 2001; Dunphy et al., 2002) were carried out using a 
bronchoscope (Section 3.2.3). 
 
 
Figure 3.5 Sensitization and challenge scheme for lambs at 10 months of age. 
 
 32 
 
3.2.3 Bronchoscopy of the experimental sheep 
Sheep were sedated with ketamine (5 mg/kg of live weight) and diazepam (0.2 mg/kg 
live weight) given slowly into the jugular vein and were then fixed in a restraining crate 
(prone position). The head was elevated and with the aid of a laryngoscope, the 
bronchoscope (Olympus GIF X20, USA) of 1.5 cm diameter was gently inserted into 
the trachea through a transparent gag (Figure 3.5A), to prevent damage to the 
instrument. The distance from the tip of the nose of the sheep to the bifurcation of the 
trachea was approximately 50 cm. The bronchoscope was progressed into the right 
bronchus until it obliterated the bronchiolar lumen, approximately 5 cm caudal to the 
bifurcation (Figure 3.5B). 
For the harvesting of bronchoaveolar lavage (BAL) on days 56, 57, and 58, 10 ml of 
isotonic saline solution at 39ºC was gently irrigated into the right (internal control) lung 
via the bronchoscope port using a hypodermic syringe (Snibson et al., 2005) (Figure. 
3.5C). After a period of 10 sec, the plunger of the syringe was pulled back (Figure 
3.5D) to withdraw up to 7 ml of bronchoaveolar lavage. The BAL fluid was put into a 
0.1% solution of dithiothreitol (DTT) to help break up mucus (Jayaram et al., 2007). 
This was stored on ice and later mixed on a rocker machine with slow and smooth 
agitation prior to Leishman’s staining. This procedure was repeated for the left (treated) 
lung of the sheep.  
For challenge on day 56, and following BAL fluid harvesting, the bronchoscopic 
approach was similar without the aspiration of BAL fluid. That is, 10 ml of PBS was 
injected into the right bronchus, followed by 1 mg of HDM in 10 ml of isotonic PBS 
solution into the left bronchus. The bronchoscope was washed and disinfected between 
animals. 
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Figure 3.6 Bronchoscopy of an experimental sheep. (A) transparent gag used to 
protect bronchoscope (arrowed); (B) Bronchoscope inserted into 
trachea of the sheep with the help of a laryngoscope; (C) Inoculation of 
the antigen/PBS into the bronchus; (D) Withdrawing the BAL fluid; (E) 
BAL in DTT solution to disperse cells; (F) BAL smear on glass slides to 
airdry, before Leishman staining.  
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3.2.4 Cytology of BAL fluid from the experimental sheep 
Leishman’s stain of cells recovered from the BAL fluid 
Fresh bronchoaveolar lavage (BAL) fluid was centrifugated (400 g, 5 min) and 20 µl of 
the cell precipitate spread and dried on a microscope slide. This was immersed in 
Leishman’s working stain (1:4 dilution of Leishman’s stain with phosphate buffer, pH 
6.8) stained for 3 min then rinsed in phosphate buffer (pH 6.8) to effect. The slides were 
then air dried completely. Slides were viewed at 600× using a compound microscope. 
At least 100 cells were identified, counted and the percentage of cell-types calculated 
(Gustashaw, 1991). 
3.2.5 ELISA Assay 
House dust mite (HDM)-specific antibodies (both IgE and IgG1) were assessed using an 
indirect ELISA assay with HDM antigens prepared from the same batch preparation as 
those used for the fetal in utero and post-lambing inoculations (Section 3.1.3). Prior to 
running the tests on sera obtained from the experimental lambs, ELISA conditions were 
optimised regarding incubation temperatures, times and reagent concentrations. The 
optimal concentration of all reagents was determined using the criss-cross serial dilution 
test. All samples were analysed in duplicate and the optimal concentration of the 
reagents was selected from the dynamic range of their standard curves. ELISA plates 
(96-welled flat bottomed Sarstedt, Australia) were coated with 2.5 µg/ml of HDM 
antigen in bicarbonate/carbonate buffer (pH 9.6) at 37°C for 2 h (Margulies, 2001). This 
was followed by a 3 × wash with 200 µl per well of washing buffer [phosphate buffered 
saline plus Tween 20 (PBST: 0.15 M NaCl, 10 mM phosphate, 0.05% Tween 20)]. 
Wells on the plates were dried by repeatedly hitting the open end downwards on a stack 
of paper towels. The plates where then blocked for 20 min at room temperature with a 
blocking buffer (2.5% BSA solution in 1 × PBS). The plates were washed as described 
previously and sealed in plastic bags and stored at -20ºC until used (Shaw et al., 1997).  
Sera for IgE analyses were mixed at 1:1 with 70% ammonium sulphate solution to 
precipitate out non-IgE antibodies (Shaw et al., 1998). Test sera for ELISA were diluted 
1:1000 for HDM-specific IgG1 or 1:4 for HDM-specific IgE. One hundred µl of diluted 
sera was added to each coated well and incubated at 37°C for 1 h (Robinson & Bowie, 
2004). This was followed by a 3 washes in PBST. The plates were then incubated with 
100 µl of monoclonal antibody (IgG1) generated in mice against sheep IgG1 (dilution, 
1:500) or IgE (dilution, 1:4) respectively, (both gifted from Richard Shaw, AgResearch, 
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Palmerston North, New Zealand) and incubated at 37°C for 2 h, followed by 3 washes 
and then incubated with goat, anti-mouse IgG (y-chain specific) peroxidase conjugate 
(Sigma A- 3673) at 1:1000 dilution for 1 h at 37°C. A final incubation with 100 µl of o-
phenylenediamine dihydrochloride (OPD) substrate (Sigmafast™, New Zealand) per 
well was carried out at room temperature for 15 min and reactions stopped with 100 µl 
per well of a 1.5 M sulphuric acid solution. The optical density (O.D.) was measured 
using a Flourstar microplate reader (BMG Technologies, Germany) with 450 nm and 
650 nm filters. Intra-plate coefficient of variation (CV) was calculated with the standard 
deviation of positive sera from 16 wells divided by their mean and varied from 9.0-
11%. Inter-plate CV was calculated (positive sera from 4 wells per plate). The standard 
deviation of the optical density (O.D.) values was divided by the mean of these values 
and was 9-15% (Theisen et al., 2001). 
Cross-reactivity of the HDM antigen with sheep lice antibody (Arlian et al., 2002; 
Arlian et al., 1984) was tested by the ELISA assay using HDM antigen and positive and 
negative sera of sheep lice (Bovicola ovis), gifted by Dr. A Pfeffer of AgResearch, 
Palmerston North, New Zealand with fetal calf serum as the blank sera (Table 3.1). 
Table 3.1 Levels of sheep IgG1 specific for sheep lice (Bovicola ovis) and house 
dust mite (Dermatophagoides pteronyssinus). 
Serum dilution 
factor 
O.D. (A650nm-450nm) 
 Fetal lamb serum 
(negative control) 
HDM 
positive 
serum 
Sheep lice 
(Bovicola ovis) 
positive serum 
Sheep lice 
(Bovicola ovis) 
negative serum 
10
2
 0.07 1.13 0.95 1.0 
10
3
 0.06 0.49 0.28 0.35 
10
4
 0.06 0.05 0.06 0.05 
10
5
 0.06 0.05 0.06 0.05 
10
6
 0.06 0.04 0.06 0.04 
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3.2.6 Gross pathology of the respiratory system  
Forty-eight hours after the experimental sheep were challenged with the HDM 
antigen/allergen by bronchoscopy, the sheep were euthanized with an intravenous 
injection of sodium pentobarbitone (Pentobarb 300
®
) (Chen et al., 1991), at 3 ml/1 kg 
live weight, followed by exsanguination (González et al., 2005). A necropsy of the 
whole carcass was conducted with special emphasis on the respiratory tract. The 
external surface of the lungs was examined visually and palpated. The bronchial and 
mediastinal lymph nodes were incised and inspected (Griffiths, 2005). A cut was made 
through the larynx and continued down the length of the trachea to the small 
bronchioles to inspect for lung worm. Any external lesions and hepatisation (red 
consolidation) (Jubb et al., 1985; Smith et al., 1972) were noted and size measured with 
a ruler. Regions with hepatisation were excised along with some normal tissue 
(González et al., 2005) for histological analysis. Classification of hepatisation of the 
lungs following necropsy was defined as: (a) extensive: > 20 mm × 20 mm × 20 mm or 
equivalent or (b) marginal: <20 mm × 20mm × 20 mm or (c) no lesion.  
3.2.7 Lung histology of the sensitized and challenged experimental sheep lung 
Sections of lung tissue (7 mm thick) including hepatisation margins were taken and 
placed in 10% PBS buffered formalin (10%) to prevent autolysis, stabilise the cells, 
make them resistant to later histological processes and reactive to staining (Kharalkar et 
al., 2009; Margarone et al., 1985). Tissue sectioning plus staining were carried out at 
AgResearch, Palmerston North, New Zealand.  
Four slides from each tissue section were read and each animal received an average 
score for perivascular and peribronchial inflammation. The total inflammation score 
was the sum of both averaged perivascular and peribronchial inflammation scores (Sur 
et al., 1999) (Table 3.2). The scoring of the inflammation was done by a histologist 
blinded to the treatment groups.  
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Table 3.2 Inflammation score of lung tissue from the sensitized and challenged 
experimental sheep (from Sur et al., 1999). 
Peribronchial and perivascular inflammation Score 
No inflammation or occasional few inflammatory cells 0 
Mild: limited focal perivascular or peribronchial inflammation 1 
Moderate: focal perivascular or peribronchial inflammation 2 
Marked: diffused perivascular or peribronchial inflammation 3 
 
3.3 Statistical Analysis 
Optical densities (O.D.) of the antibody titre levels (ELISA) were analysed using the 
general linear model (GLM) SAS 9.13 as a one-way analysis of variance (ANOVA) 
with a fixed effect model (SAS Institute Inc., 2008). Where the distribution of results 
within a group was not normal, data were log transformed prior to analysis. 
Leukocyte sub-populations in the bronchoaveolar lavage fluid measured as percentage 
values of the total cells were analysed by the procedure mixture (ProcMix) model of 
SAS 9.13, in a one-way ANOVA (SAS Institute Inc., 2008). Individual peripheral white 
blood cell populations were analysed as absolute numbers, and were log-transformed 
[log10 (PMN+1)] before analysis to normalise the data but were graphed as back-
transformed values. Data from the histology of sheep lung tissue after slaughter were 
analysed with the REML mixed-model routine in GenStat (version 12) (Payne et al., 
2009). A P value of <0.05 was set as significant for all analysed data. 
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Chapter 4 
Results 
4.1 Clinical observation of experimental ewes and lambs 
Surgery on the experimental ewes (n=16) progressed uneventfully and there was no 
mortality. Despite the previous ultrasonic diagnosis of twin pregnancies, one of the 
ewes was found to be carrying a single fetus and another ewe, triplets.  
Perinatal lamb losses included: 2 lambs from the c/HDM group and 2 lambs from the 
HDM group. All the ewes delivered their lambs without any human assistance. Lambs 
were able to stand and suckle in most cases, otherwise lambs were encouraged to nurse 
from their mothers and protection from the weather elements was provided using lamb 
covers. Attempts were made to take blood samples from the experimental lambs before 
they had suckled from their ewes on the first day of their life. However, as the ewes 
were grazed on paddocks and the lambing times were typically during the early hours of 
the morning not all lambs had samples taken before they had suckled. Lambs from 
groups HDM, c/HDM, TCL3, c/TCL3 and Ctrl were administered a booster dose of the 
same preparation that they had been given in utero. Lambs from groups PNTCL3 and 
c/PNTCL3 were given sensitisation doses by intragastric lavage identical to that given to 
the TCL3 and Ctrl groups respectively as neonates, immediately after blood sampling 
and this was repeated at 21 days of age. Lambs remained with their mothers until 
weaning time (10 weeks of age).  
From birth till 10 months of age when the lambs were sensitized with HDM, some were 
withdrawn from the experiment due to loss of identification ear tags or death (Table 
4.1). 
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Table 4.1 Lamb survival as neonates and at 10 months of age.  
Experimental group Neonates Lambs at 10 
months of age 
Lambs at 
necropsy 
HDM 5 4 4 
c/HDM 5 4 4 
TCL3 5 5 4 
c/TCL3 3 1 1 
PNTCL3 6 6 6 
c/PNTCL3 6 3 3 
Control (Ctrl) 5 5 5 
M* _ 6 5 
* = lambs acquired only for sensitization/challenge phase 
 
4.2 Antibody titres in the peripheral blood of neonates  
4.2.1 HDM-specific IgE 
Treatment of in utero and neonatal lambs with HDM antigen had a significant effect on 
the level of HDM-specific IgE recorded over the 4 week period following birth 
(P=0.04). There was also a highly significant change in the levels of HDM-specific IgE 
over time (P<0.0001). Treatment and time interactions of HDM-specific IgE levels 
showed a significant difference (P=0.01). The HDM and c/HDM groups of lambs 
showed a significantly higher level of HDM-specific IgE than the rest of the groups 
(TCL3, c/TCL3, PNTCL3, c/PNTCL3 and Ctrl) one week after lambing. Both of these 
experimental groups had a significant reduction in the level of HDM-specific IgE levels 
from the first week of birth to the second week (Figure 4.1, 4.2). The levels of HDM-
specific IgE from the rest of the groups tended to decrease from the first week although 
the reductions were not significant (Figures 4.1, 4.3 – 4.5). 
In general, the HDM-specific IgE levels detected for sibling pairs of lambs were similar 
over all the treatment groups over the 4 week period of investigation (Figures 4.2 – 4.5), 
the exception being when one of the twins had an elevated initial level (day 0), 
presumably due to colostral ingestion prior to sampling (e.g. 438/483. 492/178, 
437/487). 
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c/TCL3 / 3 
 
 
Figure 4.1 Mean HDM-specific IgE levels of the in utero/post-natal HDM or TCL3 
treated experimental lambs (serum diluted 1:4). Error bars = standard 
error of mean. 
 
Figure 4.2 HDM-specific IgE levels of in utero HDM-treated lambs and their twin 
siblings:429/435; 496/491; 490/489. Lambs # 436/111; 493/485 were not 
co-twins;their co-twins were lost at lambing.  
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Figure 4.3 HDM-specific IgE levels of in utero TCL3 treated lambs and their twin 
siblings: 430/497; 483/438; 492/178. Siblings #434/433 were both treated 
with TCL3 antigen. 
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Figure 4.4 HDM-specific IgE levels of post-natal TCL3 treated lambs and their 
twin siblings: 499 /491, 500/480, 222/180, 437/487, 440/486.  
 
 
 
Figure 4.5 HDM-specific IgE of in utero PBS (control) treated lambs and their 
twin siblings. 441/482, 497/484, 495 (a single). 
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4.2.2 HDM-specific IgG1 
Treatment of the experimental group of sheep with HDM antigen did not have a 
significant effect on the level of HDM-specific IgG1 level recorded for the experimental 
lambs over the four week period (P=0.08). Time, however, had a significant effect on 
the recorded HDM-specific IgG1 levels for the same period (P<0.0001). Time and 
treatment interaction over the period of 4 weeks was not significant (P=0.22). Although 
the highest level of HDM-specific IgG1 was recorded during the first week after birth, 
the fourth week still had levels that were easily detectable (Figure 4.6). HDM- specific 
IgG1 levels were similar for sibling pairs during the first 4 weeks of age (Figures 4.7-
4.10). 
 
Figure 4.6 Mean HDM-specific IgG1 levels of the in utero/post-natal HDM or 
TCL3-treated experimental lambs (serum diluted 1:10
3
). Error bars = 
standard error of mean. 
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Figure 4.7 HDM-specific IgG1 levels of in utero HDM treated lambs and their twin 
siblings. 429/435; 496/491; 490/489. Lambs 436/111; 493/485 were not 
co-twins.  
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Figure 4.8 HDM-specific IgG1 levels for in utero TCL3 treated lambs and their 
twin siblings. 430
 
/497, 483/438, 492/178, Siblings 434/433 were both 
treated with TCL3 antigen.  
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Figure 4.9 HDM-specific IgG1 levels of post natal TCL3 lambs and their twin 
siblings: 499 /491, 500/480, 222/180, 437/487, 440/486. 
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Figure 4.10 HDM-specific IgG1 for in utero PBS (control) lambs and their twin 
siblings: 441/482, 497/484, 495 (a single). 
 
 
Table 4.2 Correlation between lambs’ HDM-specific IgE and HDM-specific IgG1 
during the first 4 weeks of life. 
Group HDM c/HDM TCL3 c/TCL3 PNTCL3 c/PNTCL3 Ctrl 
HDM-
specific 
IgE:IgG1 
0.88 0.97 0.87 0.80 0.46 0.70 0.77 
All the experimental groups showed a strong positive correlation between their HDM-
specific IgE and IgG1 apart from the PNTCL3 group that showed a moderate positive 
correlation. 
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4.3 Antibody titres in the peripheral blood of sensitized and 
challenged sheep 
4.3.1 HDM-specific IgE 
The experimental groups of sheep did not differ in HDM-specific IgE levels (P>0.05) 
due to the treatment with HDM antigen over the sensitization period (from day 0) and 
following challenge to slaughter (day 58). However, time had a significant effect on 
HDM-specific IgE levels for the various experimental groups over the 58 day period 
(P=0.0001). There was a significant treatment and time interaction over the same period 
(P=0.05). For the PNTCL3 group there was a significant rise in HDM-specific IgE 
levels from day 0 to day 21 (P=0.001) but a significant drop between day 21 and day 56 
of sensitization (P=0.012). A similar trend was noted for the M group, which showed a 
significant rise from day 0 to day 21, then a drop from day 21 to day 56 (P=0.0001 & 
0.0010) respectively. The M group showed a significantly higher level of HDM-specific 
IgE on day 21 to the rest of the groups, apart from the HDM group. The HDM group 
had significantly higher HDM-specific IgE levels compared with the c/PNTCL3 group 
on day 21. There were no significant differences (P>0.05) in HDM-specific IgE levels 
of the groups on days 56, 57 or 58 (Figure 4.11).  
 
 
Figure 4.11 HDM-specific IgE levels of the sensitized and challenged 
experimental sheep. Sera diluted 1:4. Error bars = standard error of 
mean. 
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When individual sheep’s HDM-specific IgE levels were assessed 9 out of 33 sheep were 
atopic. Atopy was defined as HDM-specific IgE level higher than the mean of baseline 
reading of all the sheep (excluding sheep from HDM and c/HDM groups) plus 5 times 
the standard deviation of the mean of HDM-specific IgE values, at 7 days after the 
booster inoculation was given (day 14), as per Bischof et al. (2003). The M group had 
the largest proportion (4 out of 6) of experimental animals that were atopic (Figure 
4.12).  
 
Figure 4.12 HDM-specific IgE levels in sheep 7 days after the first booster 
inoculation. Atopic sheep with IgE levels greater than the mean of 
baseline reading of all sheep at day 0 (excluding sheep from HDM and 
c/HDM groups) + 5 × S.D. of the mean = [0.32 O.D]. (Bischof et al., 
2003). 
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4.3.2 HDM-specific IgG1 
Treatment of the experimental group of sheep with HDM antigen did not have any 
significant effect (P>0.05) on the levels of HDM-specific IgG1 measured from 
sensitization, through challenge to slaughter (day 0-58). There was a time effect 
(P<0.0001) but treatment and time interactions were not significant (P>0.05). There was 
a significant rise in HDM-specific IgG1 levels for all the groups between day 0 to day 
21 with the P values ranging from P<0.0001 for group M to P=0.04 for the TCL3 group 
(Figure 4.13). The PNTCL3 group was higher than the c/PNTCL3 group on days 56 
(P=0.04) and 57 (P=0.01). The c/HDM group was higher than the Ctrl group on day 56 
(P=0.006). At 48 h after challenge (day 58), c/HDM levels were higher than the M 
group (P=0.03) (Figure 4.13). 
 
 
Figure 4.13 HDM-specific IgG1 levels of the sensitized and challenged group of 
sheep. Sera diluted 1:10
3
. 
 
Error bars = standard error of mean. 
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4.4 Peripheral blood cells of sensitized and challenged sheep 
4.4.1 Eosinophils 
Peripheral blood eosinophil numbers from the different experimental groups did not 
show any significant differences over the sensitization period and following challenge 
(P=0.40) due to the treatment with HDM. There were however, significant changes over 
that time (P=0.0005). The treatment and time interaction was not significant for 
eosinophil numbers (P>0.05). Apart from the Ctrl (control) group that had a significant 
(P=0.02) increase in eosinophil numbers at 24 h after challenge, no other group had any 
significant change in eosinophil number after challenge. Numbers of eosinophils in the 
Ctrl group were significantly higher (P=0.04) than the PNTCL3 group at 24 h after 
challenge (day 57). At 48 h after challenge (day 58), the Ctrl group had significantly 
higher eosinophil numbers compared with the c/PNTCL3, the c/TCL3 (P=0.01) and the 
M group (P=0.02) (Figure 4.14). The atopic TCL3 sheep showed a significant increase 
in eosinophil numbers at 48 h post challenge compared with eosinophil numbers 24 h 
post challenge. 
 
Figure 4.14 Eosinophil numbers from the sensitized and challenged group of 
sheep. Error bars = standard error of mean.  
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4.4.2 Polymorphonuclear cells (PMNs) 
The HDM antigen given to the different experimental groups did not, overall, have a 
significant effect on the peripheral blood PMN numbers recorded for the treatment 
groups (P=0.60). However, there were significant changes in PMN numbers over time 
(P=0.004). There was no significant treatment and time interaction over the period for 
the different treatment groups (P=0.80). The M group had a significantly higher PMN 
count at 48 h post challenge (day 58) than on the day of challenge (day 56). Throughout 
the time of sensitization and following challenge there were no significant differences in 
PMN numbers between the groups apart from the day of challenge when the Ctrl group 
showed significantly higher PMN numbers compared with the TCL3 group, (P=0.05). 
The TCL3 group had a significant rise (P=0.05) in PMN numbers on day 57 (Figure 
4.15). The PMN numbers for the atopic sheep did not show any significant differences 
from non–atopic sheep during the challenge and sensitization period. 
 
Figure 4.15 Polymorphonuclear cell numbers for sensitized and challenged 
sheep. Error bars = standard error of mean. 
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4.4.3 Lymphocytes 
Peripheral blood lymphocyte numbers for the different experimental groups of sheep 
did not show any significant differences (P>0.05) during sensitization and following 
challenge. However, the lymphocyte numbers significantly varied with time over the 
period (P=0.0001). There was no significant interaction between treatment and time 
(P>0.05). At the beginning of sensitization the various groups did not have any 
significant difference in lymphocyte numbers apart from the Ctrl group showing 
significantly higher numbers than the c/TCL3 group (P=0.03). The M group showed 
significantly lower lymphocyte numbers than the HDM, PNTCL3 and TCL3 groups on 
day 21 of sensitization (Figure 4.16). On the day of challenge (day 56), the M group had 
significantly lower lymphocytes than the Ctrl, HDM and PNTCL3 groups. Similarly on 
day 57, M showed significantly lower lymphocyte numbers than the HDM group 
(P=0.046) and on day 58, the M group showed significant lower lymphocyte numbers to 
the PNTCL3 (P=0.03), c/PNTCL3 (P=0.04), HDM (P=0.02) and the Ctrl groups 
(P=0.01) (Figure 4.16). 
 
Figure 4.16 Lymphocyte numbers of the sensitized and challenged group of 
experimental sheep. Error bars = standard error of mean. 
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4.4.4 Monocytes 
Monocyte numbers in the peripheral blood of the sheep of the various treatment groups 
significantly varied over the period from start of sensitization through challenge to 
slaughter (P= 0.02). For the TCL3 group, there was a significant rise in monocyte 
numbers from day 0 to day 21 (7 days after second sensitization inoculation). The HDM 
group however, showed a significant reduction in monocyte numbers during this same 
period (Figure 4.17).  
 
 
Figure 4.17 Monocyte numbers of the sensitized and challenged sheep. Error 
bars = standard error of mean. 
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4.4.5 Basophils 
There was a no significant HDM antigen treatment effect on peripheral blood basophil 
numbers of the sheep throughout sensitization and following challenge. Neither was 
there a time effect nor treatment/time interaction. The basophil numbers from the 
c/HDM (control to in utero HDM treated sheep) showed a significant rise in basophil 
numbers (P=0.02) from day 57 to day 58 (Figure 4.18). 
 
 
Figure 4.18 Basophil numbers of the sensitized and challenged group of sheep. 
Error bars = standard error of mean. 
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4.5 Bronchoaveolar lavage (BAL) of sensitized and challenged sheep 
4.5.1 Eosinophils 
There was no significant treatment effect on eosinophil numbers in the BAL fluid of the 
left lung in the various groups. There was a significant time effect on eosinophil 
numbers in the left lung (P=0.005) but no treatment and time interaction. In the left lung 
the c/HDM group had significantly higher numbers of eosinophil at 48 h after challenge 
compared with the rest of the experimental groups. The increase in eosinophils from 24 
h to 48 h after challenge was highly significant (P=0.005). In the c/HDM group the left 
(treated) lung had significantly higher number of eosinophils than the right (control) 
lung at 48 h (P=0.001). However, the right (control) lung of the PNTCL3 group had 
more eosinophils at 48 h post challenge than the left (treated) lung (P=0.03). Similarly 
in the TCL3, group there was a significantly higher eosinophil percentage in the right 
(control) lung than the left (treated) lung at 48 h post challenge (P< 0.05) (Figure 4.19). 
The atopic sheep from the TCL3 (sheep # 483) and the PNTCL3 (sheep # 499 and 500) 
groups had significantly less eosinophils in the BAL fluid from the left (treated) lung 
than from the right (control) lung (P=0.05) at 24 h and 48 h after challenge. The atopic 
sheep from the other groups did not show any significant differences between their left 
and right lungs. 
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Figure 4.19 Eosinophil % in BAL fluid from lungs of the sensitized and 
challenged   sheep. * denotes significant difference between lungs of 
P<0.05. *** denotes significant difference  between lungs of P<0.005. 
Error bars = standard error of mean. 
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4.5.2 Polymorphonuclear cells (PMN) 
Treatment of the experimental groups of sheep did not have a significant effect (P=0.09) 
on the numbers of PMN in either the left (HDM-treated) lung or the right (control) lung 
of the sheep over the sensitization period until 48 h after challenge. Time, however, had 
a very significant effect (P<0.0001) on the PMN recorded in the left but not the right 
lung over that period. There was no treatment versus time effect on the PMN cell 
numbers in either lung.  
The TCL3 group had significantly higher numbers of PMN in the left (treated) lung at 
24 h post challenge (P=0.001) compared with the right lung and similarly the PNTCL3 
group had significantly more PMNs in the left lung (P=0.04) compared with the right 
lung at 48 h post challenge (Figure 4.20). The HDM-treated lungs (left) of the atopic 
sheep in the M group showed a significant (P=0.02) rise in PMN numbers 24 h post 
challenge. 
 
Figure 4.20 Polymorphonuclear cells % in BAL fluid from lungs of the sensitized 
and challenged sheep.* denotes significant difference between lungs of 
P<0.05. *** denotes significant difference between lungs of P<0.005. 
Error bars = standard error of mean. 
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4.5.3 Lymphocytes 
The BAL fluid harvested from the left (treated) and the right (control) lungs of the 
experimental sheep did not differ in their lymphocyte percentage before challenge with 
HDM antigen. Treatment with HDM antigen caused a significant difference in 
lymphocyte percentage (P=0.003) in the BAL fluid from the left lung of the 
experimental sheep compared with the right (PBS treated) lung. Neither time nor 
time/treatment interactions were evident in either lung regarding lymphocyte numbers. 
The M group of sheep had a significant difference in lymphocyte percentage between 
the left and right lung at 24 h post challenge with the left lung having a significant 
(P=0.006) increase in lymphocyte percentage at 24 h post challenge (Figure 4.21), due 
to the atopic sheep that had significantly higher (P = 0.001) lymphocyte numbers in the 
BAL fluid from the left (treated) as compared with the right (control), 24 h after 
challenge. In the c/HDM group at 48 h post challenge, the right lung contained 
significantly more lymphocytes than the left lung.  
 
Figure 4.21 Lymphocyte % in BAL fluid from lungs of the sensitized and 
challenged sheep. * denotes significant difference between lungs of 
P<0.05. ** denotes significant difference between lungs of P<0.01. Error 
bars = standard error of mean. 
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4.5.4 Macrophages 
Treatment had no effect on the number of BAL fluid macrophages following 
bronchiolar infusion of HDM or PBS into the lung of the experimental sheep (P>0.05). 
Time however, had a highly significant effect on the macrophage numbers in the left 
and right (P<0.0001) but there was no time and treatment interaction over the period for 
either lung (P>0.05).  
All the experimental groups of sheep showed a significant decrease in macrophage 
percentage 24 h after administration of HDM and PBS into the left and right lungs, 
respectively (Figure 4.22). 
 
Figure 4.22 Macrophage % in BAL fluid from lungs of the sensitized and 
challenged sheep. * denotes significant difference between lungs of 
P<0.05. Error bars = standard error of mean. 
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4.6 Gross pathology of the sensitized and challenged sheep 
There were, in general, no signs of coughing, wheezing or difficulty in breathing 
amongst the sheep sensitized and challenged with HDM antigen. Occasional coughs 
that were noticed amongst the flock of sheep were random and not attributed to any 
particular treatment. Clinically all the sheep were in good health and chest region 
auscultation was normal prior to slaughter. 
On necropsy, apart from areas of hepatisation (red consolidation), lung tissue seemed 
normal. Regions of hepatisation were common across the three lobes of the sheep lung 
(Figure 4.23) (Table 4.3). Dictyocaulus filaria, was found in the bronchi of 2 sheep that 
could account for associated submandibular oedema (found on 1 sheep). There were no 
signs of nodules, tubercles, pulmonary oedema or emphysema associated with this 
worm as described by Bewley (1887) and Urquhart et al (1987).  
 
 
  
6
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Table 4.3 Gross pathology of lungs of the sensitized and challenged sheep (n = 33). 
Animal ID Group Gross pathology (area of hepatisation) of lungs Comment Extensive hepatisation 
    Left lung Right lung 
923 M Left and right lungs have: 50x50x50 mm hepatisation in 
apical and cardiac lobes 
  Yes Yes 
714 M Left and right lungs have 50x10x15mm hepatisation. Lung worms in 
trachea and 
submandibular 
oedema  
Yes Yes 
716 M Left and right lungs have >3 areas hepatisation 50x50x50 
mm) in apical, cardiac and diaphragmatic lobes. 
Cough Yes Yes 
251 M Worms in left bronchus. Right lung has marginal 
hepatisation. Left lung has >3 areas of hepatisation 50x50x50 
 Yes No 
593 M Nil Rales No No 
338 M Nil   No No 
441 Ctrl Right lung has marginal hepatisation on diaphragmatic lobe; 
left lung has 50x15x32 mm hepatisation on the 
diaphragmatic lobe. 
  Yes No 
482 Ctrl Right lung has a 60x20x20 mm hepatisation at tip of cardiac 
lobe; left lung has a 60x20x30 mm hepatisation at tip of 
diaphragmatic lobe. 
  Yes Yes 
495 Ctrl Nil  No No 
497 Ctrl Right lung has no observable lesions; left lung has a 
50x20x35mm hepatisation on diaphragmatic lobes. 
  Yes No 
484 Ctrl Nil 
 
 
 
 
 
 
 
 
 
 No No 
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Animal ID Group Gross pathology (area of hepatisation) of lungs Comment Extensive hepatisation 
    Left lung Right lung 
429 HDM Right lung has hepatisation of 20x24x22 mm in cardiac lobe 
margin; left lung has marginal hepatisation on apical lobe. 
Cough and rales 
on auscultation. 
No Yes 
436 HDM Right lung has hepatisation on the margins of the cardiac 
lobe; left lung has hepatisation on the margins of cardiac and 
diaphragmatic lobes. 
  No  No 
496 HDM Nil  No No 
493 HDM Left lung has a 50x80x65 mm hepatisation on the 
diaphragmatic lobe and a 50x30x40 mm hepatisation on the 
cardiac lobe. No observable lesions on the right lung 
  Yes  No 
489 c/HDM Nil   No No 
485 c/HDM Right lung has no observable lesions; left lung has a 
50x10x30 mm hepatisation on diaphragmatic lobe. 
  Yes No 
491 c/HDM Nil   No No 
435 c/HDM Right lung has 50x15x32 mm hepatisation on the cardiac 
lobe; left lung has marginal hepatisation of the cardiac and 
diaphragmatic lobes. 
  No Yes 
483 TCL3 Nil   No No 
433 TCL3 Nil   No No 
434 TCL3 Right lung has 50x20x35 mm hepatisation on apical and 
cardiac lobes; left lung has 80x50x65 mm hepatisation on 
cardiac and 50x20x35 mm on the diaphragmatic lobes 
Rales on 
auscultation 
Yes Yes 
492 TCL3 No observable lesions on right lung; left lung has marginal 
hepatisation on apical lobe. 
Rales on 
auscultation of left 
lungs. Left lung 
had signs of 
superficial 
pleuritis 
No No 
438 c/TCL3 Nil 
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Animal ID Group Gross pathology (area of hepatisation) of lungs Comment Extensive hepatisation 
    Left lung Right lung 
500 PNTCL3 Nil   No No 
480 PNTCL3 Nil   No No 
440 PNTCL3 Right lung has 50x20x35 mm hepatisation at tip of 
diaphragmatic lobe; left lung has 50x20x35 mm hepatisation 
at tip of diaphragmatic lobe. 
  Yes Yes 
437 PNTCL3 Right apical lobe has 70x20x45 mm and left lung has 
50x20x35 mm hepatisation on diaphragmatic lobe  
  Yes Yes 
499 PNTCL3 Right lung has marginal hepatisation; left lung has  
70x30x50 mm hepatisation on diaphragmatic lobe 
 
  Yes No 
490 PNTCL3 Right lung has 60x20x15 mm hepatisation at tip of 
diaphragmatic lobe; left lung has a 60x15x10 mm 
hepatisation at tip of diaphragmatic lobe. 
  Yes Yes 
432 c/PNTCL3 Right lung has a 15x10x12 mm hepatisation on the 
diaphragmatic lobe; left lung has a 40x40x40 mm on 
diaphragmatic lobe 
  Yes No 
487 c/PNTCL3 Right lung has marginal hepatisation in diaphragmatic lobe 
left lung has 2 areas of 50x50x50 mm diaphragmatic lobe 
  Yes No 
486 c/PNTCL3 Right lung has marginal hepatisation in diaphragmatic lobe 
left lung has 2 areas of 50x50x50 mm on diaphragmatic lobe 
 Yes No 
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Figure 4.23 Gross pathology of sensitized and challenged experimental sheep 
lung at necropsy. (A) = no hepatisation (B) = marginal hepatisation 
(C)= extensive hepatisation. 
 
Table 4.4 Ratio of number of sheep with extensive left (treated) lung hepatisation 
per total number of sheep in the group. 
Group Extensive left lung 
hepatisation /number 
in the group 
HDM 1/4 
c/HDM 1/4 
TCL3 1/4 
c/ TCL3 0/1 
PNTCL3 4/6 
c/PNTCL3 3/3 
M 4/6 
Ctrl 3/5 
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4.7 Histopathology of lungs of the sensitized and challenged sheep 
At histology, there were accumulation of leucocytes in different regions (lumen of 
bronchi and bronchioles, perivascular, peribronchial and parenchyma tissue) of the 
lungs (Figure 4.2 A and B). The level of inflammation was scored from 0 – 4 which 
depicted areas of mild to severe inflammation (Figures 4.24 C and D respectively) (Sur 
et al., 1999). 
 
Figure 4.24 Histological stain (H&E) of sheep lung after sensitization and 
challenge with HDM antigen. Yellow arrow – accumulation of 
leucocytes in bronchiolar lumen. Blue arrow – accumulation of 
leucocytes at peribronchial area. Green arrow – perivascular 
accumulation of leucocytes. Black arrow – accumulation of leucocytes 
in lung parenchyma. C – mild inflammation (score – 0). D- severe 
inflammation (score - 4) 
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The different treatments given prior to the sheep being sensitized and challenged with 
HDM antigen did not affect the perivascular and peribronchial inflammation scores (Sur 
et al., 1999), overall (P>0.05). Inflammatory scores for the left lungs (treated with 
HDM) were significantly greater (P<0.05) than the right lungs, (treated with PBS) from 
the animals of treatment groups Ctrl, c/HDM, HDM, and M. However, there was no 
significant difference between the left and right lungs of animals from groups c/TCL3, 
TCL3, c/PNTCL3 and PNTCL3 (Figure 4.24; Table 4.5). 
 
Figure 4.25 Histological lung score of perivascular and peribronchial 
inflammation from the sensitized and challenged sheep. Error bars = 
standard error of mean. 
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Table 4.5 Mean inflammation indices of lung following challenge with HDM. 
Group Lung side P value 
 Left
α
 Right
β
 γ 
HDM 2.477 0.251 0.001 
c/HDM 2.258 0.676 0.012 
TCL 1.278 1.012 0.704 
c/TCL3 1.609 0.509 0.154 
PNTCL3 1.493 1.402 0.857 
c/PNTCL3 1.718 1.338 0.678 
Control (Ctrl) 1.819 0.822 0.023 
M 2.856 1.546 0.016 
α=bronchiolar infusion of 10 ml of 0.01% HDM solution  
β=bronchiolar infusion of 10 ml of isotonic saline solution  
γ= P value of difference between left and right lung of the same treatment group 
 
There was a moderate positive correlation between left lung inflammation at slaughter 
and the presence of lymphocytes (r = 0.24 & 0.36) and eosinophils (r = 0.20 & 0.29) in 
the BAL fluid, 24 and 48 h after HDM challenge, respectively. In general, the peripheral 
leucocytes were negatively correlated with inflammatory change (r ranging from -0.15 
to -0.44). Similarly, the IgE and IgG1 titres were negatively correlated with 
inflammation change albeit at low magnitude (-0.12 to -0.25 for IgE, and -0.04 to -0.27 
for IgG1) (Figure 4.25; Table 4.6). 
Table 4.6 Correlation between inflammation of left lung versus leucocytes in BAL 
fluid or peripheral blood or HDM-specific IgE and IgG1 titres in serum, 
following sensitization and challenge of all sheep. 
 
  
Time after 
sensitization 
BAL Peripheral blood Serum 
Lympho 
cyte 
Eosino 
phil 
PMN 
Lympho 
cyte 
Eosino 
phil 
PMN IgE IgG1 
21 - - - -0.20 0.035 -0.074 -0.146 -0.038 
56 0.140 -0.038 -0.157 -0.150 -0.059 -0.179 -0.254 -0.271 
57 0.238 0.197 0.086 -0.435 0.080 -0.131 -0.211 -0.113 
58 0.36 0.29 -0.003 -0.171 -0.173 -0.099 -0.121 -0.042 
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Figure 4.26 A scatter plot of correlations between cell numbers from 
brochoalveolar lavage fluid (%), peripheral blood leucocytes (absolute 
numbers) and lung histology (inflammation index) of HDM-specific 
IgG1 and IgE (O.D.) after sensitization and challenge (day 58). 
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Chapter 5 
Discussion 
In this study, introduction of lambs to helminth antigen at prenatal or neonatal stages 
minimized inflammation in the treated, compared to the control lung, after sensitization 
and challenge. The introduction of house dust mites to fetal lambs however did not have 
any significant effect on inflammation in the lungs at necropsy. Certain cellular immune 
responses (increased eosinophils and lymphocytes in the BAL) of all the various groups 
were positively correlated with inflammation found in the lung tissue at histology. 
However, there was no association between blood antibody and inflammatory change. 
In this study 16 twin-bearing ewes underwent hysterectomies, and their feti at 120 days 
of gestation, were treated with antigen prepared from either house dust mites HDM 
(Dermatophagoides pteronyssinus), or Trichostrongylus colubriformis infective larvae 
(TCL3) or phosphate buffered saline solution (PBS) which was infused into the 
stomach. Surgery was uneventful with all ewes recovering fully. This is in accordance 
with previous experimentation performed on lamb feti in utero which indicated that it is 
possible for a pregnant ewe to have a normal term gestation if surgery is carefully 
carried out in a sterile environment (Paalangara, 2000; Press et al., 2001). However, 9 
lambs from a total of 32 lambs were stillborn (lamb deaths less than 7 days premature). 
These deaths may have been due to lesions to the uterus during surgery which can be 
associated with abortion in ruminants (Poitras et al., 1986 ; Thornton et al., 1991). In 
our study, given the dose and time delay between our antigen (HDM or TCL3) 
administration and the appearance of stillbirths it is unlikely that the LPS levels in our 
preparations would have been the cause. Each lamb fetus received 0.016 mg of 
endotoxin in the HDM preparation. In one study, when doses of 1 mg, 4 mg and 100 mg 
of endotoxin were administered into the amniotic fluid of pregnant ewes at 125 days of 
gestation, there was no significant effect on the well-being of the fetus, and no preterm 
delivery or death was encountered (Jobe et al., 2000). In another study, continuous 
infusion of lower doses of endotoxin into the amniotic fluid (1 mg/h over 24 h), did not 
cause any abnormal changes in prostaglandin concentration, uterine activity or blood 
gas parameters (Grigsby et al., 2002). Moss et al. (2002) showed that intra-amniotic or 
intra-allantoic endotoxin caused
 
a localized inflammatory response but did not cause 
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preterm
 
delivery or intrauterine growth restriction and there were no improved or 
impaired lung functions or marked
 
alterations in lung structure, 2 months after birth.  
Analysis of blood serum from the experimental neonatal lambs indicated similar levels 
of HDM-specific antibody in the twin feti (Figures 4.2 - 4.5, and 4.8 - 4.11). This 
suggests that either antigen from the treated fetus was recognised immunologically by 
the ewe leading to the production of maternal antibodies in colostrum/milk which upon 
suckling by both lambs caused similar antibody titres in both siblings or alternatively, 
antigen was transported to the other control fetus which responded with an active 
immune response. According to Brambell (1961) and Silverstein et al. (1963) there is no 
transmission of antibody from the ewe to fetus during pregnancy in sheep, and further, 
antibodies are not transmitted between the feti. However, trauma to the uterus, due to 
surgery may have resulted in antigen being able to leak into the contralateral horn 
(Poitras et al., 1986 ; Williams et al., 2005). In this study the first explanation seems 
most likely and better explains the exponential decline in neonatal antibody titres 
(Figure 4.1). Confirmation by measuring antibody titres on maternal milk was not 
pursued. Efforts were made to sample lambs before they suckled from their ewe on day 
one but this was not possible in all cases. This was the likely reason for the differences 
in HDM-specific IgE levels at day 1 of age between twins (178/492, 437/487 and 
436/111: Figures 4.2-4.4). Mismothering may also have resulted in neonates suckling 
milk from ewes not their mother, leading to variable immunoglobulin levels in their 
serum (Pollard, 2006; Welch & Kilgour, 1970). The differing levels of antibody present 
in different twin sets may have been due to the variable amounts of antigen transferred 
from the treated feti and recognised immunologically by the ewe since responses to 
antigen depend on the route, dose and molecular structure (Constant & Bottomly, 1997; 
Power et al., 1998). 
The unexpectedly high levels of HDM-specific IgG1 found in all treatment groups may 
have been due to immunological cross-reactions between antibodies reactive to various 
plant and animal arthropods (mites, lice), as yet undefined, in our environment and 
HDM (Arlian et al., 2002; Arlian et al., 1984; Ayuso et al., 2002; Matthes et al., 1996; 
Panzani & Ariano, 2001). Fujikawa et al. (1996) indicated the probability of cross-
reaction between HDM antibody and cattle lice (Bovicola bovis) antigen found 
commonly on New Zealand cattle. Cross-reactivity between mange mite (Sarcoptes 
scabiei) found on New Zealand sheep and house dust mite antigens was demonstrated 
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by both ELISA and immuno-electrophoresis (Arlian et al., 1991; Stewart & Fisher, 
1986 ). Such allergenic components found in extracts of mites (Fujikawa et al., 1996) 
ranged in size from 10-70 kD; the HDM preparation used for inoculation in this trial 
was within the size range 10-250 kD. There was lice infestation on the sheep in this 
study, which is common during the winter months in New Zealand (Heath et al., 1995) 
when our study was undertaken. Antibodies to lice found in the sheep vary with 
intensity of infestation and may last in the sheep for up to 15 weeks (Colwell & Himsl-
Rayner, 2002; James et al., 2002). An indirect ELISA assay run with positive and 
negative sheep lice sera (gifted us by Dr. A Pfeffer) tested against HDM antigen gave 
similar results which suggested that anti-louse antibodies alone did not contribute to the 
background signal that predominated in this trial.  
The ratio of HDM-specific IgG1 to HDM-specific IgE was 2500:1 after correcting for 
antibody dilution, which is similar to levels described by Bischof et al. (2003). IgG1 
levels are highest in colostrum compared with milk, and the first week of suckling 
contributed the maximum amount of immunoglobulin in the lambs’ serum (Campbell et 
al., 1977; Korhonen et al., 2000). The level of HDM-specific IgG1 remained high and 
easily detectable until the fourth week as indicated by Campbell et al. (1977) who were 
able to detect maternal IgG1 levels in lambs 15 weeks after lambing. The half-life of 
bovine IgG1 is 10-22 days (presumably similar to sheep IgG1) compared with that of 
IgE (1-2 days) (Kacskovics et al., 2006; Watson, 1992), which explains the differing 
disappearance rates of the 2 antibody isotypes from the lambs’ peripheral blood.  
In this study the HDM-specific IgE and IgG1 levels of the individual neonatal lambs 
varied similarly over time with a positive correlation of >0.5 in all groups. The high 
level of HDM-specific IgE but not HDM-specific IgG1 for the in utero HDM-treated 
group may be due to the ability of the Der p I antigen in house dust mites to induce the 
production of IgE selectively since Der p I cleaves the low-affinity IgE Fc receptor 
(CD23) rather than IgG1 from B lymphocytes thus depriving B lymphocytes the ability 
to limit further IgE synthesis, through a negative feedback mechanism (Hewitt et al., 
1995; Yu et al., 1994), as observed in CD23 ‘knock-out’ mice (Yu et al., 1994).  
The second phase of our study was undertaken when lambs from phase one of the study 
were approximately 9 months old. At this stage our study had lost some lambs to death 
and loss of identification tags. Our statistical analysis was constrained by the number of 
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lambs per group as indicated in Table 4.1. In the second phase of this study there were 
no clinical signs of respiratory distress in any of the sheep following sensitization and 
challenge, which is in accordance with similar studies conducted in sheep (Bischof et 
al., 2003; Bischof et al., 2008; Collie, 2001; Collie et al., 2006; Walther et al., 1997), 
laboratory animals (Coyle et al., 1998; Kitagaki et al., 2006; Tournoy et al., 2000; Wang 
et al., 2001) and non-human primates (Gundel et al., 1991; Matangkasombut et al., 
2008; Mauser et al., 1995), highlighting the difficulty of finding an ideal model for 
asthma, a uniquely human disease. Other studies have looked at parameters such as 
airway hypo-responsiveness, resistance to airflow (Madwed & Jackson, 1997), 
bronchoconstriction, gross pathological and histological changes and infiltration of the 
respiratory system by inflammatory cells and cytokines to quantify human asthma in 
their animal models (Karol, 1994). In our study, inflammatory cells 
(polymorphonuclear, eosinophils, basophils, lymphocytes, and 
monocytes/macrophages), immunoglobulins (IgE and IgG1), gross pathology and 
histology of lung tissues were used to assess human asthma in the experimental sheep. 
Following sensitization and boosting there were significant changes in the HDM-
specific titres due to time (IgE and IgG1) and time versus treatment interactions (IgE). 
The increase in HDM-specific IgE and IgG1, 7 days after the second administration of 
HDM is expected and the transitory peak (HDM-specific IgE) and continued elevation 
(HDM-specific IgG1) is explained by the different half-lives of the two antibodies. The 
M group that had no prior experience to house dust mite antigen responded to the HDM 
antigen in line with a typical immunological response (IgE) to antigen after secondary 
inoculation (Roitt et al., 1996). Baseline (IgE) levels tended to be higher in the HDM 
group who had been sensitized as prenates and neonates. The TCL3 and the PNTCL3 
groups with their control siblings (c/TCL3 and c/PNTCL3) and the control (Ctrl) group 
had also never been inoculated with the HDM antigen but since all the sheep (except 
sheep from M group) had been together since birth, contamination of these sheep with 
HDM antigen by cross suckling as neonates may have occurred. Secondly, the sheep in 
the M group may have been exposed to different helminth species in varying doses from 
neonatal stage to the 9 month of age when they were introduced into the study.  
Sheep were identified as atopic when HDM-specific IgE levels were greater than the 
mean baseline IgE level of all experimental sheep (excluding the HDM and c/HDM 
groups of sheep) + (5 × standard deviation of the mean), 7 days after a second (booster) 
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inoculation of HDM antigen when given with Quil A as adjuvant. This was defined as 
per Bischof et al. (2003), where such animals were identified as responders or allergic. 
A minority of sheep were responders, and only in those groups where antigen (HDM or 
TCL3) had been administrated previously – with the exception of the M group. The 
variability in humoral response has been previously described (Glaser, 2005; Ippoliti et 
al., 2006) and may account for the difference within the M group. As to the other 7 
groups which were genetically related (bred from the same parent stock on the same 
farm). The reason for the general lack of humoral response is unknown but high levels 
of antibody (especially IgG1) are maintained in most animals suggesting there was 
repeated stimulation by an, as yet unknown, environmental antigen. This differed from 
the work by Bischof et al. (2003) where young lambs (4-5 months old) had more limited 
exposure to parasites, were treated with anthelminthic and housed indoors. 
During sensitization and challenge there were significant changes in eosinophils, PMNs, 
lymphocytes and monocytes due to time. In this study sheep were handled by personnel 
for injection (HDM), blood collection and bronchoscopy (HDM antigen challenge). 
These interventions and the unexpectedly cold weather in New Zealand at the time of 
the trial may have resulted in both acute and chronic stress in the experimental sheep 
(Dhabhar, 2002; Grandin, 1997; Kelley, 1980; Weeth et al., 1959), which could have 
accounted for the development of neutrophilia and lymphopenia (Dhabhar, 2002; Kehrli 
et al., 1999; Kelley, 1980) and eosinopenia (Minton & Blecha, 1990) and depressed 
humoral response (Borysenko & Borysenko, 1982; Esterling & Rabin, 1987; Kelley, 
1980; Silberman et al., 2003) to the HDM-antigen during sensitization. 
An eosinophilia (Garrod, 1929) and increased eosinophils in the BAL fluid (Nair et al., 
2009) is a characteristic of human asthmatics (Fitch et al., 2000), laboratory animals 
(Garlisi et al., 1995) and sheep (Bischof et al., 2008). The Ctrl group (n=6) in this study 
showed eosinophilia at 24 h after challenge, similar to human asthmatics, while the 
single atopic sheep in the TCL3 and PNTCL3 group showed a significant increase in the 
BAL fluid eosinophil numbers at 24 h post-challenge and peripheral blood at 48 h post 
challenge. Similarly there was a significant increase of eosinophil numbers in BAL fluid 
of the treated (left) lung of c/HDM group (P=0.001) and 1 of the 2 atopic PNTCL3 
sheep at 48 h post HDM-challenge (P=0.05), similar to findings from studies on mice 
(Coyle et al., 1998; Kitagaki et al., 2006). However, the eosinophil numbers were lower 
in the BAL fluid of the left (treated) lung as compared with the right (control) lung at 48 
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h post challenge in the non-atopic TCL3 (n=3) and the PNTCL3 (n=5) groups. In a study 
by Snibson et al. (2005) in which sheep were repeatedly challenged intra-bronchially 
with HDM (twice weekly for first 3 months and once weekly for the next three months) 
increasing differences in eosinophil numbers 2, 3 and 4 days post challenge were noted 
when compared with a separate group of sheep treated similarly but with saline 
solution. In another study the eosinophil numbers in mice (5-8 weeks old) previously 
immunised with HDM and later challenged with HDM showed airway hypo-
responsiveness and allergic airway changes without significant increase in airway 
eosinophils (Tournoy et al., 2000). A reduction in the production of Th2 cytokines such 
as interleukin- 4 and interleukin-5 which induce eosinophilia (Bischof et al., 2003; 
Platts-Mills, 2001) following the administration of HDM antigen (Bischof et al., 2003; 
Power et al., 1998) may result from prior exposure to nematode (Trichostrongylus 
colubriformis L3) antigen. Exposure to nematode causes a reduction in eotaxin (a 
chemokine pivotal in eosinophil recruitment) levels, (Garcia-Zepeda et al., 1996; Jose et 
al., 1994) as indicated in studies in mice previously infected with nematode and later 
challenged with ovalbumin (Kitaura et al., 1996; Wang et al., 2001). According to 
Smith (1992) human asthmatics can have a blood eosinophilia which may or may not 
correlate with the severity of the disease. In a study by Bousquet (1990), there was a 
significant increase in the number of peripheral-blood eosinophils in the patients that 
correlated with the clinical severity of asthma (P<0.001) and pulmonary function 
(P<0.03). Levels of eosinophils and eosinophil cationic protein were increased in the 
bronchoaveolar lavage fluid from the patients and also correlated with the severity of 
asthma (P<0.001 and P<0.002, respectively). In another study by Pizzichini et al. (1997) 
the levels of peripheral blood eosinophils correlated with levels of eosinophils in 
sputum but levels of eosinophilic cationic proteins in peripheral blood did not correlate 
with levels in sputum. The authors suggested that since eosinophils are tissue 
inflammatory cells that rise from the bone marrow and transported to the tissue of 
action (bronchial wall in the case of asthma), the peripheral blood and serum eosinophil 
cationic proteins (ECP) are weaker and less specific markers for inflammatory events in 
the airways (Gleich et al., 1993; Plager et al., 2006). As sheep do not show variable 
signs of asthma, our studies could not contribute to this knowledge.  
In this study the overall increasing trend in BAL fluid PMNs at 24 h post challenge in 
both lungs of all animals’ is non-specific (Abraham, 2003; Collie, 2001; Collie et al., 
2006). In a similar study by Bischof et al. (2003) it was noted that there was a 
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significant increase in PMN numbers in ‘non-allergic’ sheep 24 h and 48 h after 
challenge. Abraham et al. (2008) indicated that in acute asthma, neutrophil numbers in 
the BAL fluid of sheep increase and in chronic cases both eosinophil and neutrophil 
numbers are increased. It was noted in our study that 24 h after challenge the BAL fluid 
PMN numbers in the left (treated) lung of the TCL3 group were significantly higher 
than the right (control), which was also reflected in the elevated PMN in the peripheral 
blood at this time point. Similarly, higher BAL fluid PMNs numbers were noted in the 
left (versus right lung) of the PNTCL3 group at 48 h post challenge. This is unlikely to 
be due to inherent helminth-derived neutrophil chemotatic activities (Horii et al., 1984; 
Horii et al., 1988) because of the time period since the administration of parasite antigen 
(> 8 months). In this study, atopic sheep (4 of 6) within the M group showed a 
significant increase in BAL fluid PMNs numbers 24 h post challenge in the left treated 
lung, as opposed to right control lung which may have been transitory as observed 
during acute asthma attack in humans (McDowell et al., 2009). The mechanism and role 
of PMNs in the onset and progression of asthma in humans is not fully understood but 
researchers have made references to non-eosinophilic asthma and have implicated 
PMNs as playing a significant role in its onset (Douwes et al., 2002). In a human study, 
there was an increase in PMNs and eosinophils with the numbers increasing with 
severity of asthma episodes of the patients within 2 h of sputum induction (Jatakanon et 
al., 1999). According to Nagy et al. (1982) certain patients with asthma have only early 
reactions and a single early peak of neutrophil chemotactic activity with no further rise 
for up to 24 hours. A study in allergic horses showed that increased neutrophil (but not 
eosinophil) numbers in BAL fluid peaked at 5-7 h post challenge (Fairbairn et al., 
1993). In our study, the earliest analysis of PMNs was done at 24 h post challenge. 
Subsequent analysis of PMNs numbers was at 48 h post challenge, at which time, there 
was no significant difference between PMNs in both the treated and control lungs of all 
groups of sheep. In general blood PMN numbers had increased by 48 h after challenge.  
In this study overall lymphocyte numbers in all experimental groups of sheep changed 
significantly in the peripheral blood during sensitization and challenge over time, 
especially animals in the M group had decreasing numbers of lymphocytes in the blood 
reflecting a stress response to having been recently introduced into the study flock 
(Grandin, 1997; Kannan et al., 2000; Kelley, 1980; Sanger et al., 2011). A human study 
of the lymphocyte population in the BAL fluid and peripheral blood of asthmatics 
compared with non-asthmatics indicate increased lymphocytes in the BAL fluid of 
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asthmatics but not in the peripheral blood (Wilson et al., 2002). In a similar study in rats 
sensitized and challenged with ovalbumin, there were no significant changes in 
lymphocyte numbers in peripheral and pool blood of the treated and non-treated mice 
but changes in BAL fluid were noted (Schuster et al., 2000). The lymphocyte populace 
in the lung is normally a low proportion of total leucocytes, but in the asthmatic, CD4
+
 
T lymphocytes are increased in BAL fluids (Cohn et al., 2004; Frangova et al., 1996; 
Metzger et al., 1986). The difference between the BAL fluid lymphocyte percentage in 
the left and the right lung of the research sheep did not vary significantly when all 
treatments were combined. The significant rise in lymphocyte numbers in the treated 
lung of the atopic and non-atopic animals from the M group at 24 h post challenge is in 
line with this but was different to the findings by Bischof et al. (2003) where 
lymphocyte percentage in the BAL fluid of treated lungs was significantly lower in the 
‘allergic’ and ‘non-allergic’ sheep 24 h post challenge. The right (untreated) lung of the 
c/HDM group of sheep at 48 h post challenge showed more lymphocytes than the left 
lung. Lymphocytes play a role in antigen-driven inflammatory response by recognising 
and responding to activated antigen through the CD3/antigen complex and control the 
nature and extent of inflammation through the release of lymphokines (Corrigan & Kay, 
1992). 
During the sensitization procedure there was a significant increase or decrease in blood 
monocyte numbers in the TCL3 and HDM groups respectively, 7 days after booster 
inoculation of HDM antigen. Macrophage percentage in the BAL fluid of the 
experimental sheep decreased significantly at 24 h post challenge in both the right and 
left lungs. In a similar study by Bischof et al. (2003) a significant reduction in 
macrophage percentage in BAL fluid was noted at 24 h post challenge. In our study, at 
48 h post challenge, a significant decrease in macrophage percentage in BAL fluid was 
noted in the atopic (n=9) sheep while in the control sheep there were no significant 
reduction in BAL fluid macrophages. In the lungs macrophages are derived from 
interstitial spaces but during inflammation infiltrate as monocytes from peripheral blood 
(Jubb et al., 1985; Smith et al., 1972). In this study, the reduction in macrophage 
percentage in the BAL fluid is likely to be due to the even greater influx of granulocytes 
from the peripheral blood to the lungs after challenge with HDM antigen as suggested 
by various studies (Abraham, 2008; Gerblich et al., 1991; Schuster et al., 2000) but 
active retention (diminished migration) within the bronchiolar space could also occur 
(Hildemann et al., 1992; Wheeldon & Hansen-Flaschen, 1986). Macrophages may 
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possess allergen-specific IgE bound on their surfaces and when in contact with the 
related allergen, release lysosomal β-glucuronidase (Joseph et al., 1983). Macrophages 
from asthmatics release pro-inflammatory cytokines such as interleukin (IL)-1β, tumour 
necrosis factor-α (TNF α), interferon-γ (IFN-γ), IL-6 and granulocyte-macrophage 
colony-stimulating factor (GM-CSF) (John et al., 1998) and interaction of macrophages 
with IgE antibody may induce mononuclear leucocytes to develop into cytotoxic 
effector cells (Joseph et al., 1983).  
At necropsy, regions of hepatisation (red consolidation) were noted in the left and right 
lungs of the sheep to a similar extent and there were no other signs of gross pathology 
(Tables 4.3 and 4.4). These areas may have been caused by the administration of 
euthanasia agent (barbiturate) into our sheep (Grieves et al., 2008; Prien et al., 1988). 
However, there appears to be a trend for the animals treated prenatally with either TCL3 
or HDM, or their controls, to have less extensive lung changes. The low number of 
experimental animals surviving to this stage precludes any chance of statistical 
significance. Lung worm (Dictyocaulus filaria) is endemic in New Zealand sheep flocks 
(Urquhart et al., 1987) and these experimental sheep raised on paddocks under routine 
New Zealand husbandry conditions were likely to be exposed to lung worm infestation 
even though in our study, only 2 animals harboured patent adult worms. Infestation with 
the endemic lung worm Dictyocaulus filaria produces areas of hepatisation in the lungs 
(Sharma et al., 1989) and sheep lungs exposed to parasitic infestation can have 
multifocal sub-pleural grey/brown nodules throughout the dorsal and caudal lobes 
(Dawson et al., 2005 ), which were not evident in these experimental sheep. Post-
mortem examination of asthmatic lungs in humans show acutely distended lungs that 
fill the chest, completely covering the pericardium and the lungs fail to collapse when 
negative intra-thoracic pressure is released (Dunnill, 1960). Such a finding was not 
noted in our study and reflects the lack of clinical signs exhibited by the sheep. 
Histological analysis of lung tissue from the sensitized and challenged experimental 
sheep in this study showed that there was greater inflammation in the treated (left) 
lungs, as compared with the control (right) lungs in the Ctrl, HDM, c/HDM, and the M 
group. However, in those groups that had been exposed to TCL3 antigen, either directly 
(TCL3 and PNTCL3 groups) or through the likely (but unproven) intrauterine 
transmission of antigen to the untreated twin sibling (c/TCL3) there was no difference in 
inflammation between the two lungs (protective effect). This was due to a decrease of 
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inflammation in the HDM-treated lungs and an increase in the control lung. The 
confounding factors leading to the latter are nullified by the placebo-treated lung as an 
internal control (Bischof et al., 2003; Johnson et al., 2004). That the c/PNTCL3 group 
also showed this protective effect and is possibly due to oral contamination with TCL3 
as the PNTCL3 and the c/PNTCL3 animals were co-twins and suckled from the same 
mammary glands following treatment of PNTCL3 neonates. A similar protective effect 
to inflammation in the lungs was noted in a mice study when mice were pre-infected 
with cercariae from Shistosoma mansoni and later sensitized and challenged with 
ovalbumin (Pacífico et al., 2009). Similarly mice previously injected with infective 
stage larvae of Strongyloides stercoralis subcutaneously and later sensitized and 
challenged with ovalbumin showed less inflammation in the lungs (Wang et al., 2001). 
However, such a protective effect was not seen with mice previously infected with 
Toxocara canis nematode (visceral larva migrans in paratenic host) and later sensitized 
and challenged with ovalbumin, (Pinelli et al., 2001). However, the authors of this study 
later showed that toxocariasis itself causes persistent pulmonary inflammation and 
airway hypersensitivity (Pinelli et al., 2005), and may have confounded the pathology 
caused by ovalbumin.  
The pathobiologic mechanisms associated with IgE-mediated hypersensitivity are 
similar in asthma and in helminth infection (Britton, 2003); gut associated helminths 
(Ascaris suum) possess immunosuppressive capability to lung inflammation and 
hypersensitivity (Lima et al., 2002). High levels of helminth specific-IgE levels are 
produced during helminth infestation and this may saturate the more than 100,000 Fc 
receptor IgE binding sites on mast cells (Conrad et al., 1975; Wiegand et al., 1996) to 
prevent binding of allergen/mite specific-IgE molecules thus preventing degranulation 
of mast cells and inflammatory changes. It has also been shown that during helminth 
infection there is the production of large amount of polyclonal IgG4 isotype blocking 
antibodies which may cause hypo-responsiveness of the immune system to third-party 
allergens including aeroallergens (Figueiredo et al., 2010), since IgG4 competes for the 
same epitope as IgE (Turner et al., 2005). Whether such immune modulation is 
dependent on the presence of live parasites is unknown, but our results with antigen 
suggests not. Lima et al. (2002) also demonstrated that adult Ascaris suum (nematode) 
extracts suppress the IgE antibody production against unrelated antigens in mice by 
inhibiting lung inflammation and hyper-responsiveness through suppression of IL-5 or 
IL-4 and eotaxin. This finding is in accordance with the postulated protective effect of 
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parasite to asthma (van den Biggelaar et al., 2004; van den Biggelaar et al., 2001). The 
mechanism by which helminth infections down-modulate allergic diseases is unclear, 
but it may involve an increase in regulatory cytokines [e.g. interleukin (IL)-10 and 
transforming growth factor (TGF)] produced by regulatory CD4
+
T lymphocytes or other 
cell types (Doetze et al., 2000). In a study by John et al. (1998) it was observed that 
asthmatics on steroids produce more IL-10 which helps to reduce macrophage 
inflammatory protein-1α, granulocyte-macrophage colony-stimulating factor, and INFγ 
release from alveolar macrophages, a role that may be considered similar to production 
of IL-10 during helminth infestation (Fiorentino et al., 1989). 
In this study a moderate and positive correlation existed between BAL fluid 
lymphocytes (0.2 and 0.4) and eosinophils (0.2 and 0.3) and inflammation, following 
challenge with HDM (after 24 or 48 h, respectively), irrespective of prior treatment. 
Given the negative correlation between blood lymphocytes at 24 and 48 h post-
challenge and inflammation (-0.4 and -0.2 respectively), this may suggest a movement 
of the cells from blood to the BAL compartments or simply reflect the greater stress 
response in the animals with the more affected lungs. During sensitization (days 0-21) 
and challenge (day 56) HDM-specific IgE and IgG1 showed a low and negative 
correlation with inflammation in the lung of the sheep. Djukanovic et al. (2004) 
indicated that changes in the population of cells in the peripheral blood, BAL fluid and 
lung tissue at histology did not correlate with changes in HDM-specific IgE and IgG1 in 
asthmatics.  
In summary, our neonate study indicated a gradual decline in HDM-specific IgE and 
IgG1 with time, which is suggestive of maternal immunoglobulin rather than 
immunoglobulin generated by the lambs themselves. After sensitization and challenge 
(phase 2 of the study), degree of inflammation in the lungs of the sheep at necropsy 
differed among the treatment groups. Eosinophil numbers in BAL fluid were 
significantly higher in the right (control lung) of the TCL3 and the PNTCL3 groups 
compared with the left (treated) lung 48 h after challenge. According to Conroy and 
Williams (2001), in the human asthmatic, inhaled allergen activates mast cells and Th2 
lymphocytes in the lungs to generate the cytokines interleukin (IL)-4, IL-13 and tumour 
necrosis factor (TNF-a). These cytokines stimulate the generation of eotaxin by lung 
epithelial cells, fibroblasts and smooth muscle cells (Brown et al., 1998; Humbles et al., 
1997). Eotaxin acting on CCR3 on eosinophils then stimulates the selective recruitment 
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of these cells from the airway micro-vessels into the lung tissue. Hence the presence of 
eosinophils but not neutrophils may explain the difference in histological inflammation 
between the left (HDM) treated and the right (PBS) treated lungs in these groups. 
Though there were significantly higher number of neutrophils in the BAL fluid from the 
left lung of the TCL3 group at 24 h, they were not associated with inflammation at 
slaughter because they had normalised in both lungs by 48 h post challenge (our H&E 
histopathology stain after necropsy could not differentiate between leucocytes that 
caused the peribronchial and perivascular inflammation). While researchers have 
described increased eosinophils in samples of BAL fluid taken from human asthmatics 
(Fitch et al., 2000), laboratory animals (Garlisi et al., 1995) and in sheep (Bischof et al., 
2003) however, work done by Douwes et al. (2002) indicates the involvement of cells 
other than eosinophils having major involvement in the majority of asthma cases. Also 
Abraham et al. (2008) indicated that in acute asthma, neutrophil numbers in the BAL 
fluid of sheep are increased and in chronic cases both eosinophil and neutrophil 
numbers are increased. In our study, handling and manipulation stress of the 
experimental animals during the pregnancy, sensitisation and challenge may have had a 
profound effect on the immunity of individual sheep, resulting in variable responses to 
the various treatments.  
 82 
 
Chapter 6 
Conclusions and suggestions on future research directions 
The environmental factors that lead to lower prevalence of asthma amongst individuals 
whose mothers carried their pregnancy on farms and are farm-raised as opposed to 
urban born and raised are presently unknown. Our study provides some evidence to 
vindicate the belief that early-in-life exposure of sheep to parasite antigen is protective 
of asthma and this may extend to humans and explain the findings of Douwes et al. 
(2008). 
The choice of a model for research, especially animal model should be based on 
appropriateness of an analog, transferability of information, genetic uniformity of 
organisms where applicable, background knowledge of biological properties, cost and 
availability, ecological consequences and ethical implication among others (Davidson et 
al., 1987). The anatomy and physiology of the sheep is closer to that of humans’ than 
other laboratory animals (Scheerlinck et al., 2008). Other advantages of the sheep as a 
model for study of human diseases are their docile nature, comparatively easy repetitive 
sampling as compared with other smaller laboratory animals, twinning in off-spring that 
allows for genetically similar lambs to be used as control and test subjects, 
comparatively cheaper husbandry and maintenance as opposed to other large animal 
models. In human medicine, sheep have been used to model diseases in orthopaedics 
(Brayda-Bruno et al., 2001; Hayashi et al., 2000; Huffer et al., 2007; Lill et al., 2000; 
Thorndike & Turner, 1998), reproduction diseases (Jenkin & Young, 2004; Reynolds et 
al., 2005a; Reynolds et al., 2005b; Reynolds et al., 2006) and asthma (Abraham, 2008) 
and Abraham et al. (2000; 1983) in the USA and Bischof and Meeusen (2002), Bischof 
et al. (2003; 2008) in Australia. Immunologically the use of large animals, including 
sheep has been extensively reviewed (Hein & Griebel, 2003). In Lincoln University, 
New Zealand, the sheep is extensively used in studying Batten disease (Palmer et al., 
2005; 1997; 1992; 1989), Linterman et al. (2011) and human cataract (Morton et al., 
2003; Muir et al., 2005; Robertson et al., 2005). Our study adds to this knowledge of the 
sheep as a model for the study of human diseases. In our study the use of sheep as a 
model made it possible for in utero inoculation of feti with parasite antigen with 
controls and repeated longitudinal sampling following challenge of lungs, which would 
be difficult in small laboratory animals.  
 83 
 
It is indicated in the literature that there is no transmission of antigen from ewe to lamb 
in the normal placenta (Silverstein et al., 1963) and presumably vice versa. In this study, 
the trauma caused by surgery during manipulation of the ewe uterus appears to have 
breached this barrier as suggested by Poitras et al.(1986 ), leading to immunological 
recognition of the uterine contents. This finding requires further investigation, to make a 
distinction between ‘physiological’ antigen transmission and ‘pathological’ antigen 
transmission, between ewe and feti. Maternal antibody transmission from ewes could be 
prevented by covering the teats of the ewes to prevent the lambs from suckling prior to 
testing antibody levels in the lambs.  
Serological cross-reactions between ectoparasites found commonly on New Zealand 
sheep such as sheep lice (Bovicola ovis) and house dust mites have not been proven and 
though results from our study were suggestive of this, further investigations are 
warranted. The continuous exposure of all trial sheep, to pastures containing 
gastrointestinal parasite larvae such as TCL3 has probably decreased the effect of the 
early administration of TCL3 antigen and this confounding factor could be removed by, 
holding sheep indoors to eliminate helminth infection with vigorous ectoparasite 
control. Our choice of TCL3 antigen was based on its ubiquitous nature in a typical 
sheep grazing environment but other stages of the helminth (L1, L2, L4 and L5) could be 
more immunogenic or protective. 
A choice was made in our current study to take daily BAL sampling post challenge with 
slaughter at 24 and 48 h. It would be logical to take BAL samples before then (within 
first hour after challenge) to study early asthmatic changes. Alternatively we could give 
repeated challenge doses of HDM to study repeated insults to emulate the chronic 
nature of asthma (Canning, 2003; Collie, 2001).  
In our study sheep feti were inoculated with parasite antigen at 90-100 days of gestation 
when the feti lamb were immuno-competent. Inoculation of sheep feti with an asthma-
causing allergen such as HDM at the immune-tolerant stage of fetal lamb (<55 day), 
may result in the allergen being considered as ‘self’ by the fetus’s immune system thus 
reducing hypersensitive reactions such as allergic asthma to the same allergen later in 
life (Tran et al., 2001). 
  
 84 
 
References 
Abraham, E. (2003). Neutrophils and acute lung injury. Critical Care Medicine, 31(4), 
S195. 
Abraham, W. M. (2008). Modeling of asthma, COPD and cystic fibrosis in sheep. 
Pulmonary pharmacology & therapeutics, 21(5), 743-754. 
Abraham, W. M., Delehunt, J. C., Yerger, L., & Marchette, B. (1983). Characterization 
of a late phase pulmonary response after antigen challenge in allergic sheep. 
American Review of Respiratory Disease, 128(5), 839. 
Adler, A., Tager, I., & Quintero, D. R. (2005). Decreased prevalence of asthma among 
farm-reared children compared with those who are rural but not farm-reared. 
Journal of Allergy and Clinical Immunology, 115(1), 67-73. 
doi:10.1016/j.jaci.2004.10.008 
Altraja, A., Laitinen, A., Virtanen, I., Kampe, M., Simonsson, B. G., Karlsson, S. E., 
Hakansson, L., Venge, P., Sillastu, H., & Laitinen, A. L. (1996). Expression of 
laminins in the airways in various types of asthmatic patients: a morphometric 
study. American Journal of Respiratory Cell and Molecular Biology, 15(4), 482-
488. 
Araujo, M., & de Carvalho, E. (2006). Human schistosomiasis decreases immune 
responses to allergens and clinical manifestations of asthma.  
Arlian, L., Morgan, M., & Neal, J. (2002). Dust mite allergens: Ecology and 
distribution. Current Allergy and Asthma Reports, 2(5), 401-411. 
doi:10.1007/s11882-002-0074-2 
Arlian, L. G., Vyszenski-Moher, D. L., Ahmed, S. G., & Estes, S. A. (1991). Cross-
antigenicity between the scabies mite, Sarcoptes scabiei, and the house dust 
mite, Dermatophagoides pteronyssinus. Journal of Investigative Dermatology, 
96(3), 349-354. 
Arlian, L. G., Geis, D. P., Vyszenski-Moher, D. L., Bernstein, I. L., & Gallagher, J. S. 
(1984). Cross antigenic and allergenic properties of the house dust mite 
Dermatophagoides farinae and the storage mite Tyrophagus putrescentiae. 
Journal of Allergy and Clinical Immunology, 74(2), 172-179. 
Asher, M. I., Keil, U., Anderson, H. R., Beasley, R., Crane, J., Martinez, F., Mitchell, E. 
A., Pearce, N., Sibbald, B., Stewart, A. W., & et, a. (1995). International study 
of asthma and allergies in childhood (ISAAC): rationale and methods. European 
Respiratory Journal, 8(3), 483-491. 
Ayuso, R., Reese, G., Leong-Kee, S., Plante, M., & Lehrer, S. B. (2002). Molecular 
basis of arthropod cross-reactivity: IgE-binding cross-reactive epitopes of 
shrimp, house dust mite and cockroach tropomyosins. International Archives of 
Allergy and Immunology, 129 (1), 38-48. 
Bach, J.-F. (2005). Infections and autoimmune diseases. Journal of Autoimmunity, 
25(1), 74. 
Baeza-Bacab, M. (2011). ISAAC National Coordinator Mexico ISAAC Phase Three 
Principal Investigator Mérida. NEWSLETTER,  
Barnes, P. J. (1996). Pathophysiology of asthma. British Journal of Clinical 
Pharmacology, 42(1), 3-10. doi:10.1046/j.1365-2125.1996.03721.x 
Bates, J. H. T., Rincon, M., & Irvin, C. G. (2009). Animal models of asthma. American 
Journal of Physiology-Lung Cellular and Molecular Physiology, 297(3), L401-
L410. doi:10.1152/ajplung.00027.2009 
Beasley, R. (1998). Worldwide variation in prevalence of symptoms of asthma, allergic 
rhinoconjunctivitis, and atopic eczema: ISAAC. The Lancet, 351(9111), 1225-
1232. 
 85 
 
Beasley, R., Crane, J., Lai, C. K. W., & Pearce, N. (2000). Prevalence and etiology of 
asthma. Journal of Allergy and Clinical Immunology, 105(2, Part 2), S466-S472. 
Begin, R., Rola-Pleszczynski, M., Sirois, P., Masse, S., Nadeau, D., & Bureau, M. A. 
(1981). Sequential analysis of the bronchoalveolar milieu in conscious sheep. 
Journal of Applied Physiology, 50(3), 665-671. 
Bewley, H. (1887). Changes produced in the lungs of sheep by a parasitic worm 
(Strongylus filaria). Journal of Anatomy, 21(3), 374-377. 
doi:10.1007/BF03175888 
Bice, D. E., Seagrave, J., & Green, F. H. (2000). Animal models of asthma: potential 
usefulness for studying health effects of inhaled particles. Inhalation Toxicology, 
12(9), 829. 
Bischof, R. J., & Meeusen, E. N. T. (2002). Cellular kinetics of an allergic-type 
response in a sheep mammary gland model of inflammation. Clinical and 
Experimental Allergy, 32(4), 619-626. doi:doi:10.1046/j.0954-
7894.2002.01345.x 
Bischof, R. J., Snibson, K. J., Shaw, R. J., & Meeusen, E. T. (2003). Induction of 
allergic inflammation in the lungs of sensitised sheep after local challange with 
house dust mites. Clinical and Experimental Allergy, 33, 367-375. 
Bischof, R. J., Snibson, K., Velden, J., & Meeusen, E. (2008). Immune response to 
allergens in sheep sensitized to house dust mite. Journal of Inflammation, 5(1), 
16. 
Bisgaard, H., & Bønnelykke, K. (2010). Long-term studies of the natural history of 
asthma in childhood. Journal of Allergy and Clinical Immunology, 126(2), 187-
197. 
Borysenko, M., & Borysenko, J. (1982). Stress, behavior, and immunity: Animal 
models and mediating mechanisms. General Hospital Psychiatry, 4(1), 59-67. 
Bosse, Y., Riesenfeld, P. E., Pare, P. D., & Irvin, C. G. (2009). It's not all smooth 
muscle: Non-smooth muscle elements in control of resistance to airflow. Annual 
Review of Physiology, 72, 437-462. 
Bousquet, J., Jeffery, P. K., Busse, W. W., Johnson, M., & Vignola, A. M. (2000). 
Asthma. From bronchoconstriction to airways inflammation and remodeling. 
American Journal of Respiratory and Critical Care Medicine, 161(5), 1720-
1745. 
Bousquet, J., Chanez, P., Lacoste, J. Y., Barnéon, G., Ghavanian, N., Enander, I., 
Venge, P., Ahlstedt, S., Simony-Lafontaine, J., & Godard, P. (1990). 
Eosinophilic inflammation in asthma. New England Journal of Medicine, 
323(15), 1033-1039. 
Braman, S. S. (2003). Asthma in the elderly. Clinics in Geriatric Medicine, 19(1), 57-
75. doi:10.1016/s0749-0690(02)00052-6 
Braman, S. S. (2006). The global burden of asthma. Chest, 130, (1 Suppl):4S-12S. 
Brambell, R. W. (1961). Problems concerning the transmission of immunity from 
mother to young. Proceedings of the Royal Society of Medicine, 54, 992-993. 
Brasche, S., & Bischof, W. (2005). Daily time spent indoors in German homes - 
Baseline data for the assessment of indoor exposure of German occupants. 
International Journal of Hygiene and Environmental Health, 208(4), 247-253. 
doi:10.1016/j.ijheh.2005.03.003 
Brayda-Bruno, M., Fini, M., Pierini, G., Giavaresi, G., Rocca, M., & Giardino, R. 
(2001). Evaluation of systemic metal diffusion after spinal pedicular fixation 
with titanium alloy and stainless steel system: a 36-month experimental study in 
sheep. International Journal of Artificial Organs, 24(1), 41-49. 
Britton, J. (2003). Parasites, allergy, and asthma. American Journal of Respiratory and 
Critical Care Medicine, 168(3), 266-267. doi:10.1164/rccm.2305011 
 86 
 
Brogden, K. A., Ackermann, M. R., & Debey, B. M. (1995). Pasteurella haemolytica 
lipopolysaccharide-associated protein induces pulmonary inflammation after 
bronchoscopic deposition in calves and sheep. Infection and Immunity, 63(9), 
3595-3599. 
Brogger, J., Eagan, T., Eide, G. E., Bakke, P., & Gulsvik, A. (2004). Bias in 
retrospective studies of trends in asthma incidence. European Respiratory 
Journal, 23(2), 281-286. doi:10.1183/09031936.03.00041103 
Brown, J. R., Kleimberg, J., Marini, M., Sun, G., Bellini, A., & Mattoli, S. (1998). 
Kinetics of eotaxin expression and its relationship to eosinophil accumulation 
and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of 
asthmatic patients after allergen inhalation. Clinical and Experimental 
Immunology, 114, 137-146. 
Campbell, S. G., Siegel, M. J., & Knowlton, B. J. (1977). Sheep immunoglobulins and 
their transmission to the neonatal lamb. New Zealand Veterinary Journal, 25, 
361-365. 
Canning, B. J. (2003). Modeling asthma and COPD in animals: A pointless exercise? 
Current Opinion in Pharmacology, 3(3), 244-250. doi:10.1016/s1471-
4892(03)00045-6 
Chen, W., Alley, M. R., & Manktelow, B. W. (1991). Morphological and morphometric 
studies of the airways of sheep with acute airway hypersensitivity to inhaled 
Ascaris suum. International Journal of Experimental Pathology, 72(5), 543. 
Cohen, S. G. (1992). Asthma in antiquity: The Ebers papyrus. Allergy and Asthma 
Proceedings, 13, 147-154. 
Cohn, L., Elias, J. A., & Chupp, G. L. (2004). Asthma: Mechanisms of disease 
persistence and progression. Annual Review of Immunology, 22(1), 789-815. 
doi:doi:10.1146/annurev.immunol.22.012703.104716 
Collie, D. D. S. (2001). Local lung responses following local lung challange with 
recombinant lungworm antigen in systemically sensitised sheep. Clinical and 
Experimental Allergy, 31, 1636-1647. 
Collie, D. D. S., Baker, A., Mauchline, S., Porteous, D., & McLachlan, G. (1999). 
Ovine bronchoalveolar lavage cellularity: reproducibility and the effect of 
multiple repeated lavage. Research in Veterinary Science, 67(2), 137-140. 
Collie, D. D. S., McLean, N., Sallenave, J. M., Baker, A., Blundell, R., Milne, E., 
Rhind, S., & Woodall, C. (2006). Local lung responses following endobronchial 
elastase and lipopolysaccharide instillation in sheep. International Journal of 
Chronic Obstructive Pulmonary Disease, 1(2), 189. 
Colwell, D. D., & Himsl-Rayner, C. (2002). Linognathus vituli (Anoplura: 
Linognathidae): population growth, dispersal and development of humoral 
immune responses in naive calves following induced infestations. Veterinary 
Parasitology, 108(3), 237-246. 
Conrad, D. H., Bazin, H., Sehon, A. H., & Froese, A. (1975). Binding parameters of the 
interaction between rat IgE and rat mast cell receptors. Journal of Immunology, 
114(6), 1688. 
Conroy, D. M., & Williams, T. J. (2001). Eotaxin and the attraction of eosinophils to the 
asthmatic lung. Respiratory Research, 2(3), 150-156. 
Constant, S. L., & Bottomly, K. (1997). Induction of Th1 and Th2 CD4+ T cell 
responses: The alternative approaches. Annual Review of Immunology, 15(1), 
297-322. doi:doi:10.1146/annurev.immunol.15.1.297 
Contopoulos-Ioannidis, D. G., Kouri, I. N., & Ioannidis, J. P. A. (2007). Genetic 
predisposition to asthma and atopy. Respiration, 74, 8-12. 
 87 
 
Cookson, J. B. (1987). Prevalence rates of asthma in developing countries and their 
comparison with those in Europe and North America. Chest, 91(6 Supplement), 
97S-103S. doi:10.1378/chest.91.6_Supplement.97S 
Cookson, W., Musk, A. W., & Ryan, G. (2006). Associations between asthma history, 
atopy, and non‐specific bronchial responsiveness in young adults. Clinical & 
Experimental Allergy, 16(5), 425-432. 
Corrigan, C. J., & Kay, A. B. (1992). Role of T-lymphocytes and lymphokines. British 
Medical Bulletin, 48(1), 72-84. 
Coyle, A. J., Köhler, G., Tsuyuki, S., Brombacher, F., & Kopf, M. (1998). Eosinophils 
are not required to induce airway hyperresponsiveness after nematode infection. 
European Journal of Immunology, 28(9), 2640-2647. 
Cushley, M. J., Tattersfield, A. E., & Holgate, S. T. (2012). Inhaled adenosine and 
guanosine on airway resistance in normal and asthmatic subjects. British Journal 
of Clinical Pharmacology, 15(2), 161-165. 
Custovic, A., Taggart, S. C., Francis, H. C., Chapman, M. D., & Woodcock, A. (1996). 
Exposure to house dust mite allergens and the clinical activity of asthma. 
Journal of Allergy and Clinical Immunology, 98(1), 64-72  
da Cunha, S. S., Pujades-Rodriguez, M., Barreto, M. L., Genser, B., & Rodrigues, L. C. 
(2007). Ecological study of socio-economic indicators and prevalence of asthma 
in schoolchildren in urban Brazil. BMC Public Health, 7(1), 205. 
Dalsgaard, K., Hilgers, L., & Trouve, G. (1990). Classical and new approaches to 
adjuvant use in domestic food animals. Advances in Veterinary Science and 
Comparative Medicine, 35, 121-160. 
Davidson, M. K., Lindsey, J. R., & Davis, J. K. (1987). Requirements and selection of 
an animal model. Israel Journal of Medical Sciences, 23(6), 551. 
Dawson, S., Else, R. W., Rhind, S. M., & Collie, D. D. S. (2005 ). Diagnostic value of 
cytology of bronchoalveolar fluid for lung diseases of sheep. Veterinary Record, 
157: , 433-436. doi:doi:10.1136/vr.157.15.433 
Delves, P. J., Martin, S. J., Burton, D. R., & Roitt, I. M. (2006). Roitt's Essential 
Immunology (11th ed.). Massachusetts: Blackwell. 
Dhabhar, F. S. (2002). Stress-induced augmentation of immune function—the role of 
stress hormones, leukocyte trafficking, and cytokines. Brain, Behavior, and 
Immunity, 16(6), 785-798. 
Djukanovic, R. (2000). Asthma: A disease of inflammation and repair. Journal of 
Allergy and Clinical Immunology, 105(2, Part 2), S522-S526. 
doi:10.1016/s0091-6749(00)90055-1 
Djukanovic, R., Wilson, S. J., Kraft, M., Jarjour, N. N., Steel, M., Chung, K. F., Bao, 
W., Fowler-Taylor, A., Matthews, J., Busse, W. W., Holgate, S. T., & Fahy, J. 
V. (2004). Effects of treatment with anti-immunoglobulin E antibody 
omalizumab on airway inflammation in allergic asthma. American Journal of 
Respiratory and Critical Care Medicine, 170(6), 583-593. 
doi:10.1164/rccm.200312-1651OC 
Doetze, A., Satoguina, J., Burchard, G., Rau, T., Löliger, C., Fleischer, B., & Hoerauf, 
A. (2000). Antigen-specific cellular hyporesponsiveness in a chronic human 
helminth infection is mediated by Th3/Tr1-type cytokines IL-10 and 
transforming growth factor-β but not by a Th1 to Th2 shift. International 
Immunology, 12(5), 623-630. 
Douwes, J., & Pearce, N. (2002). Asthma and the westernization 'package'. 
International Journal of Epidemiology, 31(6), 1098-1102. 
doi:10.1093/ije/31.6.1098 
 88 
 
Douwes, J., Gibson, P., Pekkanen, J., & Pearce, N. (2002). Non-eosinophilic asthma: 
importance and possible mechanisms. Thorax, 57(7), 643-648. 
doi:10.1136/thorax.57.7.643 
Douwes, J., Thorne, P., Pearce, N., & Heederik, D. (2003). Bioaerosol health effects 
and exposure assessment: progress and prospects. Annals of Occupational 
Hygiene, 47(3), 187-200. doi:10.1093/annhyg/meg032 
Douwes, J., Cheng, S., Travier, N., Cohet, C., Niesink, A., McKenzie, J., Cunningham, 
C., Le Gros, G., von Mutius, E., & Pearce, N. (2008). Farm exposure in utero 
may protect against asthma, hay fever and eczema. European Respiratory 
Journal, 32(3), 603-611. doi:10.1183/09031936.00033707 
Drazen, J., & Austen, K. (1987). Leukotrienes and airway responses. American Journal 
of Respiratory and Critical Care Medicine, 136(4), 985-998. 
Dreborg, S., & Frew, A. (2008). Position paper: allergen standardization and skin tests. 
Allergy, 48(s14), 49-54. 
Duhme, H., Weiland, S. K., & Keil, U. (1998a). Epidemiological analyses of the 
relationship between environmental pollution and asthma. Toxicology Letters, 
102, 307-316. 
Duhme, H., Weiland, S. K., Rudolph, P., Wienke, A., Kramer, A., & Keil, U. (1998b). 
Asthma and allergies among children in West and East Germany: a comparison 
between Munster and Greifswald using the ISAAC phase I protocol. 
International Study of Asthma and Allergies in Childhood. European 
Respiratory Journal, 11(4), 840-847. 
Dunnill, M. S. (1960). The pathology of asthma, with special reference to changes in the 
bronchial mucosa. Journal of Clinical Pathology, 13(1), 27-33. 
Dunphy, J. L., Barcham, G. J., Bischof, R. J., Young, A. R., Nash, A. D., & Meeusen, 
E. N. T. (2002). Isolation and characterization of a novel eosinophil-specific 
galectin released into the lungs in response to allergen challenge. Journal of 
Biological Chemistry, 277(17), 14916-14924. doi:10.1074/jbc.M200214200 
Eder, W., Klimecki, W., Yu, L., von Mutius, E., Riedler, J., Braun-Fahrländer, C., 
Nowak, D., & Martinez, F. D. (2004). Toll-like receptor 2 as a major gene for 
asthma in children of European farmers. Journal of Allergy and Clinical 
Immunology, 113(3), 482-488. 
Esterling, B., & Rabin, B. S. (1987). Stress-induced alteration of T-lymphocyte subsets 
and humoral immunity in mice. Behavioral Neuroscience, 101(1), 115. 
Fairbairn, S. M., Page, C. P., Lees, P., & Cunningham, F. M. (1993). Early neutrophil 
but not eosinophil or platelet recruitment to the lungs of allergic horses 
following antigen exposure. Clinical & Experimental Allergy, 23(10), 821-828. 
Feero, W. G., Guttmacher, A. E., & Manolio, T. A. (2010). Genomewide association 
studies and assessment of the risk of disease. New England Journal of Medicine, 
363(2), 166-176. 
Feltbower, R. G., McKinney, P. A., Parslow, R. C., Stephenson, C. R., & Bodansky, H. 
J. (2003). Type 1 diabetes in Yorkshire, UK: time trends in 0–14 and 15–29-
year-olds, age at onset and age-period-cohort modelling. Diabetic Medicine, 
20(6), 437-441. doi:10.1046/j.1464-5491.2003.00960.x 
Fernandez, J., Gharahdaghi, F., & Mische, S. M. (1998). Routine identification of 
proteins from sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS 
PAGE) gels or polyvinyl difluoride membranes using matrix assisted laser 
desorption/ionization time of flight mass spectrometry (MALDI TOF MS). 
Electrophoresis, 19(6), 1036-1045. 
Figueiredo, C. A., Barreto, M. L., Rodrigues, L. C., Cooper, P. J., Silva, N. B., Amorim, 
L. D., & Alcantara-Neves, N. M. (2010). Chronic intestinal helminth infections 
 89 
 
are associated with immune hyporesponsiveness and induction of a regulatory 
network. Infection and Immunity, 78(7), 3160-3167. 
Fiorentino, D. F., Bond, M. W., & Mosmann, T. R. (1989). Two types of mouse T 
helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by 
Th1 clones. Journal of Experimental Medicine, 170(6), 2081-2095. 
Fish, J. E., & Peters, S. P. (1999). Airway remodeling and persistent airway obstruction 
in asthma. Journal of Allergy and Clinical Immunology, 104(3), 509-516. 
doi:10.1016/s0091-6749(99)70315-5 
Fitch, P. S., Brown, V., Schock, B. C., Taylor, R., Ennis, M., & Shields, M. D. (2000). 
Chronic cough in children: Bronchoalveolar lavage findings. European 
Respiratory Journal, 16(6), 1109-1114. 
Frangova, V., Sacco, O., Silvestri, M., Oddera, S., Balbo, A., Crimi, E., & Rossi, G. A. 
(1996). BAL neutrophilia in asthmatic patients. Chest, 110(5), 1236-1242. 
doi:10.1378/chest.110.5.1236 
Fujikawa, A., Ishimaru, N., Seto, A., Yamada, H., Aki, T., Shigeta, S., Wada, T., Jyo, 
T., Murooka, Y., Oka, S., & Ono, K. (1996). Cloning and characterization of a 
new allergen, Mag 3, from the house dust mite, Dermatophagoides farinae: 
Cross-reactivity with high-molecular-weight allergen. Molecular Immunology, 
33(3), 311-319. 
Fujimoto, K., Kubo, K., Okada, K., Kobayashi, T., Sekiguchi, M., & Sakai, A. (1996). 
Effect of the 21-aminosteroid U-74006F on antigen-induced bronchoconstriction 
and bronchoalveolar eosinophilia in allergic sheep. European Respiratory 
Journal, 9(10), 2044. 
Gale, E. (2002). A missing link in the hygiene hypothesis? Diabetologia, 45(4), 588-
594. doi:10.1007/s00125-002-0801-1 
Garcia-Zepeda, E. A., Rothenberg, M. E., Ownbey, R. T., Celestin, J., Leder, P., & 
Luster, A. D. (1996). Human eotaxin is a specific chemoattractant for eosinophil 
cells and provides a new mechanism to explain tissue eosinophilia. Nature 
Medicine, 2(4), 449-456. 
Garlisi, C. G., Falcone, A., Kung, T. T., Stelts, D., Pennline, K. J., Beavis, A. J., Smith, 
S. R., Egan, R. W., & Umland, S. P. (1995). T cells are necessary for Th2 
cytokine production and eosinophil accumulation in airways of antigen-
challenged allergic mice. Clinical Immunology and Immunopathology, 75(1), 
75-83. doi:10.1006/clin.1995.1055 
Garrod, L. P. (1929). Eosinophilia in asthma. British Medical Journal, 2(3594), 984. 
doi:10.1136/bmj.2.3594.984 
Gerblich, A. A., Salik, H., & Schuyler, M. R. (1991). Dynamic T-cell changes in 
peripheral blood and bronchoalveolar lavage after antigen bronchoprovocation 
in asthmatics. American Journal of Respiratory and Critical Care Medicine, 
143(3), 533-537. 
Gereda, J. E., Leung, D. Y. M., Thatayatikom, A., Streib, J. E., Price, M. R., Klinnert, 
M. D., & Liu, A. H. (2000). Relation between house-dust endotoxin exposure, 
type 1 T-cell development, and allergen sensitisation in infants at high risk of 
asthma. The Lancet, 355(9216), 1680-1683. 
Gerritsen, J., Koeter, G., Postma, D., Schouten, J., & Knol, K. (1989). Prognosis of 
asthma from childhood to adulthood. American Review of Respiratory Disease, 
140(5), 1325-1330. 
Glaser, R. (2005). Stress-associated immune dysregulation and its importance for 
human health: a personal history of psychoneuroimmunology. Brain, Behavior, 
and Immunity, 19(1), 3-11. 
Gleich, G. J., Adolphson, C. R., & Leiferman, K. M. (1993). The biology of the 
eosinophilic leukocyte. Annual Review of Medicine, 44(1), 85-101. 
 90 
 
González, J., Geijo, M. V., García-Pariente, C., Verna, A., Corpa, J. M., Reyes, L. E., 
Ferreras, M. C., Juste, R. A., García, M. J. F., & Pérez, V. (2005). 
Histopathological classification of lesions associated with natural 
paratuberculosis infection in cattle. Journal of Comparative Pathology, 133(2-
3), 184-196. doi:10.1016/j.jcpa.2005.04.007 
Grandin, T. (1997). Assessment of stress during handling and transport. Journal of 
Animal Science, 75(1), 249-257. 
Grieves, J. L., Dick Jr, E. J., Schlabritz-Loutsevich, N. E., Butler, S. D., Leland, M. M., 
Price, S. E., Schmidt, C. R., Nathanielsz, P. W., & Hubbard, G. B. (2008). 
Barbiturate euthanasia solution-induced tissue artifact in nonhuman primates. 
Journal of Medical Primatology, 37(3), 154-161. 
Griffiths, I. (2005). Postmortem examination of cattle and sheep. In Practice, 27(9), 
458-465. 
Grigsby, P. L., Hirst, J. J., Scheerlinck, J. P., Phillips, D. J., & Jenkin, G. (2002). Fetal 
responses to maternal and intra-amnionic lipopolysaccharide administration in 
sheep. Biology of Reproduction, 68, 1695-1702. 
Grytten, N., Glad, S. B., Aarseth, J. H., Nyland, H., Midgard, R., & Myhr, K. M. 
(2006). A 50-year follow-up of the incidence of multiple sclerosis in Hordaland 
County, Norway. Neurology, 66(2), 182-186. 
Gundel, R. H., Letts, L. G., & Gleich, G. J. (1991). Human eosinophil major basic 
protein induces airway constriction and airway hyperresponsiveness in primates. 
Journal of Clinical Investigation, 87(4), 1470. 
Guo, Y. L., Lin, Y. C., Sung, F. C., Huang, S. L., Ko, Y., Lai, C. J. S., Su, H. J., Shaw, 
C. K., Lin, R. S., & Dockery, D. W. (1999). Climate, traffic-related air 
pollutants, and asthma prevalence in middle-school children in Taiwan. 
Environmental Health Perspectives, 107(12), 1001-1006. 
Gustashaw, K. M. (1991). Chromosome Stains (2nd ed.). New York: Raven Press, Ltd. 
Hagel, I., Lynch, N. R., Perez, M., Di Prisco, M. C., Lopez, R., & Rojas, E. (1993). 
Modulation of the allergic reactivity of slum children by helminthic infection. 
Parasite Immunology, 15(6), 311-315. 
Hamid, Q., Tulic, M. K., Liu, M. C., & Moqbel, R. (2003). Inflammatory cells in 
asthma: Mechanisms and implications for therapy. Journal of Allergy and 
Clinical Immunology, 111(1, Supplement 1), S5-S17. doi:10.1067/mai.2003.22 
Harjutsalo, V., Sjöberg, L., & Tuomilehto, J. (2008). Time trends in the incidence of 
type 1 diabetes in Finnish children: a cohort study. The Lancet, 371(9626), 
1777-1782. 
Hartert, T. V., & Peebles, R. S., Jr. (2000). Epidemiology of asthma: the year in review. 
Current Opinion in Pulmonary Medicine, 6(1), 4-9. 
Hayashi, K., Hecht, P., Thabit Iii, G., Peters, D. M., Vanderby Jr, R., Cooley, A. J., 
Fanton, G. S., Orwin, J. F., & Markel, M. D. (2000). The biologic response to 
laser thermal modification in an in vivo sheep model. Clinical Orthopaedics and 
Related Research, 373, 265. 
Heath, A. C. G., Cole, D. J. W., Bishop, D. M., Pfeffer, A., Cooper, S. M., & Risdon, P. 
(1995). Preliminary investigations into the aetiology and treatment of cockle, a 
sheep pelt defect. Veterinary Parasitology, 56(1-3), 239-254. doi:10.1016/0304-
4017(94)00659-z 
Hein, W. R., & Griebel, P. J. (2003). A road less travelled: large animal models in 
immunological research. Nature Reviews. Immunology, 3(1), 79-84. 
Hertzen, L. v., & Haahtela, T. (2005). Signs of reversing trends in prevalence of asthma. 
Allergy, 60(3), 283-292. 
Hewitt, C. R., Brown, A. P., Hart, B. J., & Pritchard, D. I. (1995). A major house dust 
mite allergen disrupts the immunoglobulin E network by selectively cleaving 
 91 
 
CD23: innate protection by antiproteases. Journal of Experimental Medicine, 
182(5), 1537-1544. doi:10.1084/jem.182.5.1537 
Hildemann, S., Hammer, C., & Krombach, F. (1992). Heterogeneity of alveolar 
macrophages in experimental silicosis. Environmental Health Perspectives, 97, 
53. 
Hogg, J. C. (1997). The pathology of asthma. Journal of the Scandinavian Societies for 
Medical Microbiology and Pathology, 105(7-12), 735-745. doi:10.1111/j.1699-
0463.1997.tb05079.x 
Holgate, S. (1993). Mediator and cytokine mechanisms in asthma. Thorax, 48(2), 103-
109. doi:10.1136/thx.48.2.103 
Holt, P. G., & Strickland, D. H. (2010). Interactions between innate and adaptive 
immunity in asthma pathogenesis: New perspectives from studies on acute 
exacerbations. Journal of Allergy and Clinical Immunology, 125(5), 963-972. 
doi:http://dx.doi.org/10.1016/j.jaci.2010.02.011 
Holt, S., & Beasley, R. (2002). The burden of asthma in New Zealand. Wellington: 
Asthma and Respiratory Foundation of New Zealand. 
Horii, Y., Owhashi, M., Ishii, A., Bandou, K., & Usui, M. (1984). Leukocyte 
accumulation in sparganosis: demonstration of eosinophil and neutrophil 
chemotactic factors from the plerocercoid of Spirometra erinacei in vivo and in 
vitro. American Journal of Tropical Medicine and Hygiene, 33(1), 138. 
Horii, Y., Owhashi, M., Fujita, K., Nakanishi, H., & Ishii, A. (1988). A comparative 
study on eosinophil and neutrophil chemotactic activities of various helminth 
parasites. Parasitology Research, 75(1), 76-78. doi:10.1007/bf00931196 
Huffer, W. E., Benedict, J. J., Turner, A. S., Briest, A., Rettenmaier, R., Springer, M., & 
Walboomers, X. F. (2007). Repair of sheep long bone cortical defects filled with 
COLLOSS®, COLLOSS® E, OSSAPLAST®, and fresh iliac crest autograft. 
Journal of Biomedical Materials Research Part B: Applied Biomaterials, 82(2), 
460-470. 
Humbles, A. A., Conroy, D. M., Marleau, S., Rankin, S. M., Palframan, R. T., 
Proudfoot, A. E. I., Wells, T. N. C., Li, D., Jeffery, P. K., & Griffiths-Johnson, 
D. A. (1997). Kinetics of eotaxin generation and its relationship to eosinophil 
accumulation in allergic airways disease: analysis in a guinea pig model in vivo. 
Journal of Experimental Medicine, 186(4), 601. 
Huovinen, E., Kaprio, J., & Koskenvuo, M. (2003). Factors associated to lifestyle and 
risk of adult onset asthma. Respiratory Medicine, 97(3), 273-280. 
Ippoliti, F., Santis, W. D., Volterrani, A., Canitano, N., Frattolillo, D., Lucarelli, S., 
Frediani, S., & Frediani, T. (2006). Psychological stress affects response to 
sublingual immunotherapy in asthmatic children allergic to house dust mite. 
Pediatric Allergy and Immunology, 17(5), 337-345. 
James, P. J., Carmichael, I. H. C., Pfeffer, A., Martin, R. R., & O’Callaghan, M. G. 
(2002). Variation among merino sheep in susceptibilty to lice ( Bovicola ovis) 
and association with susceptibility to trichostrongylid gastrointestinal parasites. 
Veterinary Parasitology, 103(4), 355-365. 
Jarvis, D., & Burney, P. (1998). The epidemiology of allergic disease. British Medical 
Journal, 316(7131), 607-610. 
Jatakanon, A., Uasuf, C., Maziak, W., Lim, S. A. M., Chung, K. F., & Barnes, P. J. 
(1999). Neutrophilic inflammation in severe persistent asthma. American 
Journal of Respiratory and Critical Care Medicine, 160(5), 1532-1539. 
Jayaram, L., Labiris, N. R., Efthimiadis, A., Vlachos-Meyer, H., Hargreave, F. E., & 
Freitag, A. P. (2007). The efficiency of sputum cell counts in cystic fibrosis. 
Canadian Respiratory Journal, 14(2), 99-103. 
 92 
 
Jenkin, G., & Young, I. R. (2004). Mechanisms responsible for parturition; the use of 
experimental models. Animal Reproduction Science, 82, 567-581. 
Jobe, A. H., Newnham, J. P., Willet, K. E., Moss, T. J., Ervin, M. G., Padbury, J. F., 
Sly, P., & Ikegami, M. (2000). Endotoxin-induced lung maturation in preterm 
lambs is not mediated by cortisol. American Journal of Respiratory and Critical 
Care Medicine, 162(5), 1656-1661. 
John, M., Lim, S. A. M., Seybold, J., Jose, P., Robichaud, A., O'Connor, B., Barnes, P. 
J., & Fan, C. (1998). Inhaled corticosteroids increase interleukin-10 but reduce 
macrophage inflammatory protein-1alpha, granulocyte-macrophage colony-
stimulating factor, and interferon-gamma release from alveolar macrophages in 
asthma. American Journal of Respiratory and Critical Care Medicine, 157(1), 
256. 
Johnson, J. R., Wiley, R. E., Fattouh, R., Swirski, F. K., Gajewska, B. U., Coyle, A. J., 
Gutierrez-Ramos, J. C., Ellis, R., Inman, M. D., & Jordana, M. (2004). 
Continuous exposure to house dust mite elicits chronic airway inflammation and 
structural remodeling. American Journal of Respiratory and Critical Care 
Medicine, 169, 378 - 385. 
Jose, P. J., Griffiths-Johnson, D. A., Collins, P. D., Walsh, D. T., Moqbel, R., Totty, N. 
F., Truong, O., Hsuan, J. J., & Williams, T. J. (1994). Eotaxin: a potent 
eosinophil chemoattractant cytokine detected in a guinea pig model of allergic 
airways inflammation. Journal of Experimental Medicine, 179(3), 881-887. 
Joseph, M., Tonnel, A. B., Torpier, G., Capron, A., Arnoux, B., & Benveniste, J. 
(1983). Involvement of immunoglobulin E in the secretory processes of alveolar 
macrophages from asthmatic patients. Journal of Clinical Investigation, 71(2), 
221. 
Jubb, K. V. F., Kennedy, P. C., & Palmer, N. (1985). Pathology of Domestic Animals (3 
ed., Vol. 2). Sydney: Academic Press, Inc. 
Kacskovics, I., Kis, Z., Mayer, B., West, A. P., Tiangco, N. E., Tilahun, M., Cervenak, 
L., Bjorkman, P. J., Goldsby, R. A., & Szenci, O. (2006). FcRn mediates 
elongated serum half-life of human IgG in cattle. International Immunology, 
18(4), 525. 
Kannan, G., Terrill, T. H., Kouakou, B., Gazal, O. S., Gelaye, S., Amoah, E. A., & 
Samake, S. (2000). Transportation of goats: Effects on physiological stress 
responses and live weight loss. Journal of Animal Science, 78(6), 1450-1457. 
Kappelman, M. D., Rifas–Shiman, S. L., Kleinman, K., Ollendorf, D., Bousvaros, A., 
Grand, R. J., & Finkelstein, J. A. (2007). The Prevalence and Geographic 
Distribution of Crohn’s Disease and Ulcerative Colitis in the United States. 
Clinical gastroenterology and hepatology : the official clinical practice journal 
of the American Gastroenterological Association, 5(12), 1424-1429. 
Karol, M. H. (1994). Animal models of occupational asthma. European Respiratory 
Journal, 7(3), 555-568. 
Kay, A. B., Phipps, S., & Robinson, D. S. (2004). A role for eosinophils in airway 
remodelling in asthma. Trends in Immunology, 25(9), 477-482. 
Kehrli, M. E., Burton, J. L., Nonnecke, B. J., & Lee, E. K. (1999). Effects of stress on 
leukocyte trafficking and immune responses: implications for vaccination. 
Advances in Veterinary Medicine, 41, 61-81. 
Kelley, K. W. (1980). Stress and immune function: a bibliographic review. Annals of 
Veterinary Research, 11(4), 445-478. 
Kharalkar, N. M., Bauserman, S. C., & Valvano, J. W. (2009). Effect of formalin 
fixation on thermal conductivity of the biological tissue Journal of 
Biomechanical Engineering, 131(7), 074508. 
 93 
 
Kitagaki, K., Businga, T. R., Racila, D., Elliott, D. E., Weinstock, J. V., & Kline, J. N. 
(2006). Intestinal helminths protect in a murine model of asthma. Journal of 
Immunology, 177(3), 1628. 
Kitaura, M., Nakajima, T., Imai, T., Harada, S., Combadiere, C., Tiffany, H. L., 
Murphy, P. M., & Yoshie, O. (1996). Molecular cloning of human eotaxin, an 
eosinophil-selective CC chemokine, and identification of a specific eosinophil 
eotaxin receptor, CC chemokine receptor 3. Journal of Biological Chemistry, 
271(13), 7725-7730. 
Koeppen-Schomerus, G., Stevenson, J., & Plomin, R. (2001). Genes and environment in 
asthma: a study of 4 year old twins. Archives of Disease in Childhood, 85(5), 
398-400. doi:10.1136/adc.85.5.398 
Korhonen, H., Marnila, P., & Gill, H. S. (2000). Milk immunoglobulins and 
complement factors. British Journal of Nutrition, 84, 75-80. 
Laitinen, A., & Laitinen, L. A. (1994). Pathology of asthma. Allergy and Asthma 
Proceedings, 15, 323-328. 
Lau, S., Illi, S., Sommerfeld, C., Niggemann, B., Bergmann, R., von Mutius, E., & 
Wahn, U. (2000). Early exposure to house-dust mite and cat allergens and 
development of childhood asthma: a cohort study. The Lancet, 356(9239), 1392-
1397. 
Lemanske, R. F., & Busse, W. W. (2006). Asthma: Factors underlying inception, 
exacerbation, and disease progression. Journal of Allergy and Clinical 
Immunology, 117(2, Supplement 2), S456-S461. 
Lill, C. A., Fluegel, A. K., & Schneider, E. (2000). Sheep model for fracture treatment 
in osteoporotic bone: a pilot study about different induction regimens. Journal of 
Orthopaedic Trauma, 14(8), 559-565. 
Lima, C., Perini, A., Garcia, M. L. B., Martins, M. A., Teixeira, M. M., & Macedo, M. 
S. (2002). Eosinophilic inflammation and airway hyper-responsiveness are 
profoundly inhibited by a helminth (Ascaris suum) extract in a murine model of 
asthma. Clinical & Experimental Allergy, 32(11), 1659-1666. 
Linterman, K. S., Palmer, D. N., Kay, G. W., Barry, L. A., Mitchell, N. L., McFarlane, 
R. G., Black, M. A., Sands, M. S., & Hughes, S. M. (2011). Lentiviral-mediated 
gene transfer to the sheep brain: Implications for gene therapy in Batten disease. 
Human Gene Therapy, 22(8), 1011-1020. 
Liu, A. H. (2004). Something old, something new: indoor endotoxin, allergens and 
asthma. Paediatric Respiratory Reviews, 5, S65-S71. 
Los, H., Postmus, P. E., & Boomsma, D. I. (2001). Asthma genetics and intermediate 
phenotypes: A review from twin studies. Twin Research, 4, 81-93. 
Lynch, N. R., Hagel, I., Perez, M., Di Prisco, M. C., Lopez, R., & Alvarez, N. (1993). 
Effect of anthelmintic treatment on the allergic reactivity of children in a tropical 
slum. Journal of Allergy and Clinical Immunology, 92(3), 404-411. 
Madwed, J. B., & Jackson, A. C. (1997). Determination of airway and tissue resistances 
after antigen and methacholine in nonhuman primates. Journal of Applied 
Physiology, 83(5), 1690-1696. 
Mapp, C. E., Fryer, A. A., De Marzo, N., Pozzato, V., Padoan, M., Boschetto, P., 
Strange, R. C., Hemmingsen, A., & Spiteri, M. A. (2002). Glutathione S-
transferase GSTP1 is a susceptibility gene for occupational asthma induced by 
isocyanates. The Journal of allergy and clinical immunology, 109(5), 867. 
Margarone, J. E., Natiella, J. R., & Vaughan, C. D. (1985). Artifacts in oral biopsy 
specimens. Journal of Oral and Maxillofacial Surgery, 43(3), 163-172. 
doi:10.1016/0278-2391(85)90154-5 
 94 
 
Margulies, D. H. (2001). Induction of immune responses. In J. E. Coligan, B. E. Bierer, 
D. H. Margulies, E. M. Shevach & W. Strober (Eds.), Current Protocols in 
Immunology (Vol. 1, pp. 2.1.15 - 12.11.17). [New York]: John Wiley & Sons. 
Mariassy, A. T., Abraham, W. M., & Wanner, A. (1994). Effect of antigen on the 
glycoconjugate profile of tracheal secretions and the epithelial glycocalyx in 
allergic sheep. Journal of Allergy and Clinical Immunology, 93(3), 585-593. 
Marketos, S. G., & Ballas, C. N. (1982). Bronchial asthma in the medical literature of 
Greek antiquity. Journal of Asthma, 19(4), 263-269. 
doi:doi:10.3109/02770908209104771 
Martin, A. J., Landau, L. I., & Phelan, P. D. (1982). Asthma from childhood at age 21: 
the patient and his disease. British Medical Journal, 284(6313), 380-382. 
doi:10.1136/bmj.284.6313.380 
Martinez, F. D. (1999). Maturation of immune responses at the beginning of asthma. 
Journal of Allergy and Clinical Immunology, 103(3), 355-361. 
Masoli, M., Fabian, D., Holt, S., & Beasley, R. (2004). The global burden of asthma: 
executive summary of the GINA Dissemination Committee Report. Allergy, 
59(5), 469-478. doi:10.1111/j.1398-9995.2004.00526.x 
Masters, S., & Barrett-Connor, E. (1985). Parasites and asthma - predictive or 
protective. Epidemiological Reviews, 7(1), 49-58. 
Matangkasombut, P., Pichavant, M., Yasumi, T., Hendricks, C., Savage, P. B., 
DeKruyff, R. H., & Umetsu, D. T. (2008). Direct activation of natural killer T 
cells induces airway hyperreactivity in nonhuman primates. Journal of Allergy 
and Clinical Immunology, 121(5), 1287. 
Matthes, H. F., Harrison, G. B. L., Shaw, R. J., Heath, A. C. G., Pfeffer, A., & Hiepe, T. 
H. (1996). Cross-reacting antibodies to Sarcoptes suis, Chorioptes bovis and 
Notoedres cati and anti-P. ovis IgE in sera from sheep infested naturally with 
Psoroptes ovis. International Journal for Parasitology, 26(4), 437-444  
Mauser, P. J., Pitman, A. M., Fernandez, X., Foran, S. K., Adams, G. K., Kreutner, W., 
Egan, R. W., & Chapman, R. W. (1995). Effects of an antibody to interleukin-5 
in a monkey model of asthma. American Journal of Respiratory and Critical 
Care Medicine, 152(2), 467-472. 
McDowell, S. E., Ferner, H. S., & Ferner, R. E. (2009). The pathophysiology of 
medication errors: how and where they arise. British Journal of Clinical 
Pharmacology, 67(6), 605-613. 
McKay, D. M. (2006). The beneficial helminth parasite? Parasitology, 132(01), 1-12. 
doi:doi:10.1017/S003118200500884X 
Medeiros, M., Figueiredo, J. P., Almeida, M. C., Matos, M. A., Araujo, M. I., Cruz, A. 
A., Atta, A. M., Rego, M. A., De Jesus, A. R., & Taketomi, E. A. (2003). 
Schistosoma mansoni infection is associated with a reduced course of asthma. 
Journal of Allergy and Clinical Immunology, 111, 947–951. 
Meeusen, E. N., Snibson, K. J., Hirst, S. J., & Bischof, R. J. (2009). Sheep as a model 
species for the study and treatment of human asthma and other respiratory 
diseases. Drug Discovery Today: Disease Models, 6(4), 101-106. 
doi:10.1016/j.ddmod.2009.12.002 
Metzger, W. J., Richerson, H. B., Worden, K., Monick, M., & Hunninghake, G. W. 
(1986). Bronchoalveolar lavage of allergic asthmatic patients following allergen 
bronchoprovocation. Chest, 89(4), 477-483. doi:10.1378/chest.89.4.477 
Minton, J. E., & Blecha, F. (1990). Effect of acute stressors on endocrinological and 
immunological functions in lambs. Journal of Animal Science, 68(10), 3145-
3151. 
 95 
 
Moffatt, M. F., & Cookson, W. O. C. M. (1997). Linkage and candidate gene studies in 
asthma. American Journal of Respiratory and Critical Care Medicine, 156(4), 
110S-112. 
Moffatt, M. F., Gut, I. G., Demenais, F., Strachan, D. P., Bouzigon, E., Heath, S., von 
Mutius, E., Farrall, M., Lathrop, M., & Cookson, W. O. C. M. (2010). A large-
scale, consortium-based genomewide association study of asthma. New England 
Journal of Medicine, 363(13), 1211-1221. 
Moffatt, M. F., Kabesch, M., Liang, L., Dixon, A. L., Strachan, D., Heath, S., Depner, 
M., von Berg, A., Bufe, A., Rietschel, E., Heinzmann, A., Simma, B., Frischer, 
T., Willis-Owen, S. A. G., Wong, K. C. C., Illig, T., Vogelberg, C., Weiland, S. 
K., von Mutius, E., Abecasis, G. R., Farrall, M., Gut, I. G., Lathrop, G. M., & 
Cookson, W. O. C. (2007). Genetic variants regulating ORMDL3 expression 
contribute to the risk of childhood asthma. Nature, 448(7152), 470-473. 
doi:http://www.nature.com/nature/journal/v448/n7152/suppinfo/nature06014_S1
.html 
Morton, J. D., Sanderson, J., Lee, H. Y., Robertson, L. J., & Gately, K. (2003). The 
effect of oxidative damage on the calpain proteases in cultured ovine lens. 
Investigative Ophtalmology and Visual Science, 44(5), 314. 
Moss, T. J. M., Davey, M. G., Harding, R., & Newnham, J. P. (2002). Effects of intra-
amniotic endotoxin on lung structure and function two months after term birth in 
sheep. Journal of the Society for Gynecologic Investigation, 9(4), 220-225. 
doi:10.1177/107155760200900407 
Muir, M. S., Morton, J. D., & Robertson, L. J. G. (2005). Calpain II induces 
insolubilisation of ovine lens crystallins in vitro and these insoluble proteins 
may induce cataract in vivo. Investigative Ophtalmology and Visual Science, 
46(5), 3882. 
Munkholm, P., Langholz, E., Nielsen, O. H., Kreiner, S., & Binder, V. (1992). 
Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-
87: a sixfold increase in incidence. Scandinavian Journal of Gastroenterology, 
27(7), 609-614. 
Nagy, L., Lee, T. H., & Kay, A. B. (1982). Neutrophil chemotactic activity in antigen-
induced late asthmatic reactions. New England Journal of Medicine, 306(9), 
497-501. 
Nair, P., Pizzichini, M. M. M., Kjarsgaard, M., Inman, M. D., Efthimiadis, A., 
Pizzichini, E., Hargreave, F. E., & O'Byrne, P. M. (2009). Mepolizumab for 
prednisone-dependent asthma with sputum eosinophilia. New England Journal 
of Medicine, 360(10), 985-993. 
Okada, H., Kuhn, C., Feillet, H., & Bach, J. F. (2010). The ‘hygiene hypothesis’ for 
autoimmune and allergic diseases: an update. Clinical & Experimental 
Immunology, 160(1), 1-9. doi:10.1111/j.1365-2249.2010.04139.x 
Paalangara, R. F. (2000). Development of the capacity of the gut-associated immune 
system of perinatal lambs to respond to parasitic antigens. Unpublished PhD, 
Australian National University, Canberra. 
Pacífico, L. G. G., Marinho, F. A. V., Fonseca, C. T., Barsante, M. M., Pinho, V., Sales-
Junior, P. A., Cardoso, L. S., Araújo, M. I., Carvalho, E. M., & Cassali, G. D. 
(2009). Schistosoma mansoni antigens modulate experimental allergic asthma in 
a murine model: a major role for CD4+ CD25+ Foxp3+ T cells independent of 
interleukin-10. Infection and Immunity, 77(1), 98-107. 
Paganin, F., Trussard, V., Seneterre, E., Chanez, P., Giron, J., Godard, P., Sénac, J. P., 
Michel, F. B., & Bousquet, J. (1992). Chest radiography and high resolution 
computed tomography of the lungs in asthma. American Review of Respiratory 
Disease, 146(4), 1084-1087. 
 96 
 
Panzani, R. C., & Ariano, R. (2001). Arthropods and invertebrates allergy (with the 
exclusion of mites): the concept of panallergy. Allergy, 56, 1-22. 
Parker, E. A., Israel, B. A., Williams, M., Brakefield-Caldwell, W., Lewis, T. C., 
Robins, T., Ramirez, E., Rowe, Z., & Keeler, G. (2003). Community action 
against asthma. Journal of General Internal Medicine, 18(7), 558-567. 
Paul, W. E. (2003). Fundamental immunology (5th ed.). Philadelphia: Lippincott 
Williams & Wilkins. 
Pavord, I. D. (2007). Non-eosinophilic asthma and the innate immune response. Thorax, 
62(3), 193-194. 
Payne, R. W., Harding, S. A., Murray, D. A., Soutar, D. M., Baird, D. B., Glaser, A. I., 
Channing, I. C., Welham, S. J., Gilmour, A. R., Thompson, R., & Webster, R. 
(2009). The Guide to GenStat® Release 12: Part 2. Unpublished manuscript, 
Hemel Hempstead. 
Pearce, A. I., Richards, R. G., Milz, S., Schneider, E., & Pearce, S. G. (2007a). Animal 
models for implant biomaterial research in bone: a review. European Cells and 
Materials, 13, 1-10. 
Pearce, N. (1999). Epidemiology as a population science. International Journal of 
Epidemiology, 28(5), S1015-1018. 
Pearce, N., Beasley, R., & Pekkanen, J. (2000a). Role of bronchial responsiveness 
testing in asthma prevalence surveys. Thorax, 55(5), 352-354. 
doi:10.1136/thorax.55.5.352 
Pearce, N., Beasley, R., Burgess, C., & Crane, J. (1998). Asthma epidemiology: 
Principles and methods. New York: Oxford University Press. 
Pearce, N., Beasley, R., Crane, J., Burgess, C., & Jackson, R. (1995). End of the New 
Zealand asthma mortality epidemic. The Lancet, 345(8941), 41-44. 
doi:10.1016/s0140-6736(95)91159-6 
Pearce, N., Aït-Khaled, N., Beasley, R., Mallol, J., Keil, U., Mitchell, E., & Robertson, 
C. (2007b). Worldwide trends in the prevalence of asthma symptoms: phase III 
of the International Study of Asthma and Allergies in Childhood (ISAAC). 
Thorax, 62(9), 758-766. 
Pearce, N., Sunyer, J., Cheng, S., Chinn, S., Bjorksten, B., Burr, M., Keil, U., Anderson, 
H. R., & Burney, P. (2000b). Comparison of asthma prevalence in the ISAAC 
and the ECRHS. ISAAC steering committee and the European community 
respiratory health survey. International study of asthma and allergies in 
childhood. European Respiratory Journal, 16(3), 420-426. 
Peat, J. K., Tovey, E., Toelle, B. G., Haby, M. M., Gray, E. J., Mahmic, A., & 
Woolcock, A. J. (1996). House dust mite allergens. A major risk factor for 
childhood asthma in Australia. American Journal of Respiratory and Critical 
Care Medicine, 153(1), 141-146. 
Pemberton, A. D., McAleese, S. M., Huntley, J. F., Collie, D. D., Scudamore, C. L., 
McEuen, A. R., Walls, A. F., & Miller, H. R. (2000). cDNA sequence of two 
sheep mast cell tryptases and the differential expression of tryptase and sheep 
mast cell proteinase-1 in lung, dermis and gastrointestinal tract. Clinical and 
Experimental Allergy, 30, 818 - 832. 
Picher, M., Boucher, R. C. C., Thompson, L. F., & Blackburn, M. R. (2011). Animal 
Models of Airway Diseases. In J. R. Harris (Series Ed.), Purinergic Regulation 
of Respiratory Diseases (55 ed., pp. 195-234): Springer Netherlands. 
doi:10.1007/978-94-007-1217-1_8 
Pinelli, E., Dormans, J., Fonville, M., & Van der Giessen, J. (2001). A comparative 
study of toxocariasis and allergic asthma in murine models. Journal of 
Helminthology, 75(02), 137-140. 
 97 
 
Pinelli, E., Withagen, C., Fonville, M., Verlaan, A., Dormans, J., Van Loveren, H., 
Nicoll, G., Maizels, R. M., & Van Der Giessen, J. (2005). Persistent airway 
hyper-responsiveness and inflammation in Toxocara canis infected BALB/c 
mice. Clinical & Experimental Allergy, 35(6), 826-832. 
Pizzichini, E., Pizzichini, M. M., Efthimiadis, A., Dolovich, J., & Hargreave, F. E. 
(1997). Measuring airway inflammation in asthma: Eosinophils and eosinophilic 
cationic protein in induced sputum compared with peripheral blood. Journal of 
Allergy and Clinical Immunology, 99(4), 539-544. doi:10.1016/s0091-
6749(97)70082-4 
Plager, D. A., Loegering, D. A., Checkel, J. L., Tang, J., Kephart, G. M., Caffes, P. L., 
Adolphson, C. R., Ohnuki, L. E., & Gleich, G. J. (2006). Major basic protein 
homolog (MBP2): A specific human eosinophil marker. Journal of Immunology, 
177(10), 7340-7345. 
Platts-Mills, T. A. (1994). How environment affects patients with allergic disease: 
Indoor allergen and asthma. Annals of Allergy, 72(4), 381-384. 
Platts-Mills, T. A. E. (2001). The role of immunoglobulin E in allergy and asthma. 
American Journal of Respiratory and Critical Care Medicine, 164(8), S1-5. 
Platts-Mills, T. A. E., Erwin, E., Heymann, P., & Woodfolk, J. (2005). Is the hygiene 
hypothesis still a viable explanation for the increased prevalence of asthma? 
Allergy, 60, 25-31. doi:10.1111/j.1398-9995.2005.00854.x 
Platts-Mills, T. A. E., Vervloet, D., Thomas, W. R., Aalberse, R. C., & Chapman, M. D. 
(1997). Indoor allergens and asthma: report of the third international workshop. 
Journal of Allergy and Clinical Immunology, 100(6), S1-S24. 
Poitras, B. J., Miller, R. B., Wilkie, B. N., & Bosu, W. T. (1986 ). The maternal to fetal 
transfer of immunoglobulins associated with placental lesions in sheep. 
Canadian Journal of Veterinary Research, 50(1), 68-73. 
Pollard, J. C. (2006). Shelter for lambing sheep in New Zealand: a review. New Zealand 
Journal of Agricultural Research, 49(4), 395-404. 
Postma, D. S., Bleecker, E. R., Amelung, P. J., Holroyd, K. J., Xu, J., Panhuysen, C. I. 
M., Meyers, D. A., & Levitt, R. C. (1995). Genetic susceptibility to asthma - 
Bronchial hyperresponsiveness coinherited with a major gene for atopy. New 
England Journal of Medicine, 333(14), 894-900. 
doi:10.1056/nejm199510053331402 
Power, C. A., Wei, G., & Bretscher, P. A. (1998). Mycobacterial dose defines the 
Th1/Th2 nature of the immune response independently of whether immunization 
is administered by the intravenous, subcutaneous, or intradermal route. Infection 
and Immunity, 66(12), 5743-5750. 
Press, C. M., McCullagh, P., & Landsverk, T. (2001). Effect of early fetal splenectomy 
on prenatal B-cell development in sheep. Immunology, 102(2), 131-136. 
Prien, T., Traber, D. L., Linares, H. A., & Davenport, S. L. (1988). Haemolysis and 
artifactual lung damage induced by an euthanasia agent. Laboratory Animals, 
22(2), 170-172. 
Rabe, K. F., Vermeire, P. A., Soriano, J. B., & Maier, W. C. (2000). Clinical 
management of asthma in 1999: The asthma insights and reality in Europe 
(AIRE) study. European Respiratory Journal, 16(5), 802-807. 
Reynolds, L. P., Borowicz, P. P., Vonnahme, K. A., Johnson, M. L., Grazul-Bilska, A. 
T., Redmer, D. A., & Caton, J. S. (2005a). Placental angiogenesis in sheep 
models of compromised pregnancy. Journal of Physiology, 565, 43–58. 
Reynolds, L. P., Borowicz, P. P., Vonnahme, K. A., Johnson, M. L., Grazul-Bilska, A. 
T., Wallace, J. M., Caton, J. S., Redmer, D. A., & (2005b). Animal models of 
placental angiogenesis. Placenta, (26), 689–708. 
 98 
 
Reynolds, L. P., Caton, J. S., Redmer, D. A., Grazul‐Bilska, A. T., Vonnahme, K. A., 
Borowicz, P. P., Luther, J. S., Wallace, J. M., Wu, G., & Spencer, T. E. (2006). 
Evidence for altered placental blood flow and vascularity in compromised 
pregnancies. Journal of Physiology, 572(1), 51-58. 
Rice, A. J., Reynolds, P. N., Reynolds, A. M., Holmes, M. D., & Scicchitano, R. (2001). 
Tachykinin induced bronchoconstriction in sheep is NK 1 receptor mediated and 
exhibits tachyphylaxis. Respirology, 6(2), 113-123. 
Riedler, J., Braun-Fahrländer, C., Eder, W., Schreuer, M., Waser, M., Maisch, S., Carr, 
D., Schierl, R., Nowak, D., & von Mutius, E. (2001). Exposure to farming in 
early life and development of asthma and allergy: a cross-sectional survey. The 
Lancet, 358(9288), 1129-1133. doi:10.1016/s0140-6736(01)06252-3 
Robertson, L. J. G., Morton, J. D., Yamaguchi, M., Bickerstaffe, R., Shearer, T. R., & 
Azuma, M. (2005). Calpain may contribute to hereditary cataract formation in 
sheep. Investigative ophthalmology & visual science, 46(12), 4634-4640. 
Robinson, C., & Bowie, J. (2004). Aspin Sheep IgE ELISA. Unpublished manuscript, 
Palmerston North. 
Robinson, D. S. (2010). The role of the T cell in asthma. Journal of Allergy and Clinical 
Immunology, 126(6), 1081-1091. 
Roitt, I. M., Brostoff, J., & Male, D. (1996). Immunology (4 ed.). Barcelona: Mosby. 
Sandford, A. J., & Pare, P. D. (2000). The genetics of asthma . The important questions. 
American Journal of Respiratory and Critical Care Medicine, 161(3), 202S-206. 
Sanger, M. E., Doyle, R. E., Hinch, G. N., & Lee, C. (2011). Sheep exhibit a positive 
judgement bias and stress-induced hyperthermia following shearing. Applied 
Animal Behaviour Science, 131(3), 94-103. 
SAS Institute Inc. (2008). User’s Guide. Cary, NC, USA: SAS Institute. 
Scheerlinck, J. P. Y., Snibson, K. J., Bowles, V. M., & Sutton, P. (2008). Biomedical 
applications of sheep models: from asthma to vaccines. Trends in 
Biotechnology, 26(5), 259-266. 
Schulz, O., Sewell, H. F., & Shakib, F. (1998). Proteolytic cleavage of CD25, the α 
subunit of the human T cell interleukin 2 receptor, by Der p 1, a major mite 
allergen with cysteine protease activity. Journal of Experimental Medicine, 
187(2), 271-275. doi:10.1084/jem.187.2.271 
Schuster, M., Tschernig, T., Krug, N., & Pabst, R. (2000). Lymphocytes migrate from 
the blood into the bronchoalveolar lavage and lung parenchyma in the asthma 
model of the brown Norway rat. American Journal of Respiratory and Critical 
Care Medicine, 161(2), 558-566. 
Scrivener, S., Yemaneberhan, H., Zebenigus, M., Tilahun, D., Girma, S., Ali, S., 
McElroy, P., Custovic, A., Woodcock, A., Pritchard, D., Venn, A., & Britton, J. 
(2001). Independent effects of intestinal parasite infection and domestic allergen 
exposure on risk of wheeze in Ethiopia: A nested case-control study. The 
Lancet, 358(9292), 1493-1499. doi:10.1016/s0140-6736(01)06579-5 
Sharma, R. L., Bhat, T. K., & Dhar, D. N. (1989). Effect of Dictyocaulus filaria 
infection on the osmotic fragility of sheep erythrocytes. Veterinary Parasitology, 
30(3), 253-258. doi:10.1016/0304-4017(89)90020-4 
Shaw, R. J., Gatehouse, T. K., & McNeill, M. M. (1998). Serum IgE responses during 
primary and challenge infections of sheep with Trichostrongylus colubriformis. 
International Journal for Parasitology, 28(2), 293-302. 
Shaw, R. J., McNeill, M. M., Gatehouse, T. K., & Douch, P. G. C. (1997). 
Quantification of total sheep IgE concentration using anti-ovine IgE monoclonal 
antibodies in an enzyme immunoassay. Veterinary Immunology and 
Immunopathology, 57(3-4), 253-265. 
 99 
 
Shirakawa, T., Deichmann, K. A., Izuhara, K., Mao, X.-Q., Adra, C. N., & Hopkin, J. 
M. (2000). Atopy and asthma: Genetic variants of IL-4 and IL-13 signalling. 
Immunology Today, 21(2), 60-64. doi:10.1016/s0167-5699(99)01492-9 
Silberman, D. M., Wald, M. R., & Genaro, A. M. (2003). Acute and chronic stress exert 
opposing effects on antibody responses associated with changes in stress 
hormone regulation of T-lymphocyte reactivity. Journal of Neuroimmunology, 
144(1), 53-60. 
Silverstein, A. M., Uhr, J. W., Kraner, K. L., & Lukes, R. J. (1963). Fetal response to 
antigenic stimulus: Antibody production by fetal lamb. Journal of Experimental 
Medicine, 117(5), 799-812. doi:10.1084/jem.117.5.799 
Simpson, J. L., Grissell, T. V., Douwes, J., Scott, R. J., Boyle, M. J., & Gibson, P. G. 
(2007). Innate immune activation in neutrophilic asthma and bronchiectasis. 
Thorax, 62(3), 211-218. doi:10.1136/thx.2006.061358 
Sleiman, P. M. A., Flory, J., Imielinski, M., Bradfield, J. P., Annaiah, K., Willis-Owen, 
S. A. G., Wang, K., Rafaels, N. M., Michel, S., & Bonnelykke, K. (2010). 
Variants of DENND1B associated with asthma in children. New England 
Journal of Medicine, 362(1), 36-44. 
Smith, H. (1992). Asthma, inflammation, eosinophils and bronchial 
hyperresponsiveness. Clinical and Experimental Allergy, 22(2), 187-197. 
Smith, H. A., Jones, T. C., & Hunt, R. D. (1972). Veterinary pathology (4th ed.). 
Philadelphia: Lea & Fabiger. 
Snibson, K. J., Bischof, R. J., Slocombe, R. F., & Meeusen, E. N. (2005). Airway 
remodelling and inflammation in sheep lungs after chronic airway challenge 
with house dust mite. Clinical and Experimental Allergy, 35, 146-152. 
Solé, D., Melo, K. C., Camelo-Nunes, I. C., Freitas, L. S., Britto, M., Rosário, N. A., 
Jones, M., Fischer, G. B., & Naspitz, C. K. (2007). Changes in the prevalence of 
asthma and allergic diseases among Brazilian schoolchildren (13–14 years old): 
comparison between ISAAC Phases One and Three. Journal of Tropical 
Pediatrics, 53(1), 13-21. 
Sporik, R., Chapman, M. D., & Platts-Mills, T. A. E. (1992). House dust mite exposure 
as a cause of asthma. Clinical and Experimental Allergy, 22(10), 897-906. 
doi:doi:10.1111/j.1365-2222.1992.tb02062.x 
Sporik, R., Holgate, S. T., Platts-Mills, T. A., & Cogswell, J. J. (1990 ). Exposure to 
house-dust mite allergen (Der p I) and the development of asthma in childhood. 
A prospective study. New England Journal of Medicine, 323( 8 ), 502-507  
Sporik, R., Ingram, J. M., Price, W., Sussman, J. H., Honsinger, R. W., & Platt-Mills, T. 
A. (1995). Association of asthma with serum IgE and skin test reactivity to 
allergens among children living at high altitude. Tickling the dragon's breath. 
American Journal of Respiratory and Critical Care Medicine, 151(5), 1388-
1392. 
Stewart, G. A., & Fisher, W. F. (1986 ). Cross-reactivity between the house dust mite 
Dermatophagoides pteronyssinus and the mange mites Psoroptes cuniculi and 
P. ovis. I. Demonstration of antibodies to the house dust mite allergen Dpt 12 in 
sera from P. cuniculi-infested rabbits. Journal of Allergy and Clinical 
Immunology, 78(2), 293-299. 
Strachan, D. P. (1989). Hay fever, hygiene, and household size. British Medical 
Journal, 299(6710), 1259-1260. 
Strachan, D. P., Anderson, H. R., Limb, E. S., O'Neill, A., & Wells, N. (1994). A 
national survey of asthma prevalence, severity, and treatment in Great Britain. 
Archives of Disease in Childhood, 70(3), 174. 
Sumi, Y., & Hamid, Q. (2007). Airway remodeling in asthma. Allergology 
International, 56, 341-348. doi:10.2332/allergolint.R-07-153 
 100 
 
Sur, S., Wild, J. S., Choudhury, B. K., Sur, N., Alam, R., & Klinman, D. M. (1999). 
Long term prevention of allergic lung inflammation in a mouse model of asthma 
by CpG oligodeoxynucleotides. Immunology, 162(10), 6284-6293. 
Temelkovski, J., Hogan, S. P., Shepherd, D. P., Foster, P. S., & Kumar, R. K. (1998). 
An improved murine model of asthma: selective airway inflammation, epithelial 
lesions and increased methacholine responsiveness following chronic exposure 
to aerosolised allergen. Thorax, 53(10), 849. 
Theisen, M., Dodoo, D., Toure-Balde, A., Soe, S., Corradin, G., Koram, K. K., 
Kurtzhals, J. A. L., Hviid, L., Theander, T., & Akanmori, B. (2001). Selection of 
glutamate-rich protein long synthetic peptides for vaccine development: 
antigenicity and relationship with clinical protection and immunogenicity. 
Infection and Immunity, 69(9), 5223-5229. 
Thorndike, E. A., & Turner, A. S. (1998). In search of an animal model for 
postmenopausal diseases. Frontiers in Bioscience, 3, c17-26. 
Thornton, R. N., Thompson, E. J., & Dubey, J. P. (1991). Neospora abortion in New 
Zealand cattle. New Zealand Veterinary Journal, 39(4), 129-133. 
Tournoy, K. G., Kips, J. C., Schou, C., & Pauwels, R. A. (2000). Airway eosinophilia is 
not a requirement for allergen-induced airway hyperresponsiveness. Clinical and 
Experimental Allergy, 30(1), 79-85. 
Tran, N. D., Porada, C. D., Almeida-Porada, G., Glimp, H. A., Anderson, W. F., & 
Zanjani, E. D. (2001). Induction of stable prenatal tolerance to β-galactosidase 
by in utero gene transfer into preimmune sheep fetuses. Blood, 97(11), 3417-
3423. 
Tschernig, T., Neumann, D., Pich, A., Dorsch, M., & Pabst, R. (2008). Experimental 
bronchial asthma - the strength of the species rat. Current Drug Targets, 9, 466-
469. 
Turner, J. D., Faulkner, H., Kamgno, J., Kennedy, M. W., Behnke, J., Boussinesq, M., 
& Bradley, J. E. (2005). Allergen-specific IgE and IgG4 are markers of 
resistance and susceptibility in a human intestinal nematode infection. Microbes 
and Infection, 7(7), 990-996. 
Urquhart, G., Armour, J., Duncan, J., Dunn, A., & Jennings, F. (1987). Veterinary 
Parasitology (1 ed.). New York: Churchhill Livingstone Inc. 
van den Biggelaar, A. H. J., Rodrigues, L. C., van Ree, R., van der Zee, J. S., Hoeksma-
Kruize, Y. C. M., Souverijn, J. H. M., Missinou, M. A., Borrmann, S., 
Kremsner, P. G., & Yazdanbakhsh, M. (2004). Long-term treatment of intestinal 
helminths increases mite skin-test reactivity in Gabonese schoolchildren. 
Journal of Infectious Diseases, 189, 892–900  
van den Biggelaar, A. H. J., Lopuhaa, C., van Ree, R., van der Zee, J., S , Jans, J., Hoek, 
A., Migombet, B., Borrmann, S., Luckner, D., Kremsner, P., G , & 
Yazdanbakhsh, M. (2001). The prevalence of parasite infestation and house dust 
mite sensitization in Gabonese schoolchildren. International Archives of Allergy 
and Immunology, 126(3), 231. 
Vignola, A. M., Kips, J., & Bousquet, J. (2000). Tissue remodeling as a feature of 
persistent asthma. Journal of Allergy and Clinical Immunology, 105(6), 1041-
1053. doi:10.1067/mai.2000.107195 
von Mutius, E. (2002). Environmental factors influencing the development and 
progression of pediatric asthma. Journal of Allergy and Clinical Immunology, 
109(6, Part 2), 525-532. doi:10.1067/mai.2002.124565 
von Mutius, E., Martinez, F. D., Fritzsch, C., Nicolai, T., Roell, G., & Thiemann, H. H. 
(1994). Prevalence of asthma and atopy in two areas of West and East Germany. 
American Journal of Respiratory and Critical Care Medicine, 149(2), 358-364. 
 101 
 
Wahn, U., Lau, S., Bergmann, R., Kulig, M., Forster, J., Bergmann, K., Bauer, C.-P., & 
Guggenmoos-Holzmann, I. (1997). Indoor allergen exposure is a risk factor for 
sensitization during the first three years of life. Journal of Allergy and Clinical 
Immunology, 99(6), 763-769. 
Waite, D., Eyles, E., Tonkin, S., & O'Donnel, T. (2006). Asthma prevalence in 
Tokelauan children in two environments. Clinical and Experimental Allergy, 
10(1), 71-75. 
Walther, S. M., Domino, K. B., Glenny, R. W., & Hlastala, M. P. (1997). Pulmonary 
blood flow distribution in sheep: effects of anesthesia, mechanical ventilation, 
and change in posture. Anesthesiology, 87(2), 335. 
Wang, C. C., Nolan, T. J., Schad, G. A., & Abraham, D. (2001). Infection of mice with 
the helminth Strongyloides stercoralis suppresses pulmonary allergic responses 
to ovalbumin. Clinical and Experimental Allergy, 31(3), 495-503. 
Wanner, A., & Abraham, W. (1982). Experimental models of asthma. Lung, 160(1), 
231-243. doi:10.1007/bf02719297 
Waser, M., Schierl, R., Maisch, S., Carr, D., Riedler, J., Eder, W., Schreuer, M., 
Nowak, D., & Braun‐fahrländer, C. (2004). Determinants of endotoxin levels in 
living environments of farmers' children and their peers from rural areas. 
Clinical & Experimental Allergy, 34(3), 389-397. 
Watson, D. L. (1992). Biological half-life of ovine antibody in neonatal lambs and adult 
sheep following passive immunization. Veterinary Immunology and 
Immunopathology, 30(2-3), 221-232. doi:10.1016/0165-2427(92)90140-l 
Weeth, H. J., Torell, C. R., & Cassard, D. W. (1959). Effects of a simulated snowbound 
stress condition on ewes. Journal of Animal Science, 18(2), 694-700. 
Weiland, S., Husing, A., Strachan, D., Rzehak, P., & Pearce, N. (2004). Climate and the 
prevalence of symptoms of asthma, allergic rhinitis, and atopic eczema in 
children. Occupational and Environmental Medicine, 61(7), 609-615. 
Welch, R. A. S., & Kilgour, R. (1970). Mis-mothering among Romneys. New Zealand 
Journal of Agricultural Research, 121(4), 26-27. 
Wenzel, S. E., & Holgate, S. T. (2006). The mouse trap: It still yields few answers in 
asthma. American Journal of Respiratory and Critical Care Medicine, 174(11), 
1173-1176. doi:10.1164/rccm.2609002 
Wheeldon, E. B., & Hansen-Flaschen, J. H. (1986). Intravascular macrophages in the 
sheep lung. Journal of Leukocyte Biology, 40(5), 657-661. 
Wickens, K., Douwes, J., Siebers, R., Fitzharris, P., Wouters, I., Doekes, G., Mason, K., 
Hearfield, M., Cunningham, M., & Crane, J. (2003). Determinants of endotoxin 
levels in carpets in New Zealand homes. Indoor Air, 13(2), 128-135. 
doi:10.1034/j.1600-0668.2003.00187.x 
Wiegand, T. W., Williams, P. B., Dreskin, S. C., Jouvin, M. H., Kinet, J. P., & Tasset, 
D. (1996). High-affinity oligonucleotide ligands to human IgE inhibit binding to 
Fc epsilon receptor I. Journal of Immunology, 157(1), 221-230. 
Williams, R. H., Morley, E. K., Hughes, J. M., Duncanson, P., Terry, R. S., Smith, J. E., 
& Hide, G. (2005). High levels of congenital transmission of Toxoplasma gondii 
in longitudinal and cross-sectional studies on sheep farms provides evidence of 
vertical transmission in ovine hosts. Parasitology, 130(03), 301-307. 
doi:doi:10.1017/S0031182004006614 
Williamson, I. J., Martin, C. J., McGill, G., Monie, R. D., & Fennerty, A. G. (1997). 
Damp housing and asthma: A case-control study. Thorax, 52(3), 229-234. 
doi:10.1136/thx.52.3.229 
Wills-Karp, M., Santeliz, J., & Karp, C. L. (2001). The germless theory of allergic 
disease: revisiting the hygiene hypothesis. Nature Reviews. Immunology, 1(1), 
69-75. 
 102 
 
Wilson, D. R., Merrett, T. G., Varga, E. M., Smurthwaite, L., Gould, H. J., Kemp, M., 
Hooper, J., Till, S. J., & Durham, S. R. (2002). Increases in allergen-specific IgE 
in BAL after segmental allergen challenge in atopic asthmatics. American 
Journal of Respiratory and Critical Care Medicine, 165, 22 - 26. 
Wong, G. W. K., Leung, T. F., & Fok, T. F. (2004). ISAAC and risk factors for asthma 
in the Asia-Pacific. Paediatric Respiratory Reviews, 5, S163-169. 
Yang, J., Zhao, J., Yang, Y., Zhang, L., Yang, X., Zhu, X., Ji, M., Sun, N., & Su, C. 
(2007). Schistosoma japonicum egg antigens stimulate CD4+ CD25+ T cells and 
modulate airway inflammation in a murine model of asthma. Immunology, 
120(1), 8-18. doi:10.1111/j.1365-2567.2006.02472.x 
Yazdanbakhsh, M., Kremsner, P. G., & van Ree, R. (2002). Allergy, parasites, and the 
hygiene hypothesis. Science, 296(5567), 490-494. 
Yu, M., Tsai, M., Tam, S., Jones, C., Zehnder, J., & Galli, S. J. (2006). Mast cells can 
promote the development of multiple features of chronic asthma in mice. 
Journal of Clinical Investigation, 116(6), 1633. 
Yu, P., Kosco-Vilbois, M., Richards, M., Köhler, G., & Lamers, M. C. (1994). Negative 
feedback regulation of IgE synthesis by murine CD23. Nature, 369(6483), 753-
756. 
Zaccone, P., Fehervari, Z., Phillips, J. M., Dunne, D. W., & Cooke, A. (2006). Parasitic 
worms and inflammatory diseases. Parasite Immunology, 28(10), 515-523. 
doi:10.1111/j.1365-3024.2006.00879.x 
Zamel, N., McClean, P. A., Sandell, P. R., Siminovitch, K. A., & Slutsky, A. S. (1996). 
Asthma on Tristan da Cunha: Looking for the genetic link. The University of 
Toronto Genetics of Asthma Research Group. American Journal of Respiratory 
and Critical Care Medicine, 153(6), 1902-1906. 
 
 
  
 103 
 
     Appendix A 
Histological lung score.  
Sheep Group 
Lung 
side 
Slide # 
Perivascular section (score 0=4) Peribronchial section (score 0-4) Total 
score 1 2 3 4 Average 1 2 3 4 Average 
489 c/hdm left 09-119 0.5 2 1 1 1.13 1.5 1 1 1 1.13 2.25 
489 c/hdm right 09-120 0.5 0.5 0 0.5 0.38 0.5 0.5 1 0.5 0.63 1.00 
435 c/hdm left 09-123 4 4 4  4.00 4 4 4  4.00 8.00 
435 c/hdm right 09-124 2 0   1.00 2 0   1.00 2.00 
491 c/hdm left 09-151 3 1 1.5  1.83 3 1 1.5  1.83 3.67 
491 c/hdm right 09-152 0 0.5 0  0.17 0 0.5 0  0.17 0.33 
436 hdm left 09-117 4 4   4.00 4 4   4.00 8.00 
436 hdm right 09-118 1 0.5 0  0.50 1 0.5 0  0.50 1.00 
493 hdm left 09-153 3 3 4  3.33 3 3 4  3.33 6.67 
493 hdm right 09-154 0.5 0.5 0.5  0.50 0.5 0 0.5  0.33 0.83 
429 hdm left 09-167 1.5 1   1.25 1.5 1   1.25 2.50 
429 hdm right 09-168 0.5 0   0.25 0.5 0   0.25 0.50 
496 hdm left 09-147 0 2   1.00 0.5 2   1.25 2.25 
496 hdm right 09-148 0 0 0  0.00 0 0 0  0.00 0.00 
492 c/tcl left 09-159 4 1.5   2.75 4 1.5   2.75 5.50 
492 c/tcl right 09-160 0 1.5   0.75 0 1.5   0.75 1.50 
438 c/tcl left 09-175 1 1 0  0.67 1 1 0  0.67 1.33 
438 c/tcl right 09-176 0 0 0.5  0.17 0 0 0.5  0.17 0.33 
483 tcl left 09-163 1.5 0 0  0.50 1.5 0 0  0.50 1.00 
483 tcl right 09-164 0 0 0  0.00 0 0 0  0.00 0.00 
433 tcl left 09-165 0.5 0.5 0.5  0.50 1.5 0.5 0.5  0.83 1.33 
433 tcl right 09-166 0 1.5   0.75 0 1.5   0.75 1.50 
434 tcl left 09-121 4 3 1  2.67 4 3 1  2.67 5.33 
434 tcl right 09-122 4 2 1  2.33 4 2 1  2.33 4.67 
486 c/pntcl left 09-149 4 1 1.5  2.17 4 1 1.5  2.17 4.33 
486 c/pntcl right 09-150 0.5 0 3  1.17 0.5 0 3  1.17 2.33 
487 c/pntcl left 09-161 4 0 0  1.33 4 0 0  1.33 2.67 
487 c/pntcl right 09-162 4 3 0  2.33 4 3 0  2.33 4.67 
432 c/pntcl left 09-173 0.5 4 0.5  1.67 0.5 4 0.5  1.67 3.33 
432 c/pntcl right 09-174 0.5 1.5 0.5 0 0.63 0.5 1.5 0.5 0 0.63 1.25 
490 pntcl left 09-155 4 0 0  1.33 4 0 0  1.33 2.67 
490 pntcl right 09-156 4 2   3.00 4 2   3.00 6.00 
437 pntcl left 09-115 4 0.5 1  1.83 4 1 1  2.00 3.83 
437 pntcl right 09-116 0 0.5 1.5  0.67 0 0.5 1.5  0.67 1.33 
499 pntcl left 09-177 1.5 0.5 0.5 0.5 0.75 2 0.5 0.5 0.5 0.88 1.63 
499 pntcl right 09-178 0 4 0  1.33 0 4 0  1.33 2.67 
500 pntcl left 09-133 0.5 1.5 0.5  0.83 0.5 1.5 0.5  0.83 1.67 
500 pntcl right 09-134 2.5 0.5 2.5  1.83 2.5 0.5 2.5  1.83 3.67 
440 pntcl left 09-135 1 4 0.5  1.83 1 4 0.5  1.83 3.67 
440 pntcl right 09-136 4 0.5 0  1.50 4 0.5 0  1.50 3.00 
480 pntcl left 09-125 3 2 2  2.33 3 2 2  2.33 4.67 
480 pntcl right 09-126 0 1 0.5  0.50 0 1 0.5  0.50 1.00 
716 m left 09-127 4 4 4  4.00 4 4 4  4.00 8.00 
716 m right 09-128 4 4 4  4.00 4 4 4  4.00 8.00 
923 m left 09-131 3 3 3  3.00 3 3 3  3.00 6.00 
923 m right 09-132 3 3   3.00 3 3   3.00 6.00 
251 m left 09-137 4 4 4  4.00 4 4 4  4.00 8.00 
251 m right 09-138 0.5 0 0.5 0 0.25 0.5 0 0.5 0 0.25 0.50 
593 m left 09-139 0 3 0.5 0.5 1.00 0 3 0.5 0.5 1.00 2.00 
593 m right 09-140 0.5 0.5 0.5  0.50 0.5 0.5 0.5  0.50 1.00 
338 m left 09-145 2 3 3 2.5 2.63 2 3 3 1 2.25 4.88 
338 m right 09-146 1 0.5 0.5  0.67 1 0.5 0.5  0.67 1.33 
485 c/c left 09-113 0.5 0.5 1  0.67 1 0.5 1  0.83 1.50 
485 c/c right 09-114 0 0 0 0 0.00 0 0 0 0 0.00 0.00 
482 c/c left 09-129 2.5 4 4  3.50 2.5 4 4  3.50 7.00 
482 c/c right 09-130 3 1   2.00 3 1   2.00 4.00 
484 c/c left 09-169 0.5 1.5   1.00 0.5 1.5   1.00 2.00 
484 c/c right 09-170 0.5 0.5 0.5 0 0.38 0.5 0.5 0.5 0 0.38 0.75 
441 c/c left 09-171 4 0.5 0  1.50 4 0.5 0  1.50 3.00 
441 c/c right 09-172 4 0 0  1.33 4 0 0  1.33 2.67 
497 c/c left 09-157 4 2 1.5  2.50 4 2 1.5  2.50 5.00 
497 c/c right 09-158 0.5 0.5 1.5 1.5 1.00 0.5 0.5 1.5 1.5 1.00 2.00 
495 c/c left 09-141 4 0.5   2.25 4 0.5   2.25 4.50 
495 c/c right 09-142 3 0.5 0  1.17 1 0.5 0  0.50 1.67 
714 c/c left 09-143 2 1.5 0 1.5 1.25 2 1.5 0 1.5 1.25 2.50 
714 c/c right 09-144 0 0 0 0.5 0.13 0 0 0 1.5 0.38 0.50 
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